3M CO, 8-K filed on 5/17/2010
Current report filing
Consolidated Statement of Income (USD $)
In Millions, except Share and Per Share data
Year Ended
Dec. 31,
2009
2008
2007
Consolidated Statement of Income
 
 
 
Net sales
$ 23,123 
$ 25,269 
$ 24,462 
Operating expenses
 
 
 
Cost of sales
12,109 
13,379 
12,735 
Selling, general and administrative expenses
4,907 
5,245 
5,015 
Research, development and related expenses
1,293 
1,404 
1,368 
(Gain)/loss from sale of businesses
 
23 
(849)
Total operating expenses
18,309 
20,051 
18,269 
Operating income
4,814 
5,218 
6,193 
Interest expense and income
 
 
 
Interest expense
219 
215 
210 
Interest income
(37)
(105)
(132)
Total interest expense (income)
182 
110 
78 
Income before income taxes
4,632 
5,108 
6,115 
Provision for income taxes
1,388 
1,588 
1,964 
Net income including noncontrolling interest
3,244 
3,520 
4,151 
Less: Net income attributable to noncontrolling interest
51 
60 
55 
Net income attributable to 3M
3,193 
3,460 
4,096 
Weighted average 3M common shares outstanding - basic (in shares)
700,500,000 
699,200,000 
718,300,000 
Earnings per share attributable to 3M common shareholders - basic (in dollars per share)
4.56 
4.95 
5.70 
Weighted average 3M common shares outstanding - diluted (in shares)
706,700,000 
707,200,000 
732,000,000 
Earnings per share attributable to 3M common shareholders - diluted (in dollars per share)
4.52 
4.89 
5.60 
Cash dividends paid per 3M common share (in dollars per share)
2.04 
2.00 
1.92 
Consolidated Balance Sheet (USD $)
In Millions
Dec. 31, 2009
Dec. 31, 2008
Assets:
 
 
Current assets
 
 
Cash and cash equivalents
$ 3,040 
$ 1,849 
Marketable securities - current
744 
373 
Accounts receivable - net of allowances of $109 and $85
3,250 
3,195 
Inventories
 
 
Finished goods
1,255 
1,505 
Work in process
815 
851 
Raw materials and supplies
569 
657 
Total inventories
2,639 
3,013 
Other current assets
1,122 
1,168 
Total current assets
10,795 
9,598 
Marketable securities - non-current
825 
352 
Investments
103 
111 
Property, plant and equipment
19,440 
18,812 
Less: Accumulated depreciation
(12,440)
(11,926)
Property, plant and equipment - net
7,000 
6,886 
Goodwill
5,832 
5,753 
Intangible assets - net
1,342 
1,398 
Prepaid pension benefits
78 
36 
Other assets
1,275 
1,659 
Total assets
27,250 
25,793 
Liabilities and Equity
 
 
Liabilities:
 
 
Current liabilities
 
 
Short-term borrowings and current portion of long-term debt
613 
1,552 
Accounts payable
1,453 
1,301 
Accrued payroll
680 
644 
Accrued income taxes
252 
350 
Other current liabilities
1,899 
1,992 
Total current liabilities
4,897 
5,839 
Long-term debt
5,097 
5,166 
Pension and postretirement benefits
2,227 
2,847 
Other liabilities
1,727 
1,637 
Total liabilities
13,948 
15,489 
Commitments and contingencies (Note 14)
 
 
Common stock, par value $.01 per share. Shares outstanding - 2009: 710,599,119, Shares outstanding - 2008: 693,543,287
Additional paid-in capital
3,153 
3,006 
Retained earnings
23,753 
22,227 
Treasury stock
(10,397)
(11,676)
Unearned compensation
 
(40)
Accumulated other comprehensive income (loss)
(3,754)
(3,646)
Total 3M Company shareholders' equity
12,764 
9,880 
Noncontrolling interest
538 
424 
Total equity
13,302 
10,304 
Total liabilities and equity
$ 27,250 
$ 25,793 
Consolidated Balance Sheet (Parenthetical) (USD $)
In Millions, except Share and Per Share data
Dec. 31, 2009
Dec. 31, 2008
Consolidated Balance Sheet
 
 
Allowance for doubtful accounts receivable
$ 109 
$ 85 
Common stock, par value (in dollars per share)
0.01 
0.01 
Common stock, shares outstanding
710,599,119 
693,543,287 
Consolidated Statement of Changes in Stockholders Equity (USD $)
In Millions
Common Stock and Additional Paid-in Capital
Retained Earnings
Treasury Stock
Unearned Compensation
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest
Comprehensive Income
Total
1/1/2007 - 12/31/2007
 
 
 
 
 
 
 
 
Balance
$ 2,493 1
$ 17,911 1
$ (8,456)
$ (115)
$ (1,873)
$ 278 1
 
$ 10,238 1
Net income including noncontrolling interest
 
4,096 
 
 
 
55 
 
4,151 
Cumulative translation adjustment
 
 
 
 
532 
16 
 
548 
Defined benefit pension and postretirement plans adjustment
 
 
 
 
614 
(4)
 
610 
Debt and equity securities, unrealized gain (loss)
 
 
 
 
(10)
 
 
(10)
Cash flow hedging instruments, unrealized gain (loss)
 
 
 
 
(10)
 
 
(10)
Total comprehensive income
 
 
 
 
 
 
5,289 
5,289 
Adjustment to initially apply guidance concerning uncertainty in income taxes
 
(1)
 
 
 
 
 
(1)
Dividends paid
 
(1,380)
 
 
 
(20)
 
(1,400)
Transfer to noncontrolling interest
 
 
 
 
 
 
 
 
Amortization of unearned compensation
 
 
 
36 
 
 
 
36 
Stock-based compensation, net of tax impacts
305 
 
 
 
 
 
 
305 
Reacquired stock
 
 
(3,237)
 
 
 
 
(3,237)
Issuances pursuant to stock option and benefit plans
 
(331)
1,160 
 
 
 
 
829 
Issuances pursuant to acquisitions
 
 
13 
 
 
 
 
13 
Balance
2,798 
20,295 
(10,520)
(79)
(747)
325 
 
12,072 
1/1/2008 - 12/31/2008
 
 
 
 
 
 
 
 
Balance
2,798 
20,295 
(10,520)
(79)
(747)
325 
 
12,072 
Net income including noncontrolling interest
 
3,460 
 
 
 
60 
 
3,520 
Cumulative translation adjustment
 
 
 
 
(888)
82 
 
(806)
Defined benefit pension and postretirement plans adjustment
 
 
 
 
(2,072)
(20)
 
(2,092)
Debt and equity securities, unrealized gain (loss)
 
 
 
 
(11)
 
 
(11)
Cash flow hedging instruments, unrealized gain (loss)
 
 
 
 
72 
 
 
72 
Total comprehensive income
 
 
 
 
 
 
683 
683 
Adjustment to initially apply guidance concerning uncertainty in income taxes
 
 
 
 
 
 
 
 
Dividends paid
 
(1,398)
 
 
 
(23)
 
(1,421)
Transfer to noncontrolling interest
 
 
 
 
 
 
 
 
Amortization of unearned compensation
 
 
 
39 
 
 
 
39 
Stock-based compensation, net of tax impacts
217 
 
 
 
 
 
 
217 
Reacquired stock
 
 
(1,603)
 
 
 
 
(1,603)
Issuances pursuant to stock option and benefit plans
 
(130)
447 
 
 
 
 
317 
Issuances pursuant to acquisitions
 
 
 
 
 
 
 
 
Balance
3,015 
22,227 
(11,676)
(40)
(3,646)
424 
 
10,304 
1/1/2009 - 12/31/2009
 
 
 
 
 
 
 
 
Balance
3,015 
22,227 
(11,676)
(40)
(3,646)
424 
 
10,304 
Net income including noncontrolling interest
 
3,193 
 
 
 
51 
 
3,244 
Cumulative translation adjustment
 
 
 
 
286 
(13)
 
273 
Defined benefit pension and postretirement plans adjustment
 
 
 
 
(309)
(5)
 
(314)
Debt and equity securities, unrealized gain (loss)
 
 
 
 
10 
 
 
10 
Cash flow hedging instruments, unrealized gain (loss)
 
 
 
 
(80)
 
 
(80)
Total comprehensive income
 
 
 
 
 
 
3,133 
3,133 
Adjustment to initially apply guidance concerning uncertainty in income taxes
 
 
 
 
 
 
 
 
Dividends paid
 
(1,431)
 
 
 
 
 
(1,431)
Transfer to noncontrolling interest
(66)
 
 
 
(15)
81 
 
 
Amortization of unearned compensation
 
 
 
40 
 
 
 
40 
Stock-based compensation, net of tax impacts
213 
 
 
 
 
 
 
213 
Reacquired stock
 
 
(17)
 
 
 
 
(17)
Issuances pursuant to stock option and benefit plans
 
(236)
1,296 
 
 
 
 
1,060 
Issuances pursuant to acquisitions
 
 
 
 
 
 
 
 
Balance
$ 3,162 
$ 23,753 
$ (10,397)
$ 0 
$ (3,754)
$ 538 
 
$ 13,302 
Supplemental share information
Share data in Millions, except Per Share data
Year Ended
Dec. 31,
2009
2008
2007
Supplemental treasury stock share information (Millions):
 
 
 
Treasury Stock, Shares, Beginning Balance
250.5 
234.9 
209.7 
Reacquired stock
0.2 
21.4 
39.7 
Issuances pursuant to stock options and benefit plans
(17.3)
(5.8)
(14.3)
Issuances pursuant to acquisitions
 
 
(0.2)
Treasury Stock, Shares, Ending Balance
233.4 
250.5 
234.9 
Consolidated Statement of Comprehensive Income (Loss) (USD $)
In Millions
Year Ended
Dec. 31,
2009
2008
2007
Consolidated Statement of Comprehensive Income (Loss)
 
 
 
Net income including noncontrolling interest
$ 3,244 
$ 3,520 
$ 4,151 
Other comprehensive income, net of tax:
 
 
 
Cumulative translation adjustment
273 
(806)
548 
Defined benefit pension and postretirement plans adjustment
(314)
(2,092)
610 
Debt and equity securities, unrealized gain (loss)
10 
(11)
(10)
Cash flow hedging instruments, unrealized gain (loss)
(80)
72 
(10)
Total other comprehensive income (loss), net of tax
(111)
(2,837)
1,138 
Comprehensive income (loss) including noncontrolling interest
3,133 
683 
5,289 
Comprehensive (income) loss attributable to noncontrolling interest
(33)
(122)
(67)
Comprehensive income (loss) attributable to 3M
$ 3,100 
$ 561 
$ 5,222 
Consolidated Statement of Cash Flows (USD $)
In Millions
Year Ended
Dec. 31,
2009
2008
2007
Cash Flows
 
 
 
Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]
 
 
 
Cash Flows from Operating Activities
 
 
 
Net income including noncontrolling interest
$ 3,244 
$ 3,520 
$ 4,151 
Adjustments to reconcile net income including noncontrolling interest to net cash provided by operating activities
 
 
 
Depreciation and amortization
1,157 
1,153 
1,072 
Company pension and postretirement contributions
(792)
(474)
(379)
Company pension and postretirement expense
223 
105 
255 
Stock-based compensation expense
217 
202 
228 
(Gain)/loss from sale of businesses
 
23 
(849)
Deferred income taxes
701 
99 
(217)
Excess tax benefits from stock-based compensation
(14)
(21)
(74)
Changes in assets and liabilities
 
 
 
Accounts receivable
55 
197 
(35)
Inventories
453 
(127)
(54)
Accounts payable
109 
(224)
(4)
Accrued income taxes (current and long-term)
(147)
(143)
183 
Product and other insurance receivables and claims
64 
153 
158 
Other - net
(329)
70 
(189)
Net cash provided by operating activities
4,941 
4,533 
4,246 
Cash Flows from Investing Activities
 
 
 
Purchases of property, plant and equipment (PP&E)
(903)
(1,471)
(1,422)
Proceeds from sale of PP&E and other assets
74 
87 
103 
Acquisitions, net of cash acquired
(69)
(1,394)
(539)
Purchases of marketable securities and investments
(2,240)
(2,211)
(8,194)
Proceeds from sale of marketable securities and investments
718 
1,810 
6,902 
Proceeds from maturities of marketable securities
683 
692 
886 
Proceeds from sale of businesses
88 
897 
Net cash used in investing activities
(1,732)
(2,399)
(1,367)
Cash Flows from Financing Activities
 
 
 
Change in short-term debt - net
(536)
361 
(1,222)
Repayment of debt (maturities greater than 90 days)
(519)
(1,080)
(1,551)
Proceeds from debt (maturities greater than 90 days)
41 
1,756 
4,024 
Purchases of treasury stock
(17)
(1,631)
(3,239)
Reissuances of treasury stock
431 
289 
796 
Dividends paid to stockholders
(1,431)
(1,398)
(1,380)
Distributions to noncontrolling interests
 
(23)
(20)
Excess tax benefits from stock-based compensation
14 
21 
74 
Other - net
(61)
 
Net cash used in financing activities
(2,014)
(1,766)
(2,518)
Effect of exchange rate changes on cash and cash equivalents
(4)
(415)
88 
Net increase /(decrease) in cash and cash equivalents
1,191 
(47)
449 
Cash and cash equivalents at beginning of year
1,849 
1,896 
1,447 
Cash and cash equivalents at end of year
$ 3,040 
$ 1,849 
$ 1,896 
Significant Accounting Policies
Significant Accounting Policies

NOTE 1.  Significant Accounting Policies

 

Consolidation: 3M is a diversified global manufacturer, technology innovator and marketer of a wide variety of products. All significant subsidiaries are consolidated. All significant intercompany transactions are eliminated. As used herein, the term “3M” or “Company” refers to 3M Company and subsidiaries unless the context indicates otherwise.

 

Foreign currency translation: Local currencies generally are considered the functional currencies outside the United States. Assets and liabilities for operations in local-currency environments are translated at year-end exchange rates. Income and expense items are translated at average rates of exchange prevailing during the year. Cumulative translation adjustments are recorded as a component of accumulated other comprehensive income (loss) in shareholders’ equity.

 

The Company has a Venezuelan subsidiary with net sales and operating income representing less than one percent of 3M’s related consolidated financial statement amounts for 2009. Regulations in Venezuela require the purchase and sale of foreign currency to be made at an official rate of exchange that is fixed from time to time by the Venezuelan government. Certain laws in the country, however, provide an exemption for the purchase and sale of certain securities and have resulted in an indirect “parallel” market through which companies may obtain foreign currency without having to purchase it from Venezuela’s Commission for the Administration of Foreign Exchange (CADIVI). The average rate of exchange in the parallel market varies and is less favorable than the official rate. As of December 31, 2009, 3M began use of the parallel exchange rate for translation of the financial statements of its Venezuelan subsidiary. This change was based on a number of factors including 3M’s ability to convert currency in the parallel market, the limited release of funds from CADIVI for the payment of dividends by the Venezuelan subsidiary, and conclusion that 3M will or could use the parallel market for repatriation of capital or dividends. This change resulted in a decrease in accumulated other comprehensive income (cumulative translation adjustment) of approximately $55 million with a corresponding decrease in the translated assets and liabilities of 3M’s Venezuelan subsidiary at December 31, 2009. Additionally, 3M evaluates the highly inflationary status of Venezuela’s economy by considering both the Consumer Price Index (which largely is associated with the cities of Caracas and Maracaibo) and the National Consumer Price Index (developed commencing in 2008 and covering the entire country of Venezuela). Under Accounting Standards Codification (ASC) 830, Foreign Currency Matters, the reporting currency of a foreign entity’s parent is assumed to be that entity’s functional currency when the economic environment of a foreign entity is highly inflationary. Generally, an economy is considered highly inflationary when its cumulative inflation is approximately 100 percent or more for the three years that precede the beginning of a reporting period. The blended cumulative inflation rate exceeded 100 percent in November 2009. Accordingly, the financial statements of the Venezuelan subsidiary will be remeasured as if its functional currency were that of its parent beginning January 1, 2010. This remeasurement will decrease net sales of the Venezuelan subsidiary by approximately two-thirds in 2010 in comparison to 2009 (based on exchange rates as of December 31, 2009), but will not otherwise have a material impact on operating income and 3M’s consolidated results of operations.

 

Reclassifications: Certain amounts in the prior years’ consolidated financial statements have been reclassified to conform to the current year presentation.

 

Use of estimates: The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

 

Cash and cash equivalents: Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased.

 

Investments: Investments primarily include equity and cost method investments and real estate not used in the business. Available-for-sale investments are recorded at fair value. Unrealized gains and losses relating to investments classified as available-for-sale are recorded as a component of accumulated other comprehensive income (loss) in shareholders’ equity.

 

Other assets: Other assets include deferred income taxes, product and other insurance receivables, the cash surrender value of life insurance policies, and other long-term assets. Investments in life insurance are reported at the amount that could be realized under contract at the balance sheet date, with any changes in cash surrender value or contract value during the period accounted for as an adjustment of premiums paid. Cash outflows and inflows associated with life insurance activity are included in “Purchases of marketable securities and investments” and “Proceeds from sale of marketable securities and investments”, respectively.

 

Inventories: Inventories are stated at the lower of cost or market, with cost generally determined on a first-in, first-out basis.

 

Property, plant and equipment: Property, plant and equipment, including capitalized interest and internal engineering costs, are recorded at cost. Depreciation of property, plant and equipment generally is computed using the straight-line method based on the estimated useful lives of the assets. The estimated useful lives of buildings and improvements primarily range from 10 to 40 years, with the majority in the range of 20 to 40 years. The estimated useful lives of machinery and equipment primarily range from three to 15 years, with the majority in the range of five to 10 years. Fully depreciated assets are retained in property and accumulated depreciation accounts until disposal. Upon disposal, assets and related accumulated depreciation are removed from the accounts and the net amount, less proceeds from disposal, is charged or credited to operations. Property, plant and equipment amounts are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset (asset group) may not be recoverable. An impairment loss would be recognized when the carrying amount of an asset exceeds the estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition. The amount of the impairment loss to be recorded is calculated by the excess of the asset’s carrying value over its fair value. Fair value is generally determined using a discounted cash flow analysis.

 

Conditional asset retirement obligations: A liability is initially recorded at fair value for an asset retirement obligation associated with the retirement of tangible long-lived assets in the period in which it is incurred if a reasonable estimate of fair value can be made. Conditional asset retirement obligations exist for certain long-term assets of the Company. The obligation is initially measured at fair value using expected present value techniques. Over time the liabilities are accreted for the change in their present value and the initial capitalized costs are depreciated over the remaining useful lives of the related assets. The asset retirement obligation liability was $64 million and $62 million, respectively, at December 31, 2009 and 2008.

 

Goodwill: Goodwill is the excess of cost of an acquired entity over the amounts assigned to assets acquired and liabilities assumed in a business combination. Goodwill is not amortized. Goodwill is tested for impairment annually, and is tested for impairment between annual tests if an event occurs or circumstances change that would indicate the carrying amount may be impaired. Impairment testing for goodwill is done at a reporting unit level, with all goodwill assigned to a reporting unit. Reporting units are one level below the business segment level, but can be combined when reporting units within the same segment have similar economic characteristics. An impairment loss generally would be recognized when the carrying amount of the reporting unit’s net assets exceeds the estimated fair value of the reporting unit. The estimated fair value of a reporting unit is determined using earnings for the reporting unit multiplied by a price/earnings ratio for comparable industry groups, or by using a discounted cash flow analysis. The price/earnings ratio is adjusted, if necessary, to take into consideration the market value of the Company.

 

Intangible assets: Intangible assets include patents, tradenames and other intangible assets acquired from an independent party. Intangible assets with an indefinite life, namely certain tradenames, are not amortized. Intangible assets with a definite life are amortized on a straight-line basis, with estimated useful lives ranging from one to 20 years. Indefinite-lived intangible assets are tested for impairment annually, and are tested for impairment between annual tests if an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Intangible assets with a definite life are tested for impairment whenever events or circumstances indicate that the carrying amount of an asset (asset group) may not be recoverable. An impairment loss is recognized when the carrying amount of an asset exceeds the estimated undiscounted cash flows used in determining the fair value of the asset. The amount of the impairment loss to be recorded is calculated by the excess of the asset’s carrying value over its fair value. Fair value is generally determined using a discounted cash flow analysis. Costs related to internally developed intangible assets, such as patents, are expensed as incurred, primarily in “Research, development and related expenses.”

 

Revenue (sales) recognition: The Company sells a wide range of products to a diversified base of customers around the world and has no material concentration of credit risk. Revenue is recognized when the risks and rewards of ownership have substantively transferred to customers. This condition normally is met when the product has been delivered or upon performance of services. The Company records estimated reductions to revenue or records expense for customer and distributor incentives, primarily comprised of rebates and free goods, at the time of the initial sale. These sales incentives are accounted for in accordance with ASC 605, Revenue Recognition. The estimated reductions of revenue for rebates are based on the sales terms, historical experience, trend analysis and projected market conditions in the various markets served. Since the Company serves numerous markets, the rebate programs offered vary across businesses, but the most common incentive relates to amounts paid or credited to customers for achieving defined volume levels or growth objectives. Free goods are accounted for as an expense and recorded in cost of sales. Sales, use, value-added and other excise taxes are not recognized in revenue.

 

The majority of 3M’s sales agreements are for standard products and services with customer acceptance occurring upon delivery of the product or performance of the service. 3M also enters into agreements that contain multiple elements (such as equipment, installation and service) or non-standard terms and conditions. For multiple-element arrangements, 3M recognizes revenue for delivered elements when it has stand-alone value to the customer, the fair values of undelivered elements are known, customer acceptance of the delivered elements has occurred, and there are only customary refund or return rights related to the delivered elements. In addition to the preceding conditions, equipment revenue is not recorded until the installation has been completed if equipment acceptance is dependent upon installation, or if installation is essential to the functionality of the equipment. Installation revenues are not recorded until installation has been completed. For prepaid service contracts, sales revenue is recognized on a straight-line basis over the term of the contract, unless historical evidence indicates the costs are incurred on other than a straight-line basis. License fee revenue is recognized as earned, and no revenue is recognized until the inception of the license term. On occasion, agreements will contain milestones, or 3M will recognize revenue based on proportional performance. For these agreements, and depending on the specifics, 3M may recognize revenue upon completion of a substantive milestone, or in proportion to costs incurred to date compared with the estimate of total costs to be incurred.

 

Accounts receivable and allowances: Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains allowances for bad debts, cash discounts, product returns and various other items. The allowance for doubtful accounts and product returns is based on the best estimate of the amount of probable credit losses in existing accounts receivable and anticipated sales returns. The Company determines the allowances based on historical write-off experience by industry and regional economic data and historical sales returns. The Company reviews the allowance for doubtful accounts monthly. The Company does not have any significant off-balance-sheet credit exposure related to its customers.

 

Advertising and merchandising: These costs are charged to operations in the year incurred, and totaled $414 million in 2009, $468 million in 2008 and $469 million in 2007.

 

Research, development and related expenses: These costs are charged to operations in the year incurred and are shown on a separate line of the Consolidated Statement of Income. Research, development and related expenses totaled $1.293 billion in 2009, $1.404 billion in 2008 and $1.368 billion in 2007. Research and development expenses, covering basic scientific research and the application of scientific advances in the development of new and improved products and their uses, totaled $838 million in 2009, $851 million in 2008 and $788 million in 2007. Related expenses primarily include technical support provided by 3M to customers who are using existing 3M products; internally developed patent costs, which include costs and fees incurred to prepare, file, secure and maintain patents; and amortization of acquired patents.

 

Internal-use software: The Company capitalizes direct costs of materials and services used in the development of internal-use software. Amounts capitalized are amortized over a period of three to seven years, generally on a straight-line basis, unless another systematic and rational basis is more representative of the software’s use. Amounts are reported as a component of either machinery and equipment or capital leases within property, plant and equipment.

 

Environmental: Environmental expenditures relating to existing conditions caused by past operations that do not contribute to current or future revenues are expensed. Reserves for liabilities for anticipated remediation costs are recorded on an undiscounted basis when they are probable and reasonably estimable, generally no later than the completion of feasibility studies or the Company’s commitment to a plan of action. Environmental expenditures for capital projects that contribute to current or future operations generally are capitalized and depreciated over their estimated useful lives.

 

Income taxes: The provision for income taxes is determined using the asset and liability approach. Under this approach, deferred income taxes represent the expected future tax consequences of temporary differences between the carrying amounts and tax basis of assets and liabilities. The Company records a valuation allowance to reduce its deferred tax assets when uncertainty regarding their realizability exists. As of December 31, 2009, no significant valuation allowances were recorded. As of January 1, 2007, the Company adopted new standards related to accounting for uncertainty in income taxes. 3M follows this guidance to record uncertainties and judgments in the application of complex tax regulations in a multitude of jurisdictions (refer to Note 8 for additional information).

 

Earnings per share: The difference in the weighted average 3M shares outstanding for calculating basic and diluted earnings per share attributable to 3M common shareholders is the result of the dilution associated with the Company’s stock-based compensation plans. Certain options outstanding under these stock-based compensation plans during the years 2009, 2008 and 2007 were not included in the computation of diluted earnings per share attributable to 3M common shareholders because they would not have had a dilutive effect (54.3 million average options for 2009, 41.0 million average options for 2008, and 21.6 million average options for 2007). As discussed in Note 10, the conditions for conversion related to the Company’s Convertible Notes have never been met. If the conditions for conversion are met, 3M may choose to pay in cash and/or common stock; however, if this occurs, the Company has the intent and ability to settle this debt security in cash. Accordingly, there was no impact on diluted earnings per share attributable to 3M common shareholders. The computations for basic and diluted earnings per share for the years ended December 31 follow:

 

Earnings Per Share Computations

 

(Amounts in millions, except per share amounts)

 

2009

 

2008

 

2007

 

Numerator:

 

 

 

 

 

 

 

Net income attributable to 3M

 

$

3,193

 

$

3,460

 

$

4,096

 

Denominator:

 

 

 

 

 

 

 

Denominator for weighted average 3M common shares outstanding — basic

 

700.5

 

699.2

 

718.3

 

Dilution associated with the Company’s stock-based compensation plans

 

6.2

 

8.0

 

13.7

 

Denominator for weighted average 3M common shares outstanding — diluted

 

706.7

 

707.2

 

732.0

 

 

 

 

 

 

 

 

 

Earnings per share attributable to 3M common shareholders — basic

 

$

4.56

 

$

4.95

 

$

5.70

 

Earnings per share attributable to 3M common shareholders — diluted

 

$

4.52

 

$

4.89

 

$

5.60

 

 

Stock-based compensation: The Company recognizes compensation expense for both its General Employees’ Stock Purchase Plan (GESPP) and the Long-Term Incentive Plan (LTIP). Under applicable accounting standards, the fair value of share-based compensation is determined at the grant date and the recognition of the related expense is recorded over the period in which the share-based compensation vests. Refer to Note 16 for additional information.

 

Comprehensive income: Total comprehensive income and the components of accumulated other comprehensive income (loss) are presented in the Consolidated Statements of Changes in Equity and Comprehensive Income. Accumulated other comprehensive income (loss) is composed of foreign currency translation effects (including hedges of net investments in international companies), defined benefit pension and postretirement plan adjustments, unrealized gains and losses on available-for-sale debt and equity securities, and unrealized gains and losses on cash flow hedging instruments.

 

Derivatives and hedging activities: All derivative instruments within the scope of ASC 815, Derivatives and Hedging, are recorded on the balance sheet at fair value. The Company uses interest rate swaps, currency and commodity price swaps, and foreign currency forward and option contracts to manage risks generally associated with foreign exchange rate, interest rate and commodity market volatility. All hedging instruments that qualify for hedge accounting are designated and effective as hedges, in accordance with U.S. generally accepted accounting principles. If the underlying hedged transaction ceases to exist, all changes in fair value of the related derivatives that have not been settled are recognized in current earnings. Instruments that do not qualify for hedge accounting are marked to market with changes recognized in current earnings. The Company does not hold or issue derivative financial instruments for trading purposes and is not a party to leveraged derivatives. However, the Company does have contingently convertible debt that, if conditions for conversion are met, is convertible into shares of 3M common stock (refer to Note 10 in this document).

 

New Accounting Pronouncements

 

In June 2009, the Financial Accounting Standards Board (FASB) issued a standard that established the FASB Accounting Standards Codification™ (ASC) and amended the hierarchy of generally accepted accounting principles (GAAP) such that the ASC became the single source of authoritative nongovernmental U.S. GAAP. The ASC did not change current U.S. GAAP, but was intended to simplify user access to all authoritative U.S. GAAP by providing all the authoritative literature related to a particular topic in one place. All previously existing accounting standard documents were superseded and all other accounting literature not included in the ASC is considered non-authoritative. New accounting standards issued subsequent to June 30, 2009 are communicated by the FASB through Accounting Standards Updates (ASUs). For 3M, the ASC was effective July 1, 2009. This standard did not have an impact on 3M’s consolidated results of operations or financial condition. However, throughout the notes to the consolidated financial statements references that were previously made to various former authoritative U.S. GAAP pronouncements have been changed to coincide with the appropriate section of the ASC.

 

In June 2006, the FASB issued an accounting standard codified in ASC 740, Income Taxes, related to accounting for uncertainty in income taxes. This standard was adopted by 3M effective January 1, 2007. Refer to Note 8 for additional information concerning this standard.

 

In September 2006, the FASB issued an accounting standard codified in ASC 820, Fair Value Measurements and Disclosures. This standard established a single definition of fair value and a framework for measuring fair value, set out a fair value hierarchy to be used to classify the source of information used in fair value measurements, and required disclosures of assets and liabilities measured at fair value based on their level in the hierarchy. This standard applies under other accounting standards that require or permit fair value measurements. 3M adopted the standard as amended by subsequent FASB standards beginning January 1, 2008 on a prospective basis. One of the amendments deferred the effective date for one year relative to nonfinancial assets and liabilities that are measured at fair value, but are recognized or disclosed at fair value on a nonrecurring basis. This deferral applied to such items as nonfinancial assets and liabilities initially measured at fair value in a business combination (but not measured at fair value in subsequent periods) or nonfinancial long-lived asset groups measured at fair value for an impairment assessment. These remaining aspects of the fair value measurement standard were adopted by the Company prospectively beginning January 1, 2009 and did not have a material impact on 3M’s consolidated results of operations or financial condition. Refer to Note 13 for additional disclosures of assets and liabilities that are measured at fair value on a nonrecurring basis as a result of this adoption.

 

In February 2007, the FASB issued an accounting standard codified in ASC 825, Financial Instruments, that permits an entity to choose, at specified election dates, to measure eligible financial instruments and certain other items at fair value that were not currently required to be measured at fair value. An entity reports unrealized gains and losses on items for which the fair value option has been elected in earnings at each subsequent reporting date. Upfront costs and fees related to items for which the fair value option is elected are recognized in earnings as incurred and not deferred. This standard also established presentation and disclosure requirements designed to facilitate comparisons between entities that choose different measurement attributes for similar types of assets and liabilities. This standard was effective for financial statements issued for fiscal years beginning after November 15, 2007 (January 1, 2008 for 3M) and interim periods within those fiscal years. At the effective date, an entity could elect the fair value option for eligible items that existed at that date. The entity was required to report the effect of the first remeasurement to fair value as a cumulative-effect adjustment to the opening balance of retained earnings. The Company did not elect the fair value option for eligible items that existed as of January 1, 2008.

 

In June 2007, the FASB ratified a standard regarding the accounting for nonrefundable advance payments for goods or services to be used in future research and development activities that requires nonrefundable advance payments made by the Company for future R&D activities to be capitalized and recognized as an expense as the goods or services are received by the Company. This standard was effective for 3M with respect to new arrangements entered into beginning January 1, 2008 and did not have a material impact on 3M’s consolidated results of operations or financial condition.

 

In December 2007, the FASB issued and, in April 2009, amended a new business combinations standard codified within ASC 805, which changed the accounting for business acquisitions. Accounting for business combinations under this standard requires the acquiring entity in a business combination to recognize all (and only) the assets acquired and liabilities assumed in the transaction and establishes the acquisition-date fair value as the measurement objective for all assets acquired and liabilities assumed in a business combination. Certain provisions of this standard impact the determination of acquisition-date fair value of consideration paid in a business combination (including contingent consideration); exclude transaction costs from acquisition accounting; and change accounting practices for acquisition-related restructuring costs, in-process research and development, indemnification assets, and tax benefits. For 3M, this standard was effective for business combinations and adjustments to an acquired entity’s deferred tax asset and liability balances occurring after December 31, 2008. This standard had no immediate impact upon adoption by 3M, and was applied to the business combinations disclosed in Note 2 that were completed post-2008 and to applicable adjustments to acquired entity deferred tax items occurring after December 31, 2008.

 

In December 2007, the FASB issued a new standard which established the accounting for and reporting of noncontrolling interests (NCIs) in partially owned consolidated subsidiaries and the loss of control of subsidiaries. Certain provisions of this standard indicate, among other things, that NCIs (previously referred to as minority interests) be treated as a separate component of equity, not as a liability (as was previously the case); that increases and decreases in the parent’s ownership interest that leave control intact be treated as equity transactions, rather than as step acquisitions or gains or losses on purchases or sales; and that losses of a partially owned consolidated subsidiary be allocated to the NCI even when such allocation might result in a deficit balance. This standard also required changes to certain presentation and disclosure requirements. For 3M, the standard was effective beginning January 1, 2009. The provisions of the standard were applied to all NCIs prospectively, except for the presentation and disclosure requirements, which were applied retrospectively to all periods presented. As a result, upon adoption, 3M retroactively reclassified the “Minority interest in subsidiaries” balance previously included in the “Other liabilities” section of the consolidated balance sheet to a new component of equity with respect to NCIs in consolidated subsidiaries. The adoption also impacted certain captions previously used on the consolidated statement of income, largely identifying net income including NCI and net income attributable to 3M. Additional disclosures required by this standard are also included in Note 6. The adoption of this standard did not have a material impact on 3M’s consolidated financial position or results of operations.

 

In December 2007, the FASB ratified a standard related to accounting for collaborative arrangements which discusses how parties to a collaborative arrangement (which does not establish a legal entity within such arrangement) should account for various activities. The standard indicates that costs incurred and revenues generated from transactions with third parties (i.e. parties outside of the collaborative arrangement) should be reported by the collaborators on the respective line items in their income statements pursuant to ASC 605-45, Principle Agent Considerations. Additionally, the guidance provides that income statement characterization of payments between the participants in a collaborative arrangement should be based upon existing authoritative standards; analogy to such standards if not within their scope; or a reasonable, rational, and consistently applied accounting policy election. This guidance was effective for 3M beginning January 1, 2009 and applied retrospectively to all periods presented for collaborative arrangements existing as of the date of adoption. The adoption of this standard did not have a material impact on 3M’s consolidated results of operations or financial condition.

 

In March 2008, the FASB issued an accounting standard related to disclosures about derivative instruments and hedging activities, codified in ASC 815, which requires additional disclosures about an entity’s strategies and objectives for using derivative instruments; the location and amounts of derivative instruments in an entity’s financial statements; how derivative instruments and related hedged items are accounted for under ASC 815, and how derivative instruments and related hedged items affect its financial position, financial performance, and cash flows. Certain disclosures are also required with respect to derivative features that are credit-risk-related. The standard was effective for 3M beginning January 1, 2009 on a prospective basis. The additional disclosures required by this standard are included in Note 12.

 

In April 2008, the FASB issued an accounting standard which amended the list of factors an entity should consider in developing renewal or extension assumptions used in determining the useful life of recognized intangible assets under ASC 350, Intangibles - Goodwill and Other. This new standard applies to (1) intangible assets that are acquired individually or with a group of other assets and (2) intangible assets acquired in both business combinations and asset acquisitions. Under this standard, entities estimating the useful life of a recognized intangible asset must consider their historical experience in renewing or extending similar arrangements or, in the absence of historical experience, must consider assumptions that market participants would use about renewal or extension. For 3M, this standard required certain additional disclosures beginning January 1, 2009 (which are included in Notes 2 and 3) and application to useful life estimates prospectively for intangible assets acquired after December 31, 2008. The adoption of this standard did not have a material impact on 3M’s consolidated results of operations or financial condition.

 

In May 2008, the FASB issued an accounting standard which addresses convertible debt securities that, upon conversion by the holder, may be settled by the issuer fully or partially in cash (rather than settled fully in shares) and specifies that issuers of such instruments should separately account for the liability and equity components in a manner that reflects the issuer’s nonconvertible debt borrowing rate when related interest cost is recognized. This standard was effective for 3M beginning January 1, 2009 with retrospective application to all periods presented. This standard impacted the Company’s “Convertible Notes” (refer to Note 10 to the Consolidated Financial Statements for more detail), and required that additional interest expense essentially equivalent to the portion of issuance proceeds be retroactively allocated to the instrument’s equity component and be recognized over the period from the Convertible Notes’ issuance on November 15, 2002 through November 15, 2005 (the first date holders of these Notes had the ability to put them back to 3M). 3M adopted this standard in January 2009. Its retrospective application had no impact on results of operations for periods following 2005, but on post-2005 consolidated balance sheets, it resulted in an increase of approximately $22 million in previously reported opening additional paid in capital and a corresponding decrease in previously reported opening retained earnings.

 

In early October 2008, the FASB issued an accounting standard codified in ASC 820, Fair Value Measurements and Disclosures, which illustrated key considerations in determining the fair value of a financial asset in an inactive market. This standard was effective for 3M beginning with the quarter ended September 30, 2008. Its additional guidance was incorporated in the measurements of fair value of applicable financial assets disclosed in Note 13 and did not have a material impact on 3M’s consolidated results of operations or financial condition.

 

In November 2008, the FASB ratified a standard related to certain equity method investment accounting considerations. The standard indicates, among other things, that transaction costs for an investment should be included in the cost of the equity-method investment (and not expensed) and shares subsequently issued by the equity-method investee that reduce the investor’s ownership percentage should be accounted for as if the investor had sold a proportionate share of its investment, with gains or losses recorded through earnings. For 3M, the standard was effective for transactions occurring after December 31, 2008. The adoption of this standard did not have a material impact on 3M’s consolidated results of operations or financial condition.

 

In November 2008, the FASB ratified an accounting standard related to intangible assets acquired in a business combination or asset acquisition that an entity does not intend to use or intends to hold to prevent others from obtaining access (a defensive intangible asset). Under the standard a defensive intangible asset needs to be accounted for as a separate unit of accounting and would be assigned a useful life based on the period over which the asset diminishes in value. For 3M, the standard was effective for transactions occurring after December 31, 2008. The Company considered this standard in terms of intangible assets acquired in business combinations or asset acquisitions that closed after December 31, 2008.

 

In December 2008, the FASB issued an accounting standard regarding a company’s disclosures about postretirement benefit plan assets. This standard requires additional disclosures about plan assets for sponsors of defined benefit pension and postretirement plans including expanded information regarding investment strategies, major categories of plan assets, and concentrations of risk within plan assets. Additionally, this standard requires disclosures similar to those required for fair value measurements and disclosures under ASC 820 with respect to the fair value of plan assets such as the inputs and valuation techniques used to measure fair value and information with respect to classification of plan assets in terms of the hierarchy of the source of information used to determine their value. For 3M, the disclosures under this standard are required beginning with the annual period ended December 31, 2009. The additional disclosures are included in Note 11.

 

In April 2009, the FASB issued an accounting standard which provides guidance on (1) estimating the fair value of an asset or liability when the volume and level of activity for the asset or liability have significantly declined and (2) identifying transactions that are not orderly. The standard also amended certain disclosure provisions for fair value measurements and disclosures in ASC 820 to require, among other things, disclosures in interim periods of the inputs and valuation techniques used to measure fair value as well as disclosure of the hierarchy of the source of underlying fair value information on a disaggregated basis by specific major category of investment. For 3M, this standard was effective prospectively beginning April 1, 2009. The adoption of this standard did not have a material impact on 3M’s consolidated results of operations or financial condition.

 

In April 2009, the FASB issued an accounting standard which modifies the requirements for recognizing other-than-temporarily impaired debt securities and changes the existing impairment model for such securities. The standard also requires additional disclosures for both annual and interim periods with respect to both debt and equity securities. Under the standard, impairment of debt securities is considered other-than-temporary if an entity (1) intends to sell the security, (2) more likely than not will be required to sell the security before recovering its cost, or (3) does not expect to recover the security’s entire amortized cost basis (even if the entity does not intend to sell). The standard further indicates that, depending on which of the above factor(s) causes the impairment to be considered other-than-temporary, (1) the entire shortfall of the security’s fair value versus its amortized cost basis or (2) only the credit loss portion would be recognized in earnings while the remaining shortfall (if any) would be recorded in other comprehensive income. The standard requires entities to initially apply its provisions to previously other-than-temporarily impaired debt securities existing as of the date of initial adoption by making a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The cumulative-effect adjustment potentially reclassifies the noncredit portion of a previously other-than-temporarily impaired debt security held as of the date of initial adoption from retained earnings to accumulated other comprehensive income. For 3M, this standard was effective beginning April 1, 2009. The adoption of this standard did not have a material impact on 3M’s consolidated results of operations or financial condition. Additional disclosures required by this standard are included in Note 9.

 

In April 2009, the FASB issued an accounting standard regarding interim disclosures about fair value of financial instruments. The standard essentially expands the disclosure about fair value of financial instruments that were previously required only annually to also be required for interim period reporting. In addition, the standard requires certain additional disclosures regarding the methods and significant assumptions used to estimate the fair value of financial instruments. This standard was effective for 3M beginning April 1, 2009 on a prospective basis. The additional disclosures required by this standard are included in Note 13.

 

In June 2009, the FASB issued a new standard regarding the accounting for transfers of financial assets amending the existing guidance on transfers of financial assets to, among other things, eliminate the qualifying special-purpose entity concept, include a new unit of account definition that must be met for transfers of portions of financial assets to be eligible for sale accounting, clarify and change the derecognition criteria for a transfer to be accounted for as a sale, and require significant additional disclosure. For 3M, this standard is effective for new transfers of financial assets beginning January 1, 2010. Because 3M historically does not have significant transfers of financial assets, the adoption of this standard is not expected to have a material impact on 3M’s consolidated results of operations or financial condition.

 

In June 2009, the FASB issued a new standard that revises the consolidation guidance for variable-interest entities. The modifications include the elimination of the exemption for qualifying special purpose entities, a new approach for determining who should consolidate a variable-interest entity, and changes to when it is necessary to reassess who should consolidate a variable-interest entity. For 3M, this standard is effective January 1, 2010. The Company does not expect the adoption of this standard to have a material impact on 3M’s consolidated results of operations or financial condition.

 

In August 2009, the FASB issued ASU No. 2009-05, Measuring Liabilities at Fair Value, which provides additional guidance on how companies should measure liabilities at fair value under ASC 820. The ASU clarifies that the quoted price for an identical liability should be used. However, if such information is not available, a entity may use the quoted price of an identical liability when traded as an asset, quoted prices for similar liabilities or similar liabilities traded as assets, or another valuation technique (such as the market or income approach). The ASU also indicates that the fair value of a liability is not adjusted to reflect the impact of contractual restrictions that prevent its transfer and indicates circumstances in which quoted prices for an identical liability or quoted price for an identical liability traded as an asset may be considered level 1 fair value measurements (see Note 13 for a description of level 1 measurements). For 3M, this ASU was effective October 1, 2009. The adoption of this ASU did not have a material impact on 3M’s consolidated results of operations or financial condition.

 

In September 2009, the FASB issued ASU No. 2009-12, Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent), that amends ASC 820 to provide guidance on measuring the fair value of certain alternative investments such as hedge funds, private equity funds and venture capital funds. The ASU indicates that, under certain circumstances, the fair value of such investments may be determined using net asset value (NAV) as a practical expedient, unless it is probable the investment will be sold at something other than NAV. In those situations, the practical expedient cannot be used and disclosure of the remaining actions necessary to complete the sale is required. The ASU also requires additional disclosures of the attributes of all investments within the scope of the new guidance, regardless of whether an entity used the practical expedient to measure the fair value of any of its investments. The disclosure provisions of this ASU are not applicable to an employer’s disclosures about pension and other postretirement benefit plan assets. 3M does not have any significant direct investments within the scope of ASU No. 2009-12, but certain plan assets of the Company’s benefit plans are valued based on NAV as indicated in Note 11. For 3M, this ASU was effective October 1, 2009. The adoption of this ASU did not have a material impact on 3M’s consolidated results of operations or financial condition.

 

In October 2009, the FASB issued ASU No. 2009-13, Multiple-Deliverable Revenue Arrangements—a consensus of the FASB Emerging Issues Task Force, that provides amendments to the criteria for separating consideration in multiple-deliverable arrangements. As a result of these amendments, multiple-deliverable revenue arrangements will be separated in more circumstances than under existing U.S. GAAP. The ASU does this by establishing a selling price hierarchy for determining the selling price of a deliverable. The selling price used for each deliverable will be based on vendor-specific objective evidence if available, third-party evidence if vendor-specific objective evidence is not available, or estimated selling price if neither vendor-specific objective evidence nor third-party evidence is available. A vendor will be required to determine its best estimate of selling price in a manner that is consistent with that used to determine the price to sell the deliverable on a standalone basis. This ASU also eliminates the residual method of allocation and will require that arrangement consideration be allocated at the inception of the arrangement to all deliverables using the relative selling price method, which allocates any discount in the overall arrangement proportionally to each deliverable based on its relative selling price. Expanded disclosures of qualitative and quantitative information regarding application of the multiple-deliverable revenue arrangement guidance are also required under the ASU. The ASU does not apply to arrangements for which industry specific allocation and measurement guidance exists, such as long-term construction contracts and software transactions. For 3M, ASU No. 2009-13 is effective beginning January 1, 2011. 3M may elect to adopt the provisions prospectively to new or materially modified arrangements beginning on the effective date or retrospectively for all periods presented. The Company is currently evaluating the impact of this standard on 3M’s consolidated results of operations and financial condition.

 

In October 2009, the FASB issued ASU No. 2009-14, Certain Revenue Arrangements That Include Software Elements—a consensus of the FASB Emerging Issues Task Force, that reduces the types of transactions that fall within the current scope of software revenue recognition guidance. Existing software revenue recognition guidance requires that its provisions be applied to an entire arrangement when the sale of any products or services containing or utilizing software when the software is considered more than incidental to the product or service. As a result of the amendments included in ASU No. 2009-14, many tangible products and services that rely on software will be accounted for under the multiple-element arrangements revenue recognition guidance rather than under the software revenue recognition guidance. Under the ASU, the following components would be excluded from the scope of software revenue recognition guidance:  the tangible element of the product, software products bundled with tangible products where the software components and non-software components function together to deliver the product’s essential functionality, and undelivered components that relate to software that is essential to the tangible product’s functionality. The ASU also provides guidance on how to allocate transaction consideration when an arrangement contains both deliverables within the scope of software revenue guidance (software deliverables) and deliverables not within the scope of that guidance (non-software deliverables). For 3M, ASU No. 2009-14 is effective beginning January 1, 2011. 3M may elect to adopt the provisions prospectively to new or materially modified arrangements beginning on the effective date or retrospectively for all periods presented. However, 3M must elect the same transition method for this guidance as that chosen for ASU No. 2009-13. The Company is currently evaluating the impact of this standard on 3M’s consolidated results of operations and financial condition.

 

In January 2010, the FASB issued ASU No. 2010-6, Improving Disclosures About Fair Value Measurements, that amends existing disclosure requirements under ASC 820 by adding required disclosures about items transferring into and out of levels 1 and 2 in the fair value hierarchy; adding separate disclosures about purchase, sales, issuances, and settlements relative to level 3 measurements; and clarifying, among other things, the existing fair value disclosures about the level of disaggregation. For 3M this ASU is effective for the first quarter of 2010, except for the requirement to provide level 3 activity of purchases, sales, issuances, and settlements on a gross basis, which is effective beginning the first quarter of 2011. Since this standard impacts disclosure requirements only, its adoption will not have a material impact on 3M’s consolidated results of operations or financial condition.

 

Acquisitions and Divestitures
Acquisitions and Divestitures

NOTE 2.  Acquisitions and Divestitures

 

Acquisitions:

 

The impact on the consolidated balance sheet of the purchase price allocations related to acquisitions, including adjustments relative to other acquisitions within the allocation period, follows:

 

 

 

 

 

2008 Acquisitions

 

 

 

(Millions)
Asset (Liability)

 

2009 Total

 

Aearo
Holding
Corp.

 

Other
Acquisitions

 

2008 Total

 

2007 Total

 

Accounts receivable

 

$

31

 

$

76

 

$

70

 

$

146

 

$

69

 

Inventory

 

10

 

81

 

89

 

170

 

79

 

Other current assets

 

 

7

 

8

 

15

 

5

 

Property, plant, and equipment — net

 

15

 

78

 

83

 

161

 

68

 

Purchased intangible assets

 

93

 

417

 

377

 

794

 

131

 

Purchased goodwill

 

(25

)

798

 

594

 

1,392

 

326

 

Accounts payable and other liabilities, net of other assets

 

(21

)

(200

)

(104

)

(304

)

(80

)

Interest bearing debt

 

(18

)

(684

)

(125

)

(809

)

(34

)

Deferred tax asset/(liability)

 

(16

)

(50

)

(121

)

(171

)

(12

)

 

 

 

 

 

 

 

 

 

 

 

 

Net assets acquired

 

$

69

 

$

523

 

$

871

 

$

1,394

 

$

552

 

 

 

 

 

 

 

 

 

 

 

 

 

Supplemental information:

 

 

 

 

 

 

 

 

 

 

 

Cash paid

 

$

73

 

$

562

 

$

897

 

$

1,459

 

$

546

 

Less: Cash acquired

 

4

 

39

 

26

 

65

 

7

 

Cash paid, net of cash acquired

 

$

69

 

$

523

 

$

871

 

$

1,394

 

$

539

 

Non-cash (3M shares at fair value)

 

 

 

 

 

13

 

Net assets acquired

 

$

69

 

$

523

 

$

871

 

$

1,394

 

$

552

 

 

Pro forma information related to acquisitions was not included because the impact on the Company’s consolidated results of operations was not considered to be material. In-process research and development associated with these business combinations were not material.

 

In addition to business combinations, 3M periodically acquires certain tangible and/or intangible assets and purchases interests in certain enterprises that do not otherwise qualify for accounting as business combinations. These transactions are largely reflected as additional asset purchase and investment activity.

 

2009 acquisitions:

 

During 2009, 3M completed four business combinations. The purchase price paid for these business combinations (net of cash acquired) and certain acquisition costs and contingent consideration paid for pre-2009 business combinations during 2009 aggregated to $69 million.

 

(1) In January 2009, 3M (Safety, Security and Protection Services Business) purchased 100 percent of the outstanding shares of Alltech Solutions, a provider of water pipe rehabilitation services based in Moncton, New Brunswick, Canada.

 

(2) In February 2009, 3M (Industrial and Transportation Business) purchased the assets of Compac Corp.’s pressure sensitive adhesive tape business, a global leader in providing custom solutions in coating, laminating and converting flexible substrates headquartered in Hackettstown, N.J.

 

(3) In April 2009, 3M (Industrial and Transportation Business) purchased 100 percent of the outstanding shares of Meguiar’s International, UK, a distributor of Meguiar’s Inc. products based in Daventry, United Kingdom.

 

(4) In July 2009, 3M (Consumer and Office Business) purchased the ACE® branded (and related brands) elastic bandage, supports and thermometer product lines, which are sold broadly through consumer channels in North America.

 

Purchased identifiable intangible assets related to the four acquisitions that closed in 2009 totaled $28 million. This included $20 million of identifiable intangible assets that will be amortized on a straight-line basis over a weighted-average life of eight years (lives ranging from three to 12 years) and $8 million of indefinite-lived intangible assets related to the well-recognized ACE® brand. Acquired identifiable intangible assets for which significant assumed renewals or extensions of underlying arrangements impacted the determination of their useful lives were not material.

 

2008 acquisitions:

 

During 2008, 3M completed 18 business combinations. The purchase price paid for business combinations (net of cash acquired) and certain contingent consideration paid during the twelve months ended December 31, 2008 for previous acquisitions aggregated to $1.394 billion.

 

The largest of these 2008 acquisitions was the April 2008 purchase of 100 percent of the outstanding shares of Aearo Holding Corp., the parent company of Aearo Technologies Inc. (hereafter referred to as Aearo), a manufacturer of personal protection and energy absorbing products. Aearo products are primarily included in the Safety, Security and Protection Services Business, but thermal acoustics systems products are included in the Industrial and Transportation Business and products for the consumer retail portion of Aearo’s business are included in the Consumer and Office Business. Cash paid, net of cash acquired, for Aearo totaled approximately $523 million and debt assumed from Aearo totaled approximately $684 million, which was immediately paid off.

 

The 17 additional business combinations are summarized as follows:

 

(1) In March 2008, 3M (Industrial and Transportation Business) purchased certain assets of Hitech Polymers Inc., a manufacturer of specialty thermoplastic polymers and provider of toll thermoplastic compounding services based in Hebron, Kentucky.

 

(2) In April 2008, 3M (Health Care Business) purchased 100 percent of the outstanding shares of Les Entreprises Solumed Inc., a Quebec-based developer and marketer of leading-edge medical products designed to prevent infections in operating rooms and hospitals.

 

(3) In April 2008, 3M (Consumer and Office Business) purchased 100 percent of the outstanding shares of Kolors Kevarkian, S.A., a manufacturer of branded floor cleaning tools based in Argentina.

 

(4) In July 2008, 3M (Industrial and Transportation Business) purchased 100 percent of the outstanding shares of K&H Surface Technologies Pty. Ltd., an Australian-based manufacturing company specializing in a range of repair products for the professional do-it-yourself automotive refinish markets.

 

(5) In July 2008, 3M (Safety, Security and Protection Services Business) purchased 100 percent of the outstanding shares of Quest Technologies Inc., a manufacturer of environmental monitoring equipment, including noise, heat stress and vibration monitors that is headquartered in Oconomowoc, Wisconsin.

 

(6) In July 2008, 3M (Health Care Business) purchased 100 percent of the outstanding shares of IMTEC Corp., a manufacturer of dental implants and cone beam computed tomography scanning equipment for dental and medical radiology headquartered in Ardmore, Oklahoma.

 

(7) In August 2008, 3M (Health Care Business) purchased 100 percent of the outstanding shares of TOP-Service für Lingualtechnik GMbH, an orthodontic technology and services company based in Bad Essen, Germany offering a digital lingual orthodontic solution.

 

(8) In August 2008, 3M (Industrial and Transportation Business) purchased 100 percent of the outstanding shares of Polyfoam Products Inc., a structural adhesives company specializing in foam adhesives for tile roofing and other adhesive products for the building industry that is headquartered in Tomball, Texas.

 

(9) In August 2008, 3M (Industrial and Transportation Business) purchased 100 percent of the outstanding shares of Dedication to Detail, Inc., a Philadelphia-based manufacturer of paint finishing systems, including buffing and polishing pads.

 

(10) In September 2008, 3M (Industrial and Transportation Business) purchased 100 percent of the outstanding shares of Ligacon AG, a Switzerland-based manufacturer and supplier of filtration systems and filter elements for the pharmaceutical, biotech and general industrial markets.

 

(11) In October 2008, 3M (Industrial and Transportation Business) purchased 100 percent of the outstanding shares of EMFI S.A. and SAPO S.A.S., manufacturers of polyurethane-based structural adhesives and sealants, which are headquartered in Haguenau, France.

 

(12) In October 2008, 3M (Industrial and Transportation Business) purchased 100 percent of the outstanding shares of Meguiar’s Inc., a 100-year-old business that manufactures the leading Meguiar’s brand of car care products for cleaning and protecting automotive surfaces, which is headquartered in Irvine, California.

 

(13) In November 2008, 3M (Health Care Business) purchased certain assets of Food Diagnostics AS, a provider of food diagnostics products and services for the food safety industry, which is headquartered in Oslo, Norway.

 

(14) In November 2008, 3M (Electro and Communications Business) purchased 100 percent of the outstanding shares of Grafoplast S.p.A, a manufacturer of wire identification systems for the wire and cable market, which is headquartered in Predosa, Italy.

 

(15) In December 2008, 3M (Display and Graphics Business) purchased 100 percent of the outstanding shares of Financiere Burgienne, a provider of finished license plates under the FAAB and FABRICAUTO brands in France.

 

(16) In December 2008, 3M (Industrial and Transportation Business) purchased 100 percent of the outstanding shares of ABRASIVOS S.A., a manufacturer of coated abrasives, headquartered in Lima, Peru.

 

(17) In December 2008, 3M (Consumer and Office Business) purchased certain assets of the Futuro health supports and compression hosiery product line business, headquartered in Cincinnati, OH, from Beiersdorf AG.

 

Purchased identifiable intangible assets totaled $794 million and will be amortized on a straight-line basis over a weighted-average life of 13 years (lives ranging from one to 19 years). Acquired patents of $40 million will be amortized over a weighted-average life of 11 years and other acquired intangibles of $696 million, primarily customer relationships and tradenames, will be amortized over a weighted-average life of 13 years. Indefinite-lived assets of $58 million were purchased in the Meguiar’s acquisition detailed above, which relate to a well recognized brand name for a company that has been in existence for more than 100 years.

 

2007 acquisitions:

 

During 2007, the purchase price paid for business combinations totaled $539 million, net of cash acquired, plus approximately 150 thousand shares of 3M common stock, which had a market value of approximately $13 million.

 

The 16 business combinations completed during 2007 are summarized as follows:

 

1) In February 2007, 3M (Industrial and Transportation Business) purchased certain assets of Accuspray Application Technologies Inc., a manufacturer of spray paint equipment with a wide array of spray guns for architectural, automotive refinishing, industrial and woodworking applications.

 

2) In February 2007, 3M (Industrial and Transportation Business) purchased Sealed Air Corporation’s 50 percent interest in PolyMask Corporation, a joint venture between 3M and Sealed Air that produces protective films. The acquisition of Sealed Air’s interest results in 100 percent ownership by 3M.

 

3) In February 2007, 3M (Health Care Business) purchased 100 percent of the outstanding shares of Acolyte Biomedica Ltd., a Salisbury, U.K.-based provider of an automated microbial detection platform that aids in the rapid detection, diagnosis, and treatment of infectious diseases.

 

4) In May 2007, 3M (Safety, Security and Protection Services Business) purchased 100 percent of the outstanding shares of E Wood Holdings PLC, a North Yorkshire, UK-based manufacturer of high performance protective coatings for oil, gas, water, rail and automotive industries.

 

5) In May 2007, 3M (Electro and Communications Business) purchased certain assets of Innovative Paper Technologies LLC, a manufacturer of inorganic-based technical papers, boards and laminates for a wide variety of high temperature applications and Powell LLC, a supplier of non-woven polyester mats for the electrical industry.

 

6) In May 2007, 3M (Health Care Business) purchased certain assets of Articulos de Papel DMS Chile, a Santiago, Chile-based manufacturer of disposable surgical packs, drapes, gowns and kits.

 

7) In June 2007, 3M (Industrial and Transportation Business) purchased certain assets of Diamond Productions Inc., a manufacturer of superabrasive diamond and cubic boron nitride wheels and tools for dimensioning and finishing hard-to-grind materials in metalworking, woodworking and stone fabrication markets in exchange for approximately 150 thousand shares of 3M common stock, which had a market value of $13 million at the acquisition measurement date and was previously held as 3M treasury stock.

 

8) In July 2007, 3M (Safety, Security and Protection Services Business) purchased 100 percent of the outstanding shares of Rochford Thompson Equipment Ltd., a manufacturer of optical character recognition passport readers used by airlines and immigration authorities, headquartered in Newbury, U.K.

 

9) In August 2007, 3M (Health Care Business) purchased certain assets of Neoplast Co. Ltd., a manufacturer/distributor of surgical tapes and dressings and first aid bandages for both the professional and consumer markets across the Asia Pacific region.

 

10) In October 2007, 3M (Health Care Business) purchased 100 percent of the outstanding shares of Abzil Industria e Comercio Ltda., a manufacturer of orthodontic products based in Sao Jose do Rio Preto, Sao Paulo, Brazil.

 

11) In October 2007, 3M (Industrial and Transportation Business) purchased 100 percent of the outstanding shares of Venture Tape Corp. and certain related entities, a global provider of pressure sensitive adhesive tapes based in Rockland, Mass.

 

12) In October 2007, 3M (Display and Graphics Business) purchased certain assets of Macroworx Media Pvt Ltd., a software company that specializes in the design and development of digital signage solutions based in Bangalore, India.

 

13) In October 2007, 3M (Health Care Business) purchased 100 percent of the outstanding shares of Lingualcare Inc., a Dallas-based orthodontic technology and services company offering the iBraces system, a customized, lingual orthodontic solution.

 

14) In November 2007, 3M (Industrial and Transportation Business) purchased certain assets of Standard Abrasives, a manufacturer of coated abrasive specialties and non-woven abrasive products for the metalworking industry headquartered in Simi Valley, Ca.

 

15) In November 2007, 3M (Industrial and Transportation Business) purchased 100 percent of the outstanding shares of Unifam Sp. z.o.o., a manufacturer of cut-off wheels, depressed center grinding wheels and flap discs based in Poland.

 

16) In November 2007, 3M (Industrial and Transportation Business) purchased certain assets of Bondo Corp., a manufacturer of auto body repair products for the automotive aftermarket and various other professional and consumer applications based in Atlanta, Ga.

 

Purchased identifiable intangible assets for the 16 business combinations closed during the twelve months ended December 31, 2007 totaled $124 million and will be amortized on a straight-line basis over lives ranging from two to 10 years (weighted-average life of six years).

 

Divestitures:

 

In June 2008, 3M completed the sale of HighJump Software, a 3M Company, to Battery Ventures, a technology venture capital and private equity firm. 3M received proceeds of $85 million for this transaction and recognized, net of assets sold, transaction and other costs, a pre-tax loss of $23 million (recorded in the Safety, Security and Protection Services segment) in 2008.

 

In June 2007, 3M completed the sale of its Opticom Priority Control Systems and Canoga Traffic Detection businesses to TorQuest Partners Inc., a Toronto-based investment firm. 3M received proceeds of $80 million for this transaction and recognized, net of assets sold, transaction and other costs, a pre-tax gain of $68 million (recorded in the Display and Graphics segment) in 2007. In January 2007, 3M completed the sale of its global branded pharmaceuticals business in Europe to Meda AB. 3M received proceeds of $817 million for this transaction and recognized, net of assets sold, a pre-tax gain of $781 million (recorded in the Health Care segment) in 2007.

 

In connection with the pharmaceuticals transaction, 3M entered into agreements whereby its Drug Delivery Systems Division became a source of supply to the acquiring company. Because of the extent of 3M cash flows from these agreements in relation to those of the disposed-of businesses, the operations of the branded pharmaceuticals business are not classified as discontinued operations. See Note 4 for further discussion of restructuring actions that resulted from the divestiture of the Company’s global branded pharmaceuticals business.

 

Goodwill and Intangible Assets
Goodwill and Intangible Assets

NOTE 3.  Goodwill and Intangible Assets

 

Purchased goodwill from the four acquisitions that closed in 2009 totaled $15 million, $9 million of which is deductible for tax purposes. Purchased goodwill from acquisitions totaled $1.392 billion in 2008, $34 million of which is deductible for tax purposes. The acquisition activity in the following table also includes the impacts of adjustments to the preliminary allocation of purchase price and certain acquisition costs and contingent consideration for pre-2009 acquisitions, which reduced goodwill by $40 million in 2009. The amounts in the “Translation and other” column in the following table primarily relate to changes in foreign currency exchange rates, except for the $77 million decrease in goodwill related to the second-quarter 2008 sale of 3M’s HighJump Software business (included in the Safety, Security and Protection Services business). The goodwill balance by business segment follows:

 

Goodwill

 

(Millions)

 

Dec. 31,
2007
Balance

 

2008
acquisition
activity

 

2008
translation
and other

 

Dec. 31,
2008
Balance

 

2009
acquisition
activity

 

2009
translation
and other

 

Dec. 31,
2009
Balance

 

Industrial and Transportation

 

$

1,546

 

$

215

 

$

(24

)

$

1,737

 

$

(4

)

$

50

 

$

1,783

 

Health Care

 

839

 

170

 

(21

)

988

 

5

 

14

 

1,007

 

Consumer and Office

 

94

 

34

 

27

 

155

 

11

 

(11

)

155

 

Safety, Security and Protection Services

 

589

 

792

 

(224

)

1,157

 

6

 

57

 

1,220

 

Display and Graphics

 

894

 

140

 

8

 

1,042

 

(44

)

(8

)

990

 

Electro and Communications

 

627

 

41

 

6

 

674

 

1

 

2

 

677

 

Total Company

 

$

4,589

 

$

1,392

 

$

(228

)

$

5,753

 

$

(25

)

$

104

 

$

5,832

 

 

Accounting standards require that goodwill be tested for impairment annually and between annual tests in certain circumstances such as a change in reporting units or the testing of recoverability of a significant asset group within a reporting unit. At 3M, reporting units generally correspond to a division.

 

As discussed in Note 17 to the Consolidated Financial Statements, effective in the first quarter of 2010, 3M made certain product moves between its business segments, with the resulting impact reflected in the goodwill balances by business segment above for all periods presented. For those changes that resulted in reporting unit changes, the Company applied the relative fair value method to determine the impact to reporting units. During the first quarter of 2010, the Company completed its assessment of any potential goodwill impairment for reporting units impacted by this new structure and determined that no impairment existed.

 

As discussed in Note 13, in June 2009, 3M tested the long lived assets grouping associated with the U.K. passport production activity of 3M’s Security Systems Division for recoverability. This circumstance required the Company to also test goodwill for impairment at the reporting unit (Security Systems Division) level. 3M completed its assessment of potential goodwill impairment for this reporting unit and determined that no goodwill impairment existed as of June 30, 2009. The Company also completed its annual goodwill impairment test in the fourth quarter of 2009 for all reporting units and determined that no impairment existed. In addition, the Company had no impairments of goodwill in prior years.

 

Acquired Intangible Assets

 

For 2009, acquired intangible asset activity through business combinations increased the gross carrying amount by $93 million. Balances are also impacted by changes in foreign currency exchange rates. The gross carrying amount and accumulated amortization of acquired intangible assets as of December 31 follow:

 

(Millions)

 

2009

 

2008

 

Patents

 

$

457

 

$

475

 

Other amortizable intangible assets (primarily tradenames and customer-related intangibles)

 

1,519

 

1,381

 

Non-amortizable intangible assets (tradenames)

 

138

 

130

 

Total gross carrying amount

 

$

2,114

 

$

1,986

 

Accumulated amortization — patents

 

(339

)

(318

)

Accumulated amortization — other

 

(433

)

(270

)

Total accumulated amortization

 

(772

)

(588

)

Total intangible assets — net

 

$

1,342

 

$

1,398

 

 

3M has non-amortizable tradenames with a carrying value of $138 million as of December 31, 2009, and $130 million as of December 31, 2008. These tradenames are not amortized because of the long-time established name recognition in their respective industries.

 

Amortization expense for acquired intangible assets increased significantly in 2009 and 2008 due to the significant amount of acquired intangibles in 2008 and 2007 (Note 2). Amortization expense for the years ended December 31 follows:

 

(Millions)

 

2009

 

2008

 

2007

 

Amortization expense

 

$

181

 

$

122

 

$

87

 

 

Expected amortization expense for acquired amortizable intangible assets recorded as of December 31, 2009 follows:

 

(Millions)

 

2010

 

2011

 

2012

 

2013

 

2014

 

After 2014

 

Amortization expense

 

$

161

 

$

133

 

$

126

 

$

119

 

$

111

 

$

554

 

 

The preceding expected amortization expense is an estimate. Actual amounts of amortization expense may differ from estimated amounts due to additional intangible asset acquisitions, changes in foreign currency exchange rates, impairment of intangible assets, accelerated amortization of intangible assets and other events. 3M expenses the costs incurred to renew or extend the term of intangible assets.

 

Restructuring Actions and Exit Activities
Restructuring Actions and Exit Activities

NOTE 4.  Restructuring Actions and Exit Activities

 

Restructuring actions and exit activities generally include significant actions involving employee-related severance charges, contract termination costs, and impairment of assets associated with such actions.

 

Employee-related severance charges are largely based upon distributed employment policies and substantive severance plans. These charges are reflected in the quarter in which management approves the associated actions, the actions are probable, and the amounts are estimable. Severance amounts for which affected employees were required to render service in order to receive benefits at their termination dates were measured at the date such benefits were communicated to the applicable employees and recognized as expense over the employees’ remaining service periods.

 

Contract termination and other charges primarily reflect costs to terminate a contract before the end of its term (measured at fair value at the time the Company provided notice to the counterparty) or costs that will continue to be incurred under the contract for its remaining term without economic benefit to the Company. As discussed in accounting policies in Note 1, asset impairment charges related to intangible assets and property, plant and equipment reflect the excess of the assets’ carrying values over their fair values.

 

The following provides information, respectively, concerning the Company’s 2009/2008 restructuring actions, its 2007/2006 restructuring actions, and its exit activities during 2008 and 2007.

 

2009 and 2008 Restructuring Actions:

 

During the fourth quarter of 2008 and the first nine months of 2009, management approved and committed to undertake certain restructuring actions. Due to the rapid decline in global business activity in the fourth quarter of 2008 and into the first three quarters of 2009, 3M aggressively reduced its cost structure and rationalized several facilities, including manufacturing, technical and office facilities. These actions included all geographies, with particular attention in the developed areas of the world that have and are experiencing large declines in business activity, and included the following:

 

·                  During the fourth quarter of 2008, 3M announced the elimination of more than 2,400 positions. Of these employment reductions, about 31 percent were in the United States, 29 percent in Europe, 24 percent in Latin America and Canada, and 16 percent in the Asia Pacific area. These restructuring actions resulted in a fourth-quarter 2008 pre-tax charge of $229 million, with $186 million for employee-related items/benefits and other, and $43 million related to fixed asset impairments. The preceding charges were recorded in cost of sales ($84 million), selling, general and administrative expenses ($135 million), and research, development and related expenses ($10 million). Cash payments in 2008 related to this restructuring were not material.

 

·                  During the first quarter of 2009, 3M announced the elimination of approximately 1,200 positions. Of these employment reductions, about 43 percent were in the United States, 36 percent in Latin America, 16 percent in Europe and 5 percent in the Asia Pacific area. These restructuring actions resulted in a first-quarter 2009 pre-tax charge of $67 million, with $61 million for employee-related items/benefits and $6 million related to fixed asset impairments. The preceding charges were recorded in cost of sales ($17 million), selling, general and administrative expenses ($47 million), and research, development and related expenses ($3 million).

 

·                  During the second quarter of 2009, 3M announced the permanent reduction of approximately 900 positions, the majority of which were concentrated in the United States, Western Europe and Japan. In the United States, another 700 people accepted a voluntary early retirement incentive program offer. As discussed in Note 11, a $21 million non-cash charge was related to the approximately 700 participants who accepted the voluntary early retirement incentive program offer. Of these aggregate employment reductions, about 66 percent were in the United States, 17 percent in the Asia Pacific area, 14 percent in Europe and 3 percent in Latin America and Canada. These restructuring actions in total resulted in a second-quarter 2009 pre-tax charge of $116 million, with $103 million for employee-related items/benefits and $13 million related to fixed asset impairments. The preceding charges were recorded in cost of sales ($68 million), selling, general and administrative expenses ($44 million), and research, development and related expenses ($4 million).

 

·                  During the third quarter of 2009, 3M announced the elimination of approximately 200 positions, with the majority of those occurring in Western Europe and, to a lesser extent, the United States. These restructuring actions, including a non-cash charge related to a pension settlement in Japan (discussed further in Note 11), resulted in a third-quarter 2009 net pre-tax charge of $26 million for employee-related items/benefits and other, which is net of $7 million of adjustments to prior 2008 and 2009 restructuring actions. The preceding charges were recorded in cost of sales ($25 million) and research, development and related expenses ($1 million).

 

The restructuring expenses related to these actions are summarized by income statement line as follows:

 

(Millions)

 

2009

 

2008

 

Cost of sales

 

$

110

 

$

84

 

Selling, general and administrative expenses

 

91

 

135

 

Research, development and related expenses

 

8

 

10

 

Total restructuring expense

 

$

209

 

$

229

 

 

Components of these restructuring actions by business segment and a roll-forward of associated balances follow below. Cash payments in 2008 related to these actions were not material.

 

(Millions)

 

Employee-
Related
Items/
Benefits
and Other

 

Asset
Impairments

 

Total

 

 

 

 

 

 

 

 

 

Expenses incurred in 2008:

 

 

 

 

 

 

 

Industrial and Transportation

 

$

33

 

$

7

 

$

40

 

Health Care

 

37

 

14

 

51

 

Consumer and Office

 

17

 

1

 

18

 

Safety, Security and Protection Services

 

12

 

 

12

 

Display and Graphics

 

15

 

9

 

24

 

Electro and Communications

 

7

 

 

7

 

Corporate and Unallocated

 

65

 

12

 

77

 

Total 2008 expenses

 

$

186

 

$

43

 

$

229

 

 

 

 

 

 

 

 

 

Non-cash changes in 2008

 

$

 

$

(43

)

$

(43

)

 

 

 

 

 

 

 

 

Expenses incurred in 2009:

 

 

 

 

 

 

 

Industrial and Transportation

 

$

84

 

$

5

 

$

89

 

Health Care

 

20

 

 

20

 

Consumer and Office

 

13

 

 

13

 

Safety, Security and Protection Services

 

16

 

 

16

 

Display and Graphics

 

9

 

13

 

22

 

Electro and Communications

 

11

 

 

11

 

Corporate and Unallocated

 

37

 

1

 

38

 

Total 2009 expenses

 

$

190

 

$

19

 

$

209

 

 

 

 

 

 

 

 

 

Non-cash changes in 2009

 

$

(34

)

$

(19

)

$

(53

)

Cash payments, net of adjustments, in 2009

 

$

(266

)

$

 

$

(266

)

Accrued liability balance as of December 31, 2009

 

$

76

 

$

 

$

76

 

 

The majority of the remaining employee related items and benefits are expected to be paid out in cash in the first six months of 2010.

 

2007 and 2006 Restructuring Actions:

 

During the fourth quarter of 2006 and the first six months of 2007, management approved and committed to undertake the following restructuring actions:

 

·                  Pharmaceuticals business actions — employee-related, asset impairment and other costs pertaining to the Company’s exit of its branded pharmaceuticals operations. These costs included severance and benefits for pharmaceuticals business employees who are not obtaining employment with the buyers as well as impairment charges associated with certain assets not transferred to the buyers.

 

·                  Overhead reduction actions — employee-related costs for severance and benefits, costs associated with actions to reduce the Company’s cost structure.

 

·                  Business-specific actions — employee-related costs for severance and benefits, fixed and intangible asset impairments, certain contractual obligations, and expenses from the exit of certain product lines.

 

In connection with this targeted 2007/2006 restructuring plan, the Company eliminated a total of approximately 1,900 positions from various functions within the Company. Approximately 390 positions were pharmaceuticals business employees, approximately 960 positions related primarily to corporate staff overhead reductions, and approximately 550 positions were business-specific reduction actions. Of the 1,900 employment reductions, about 58 percent are in the United States, 21 percent in Europe, 12 percent in Latin America and Canada, and 9 percent in the Asia Pacific area. As a result of the second-quarter 2007 phaseout of operations at a New Jersey roofing granule facility and the sale of the Company’s Opticom Priority Control Systems and Canoga Traffic Detection businesses, the Company eliminated approximately 100 additional positions.

 

Actions with respect to the 2007/2006 restructuring plan were substantially completed in 2007. The net restructuring expenses (credits) incurred in 2007 related to these actions are summarized by income statement line as follows:

 

(Millions)

 

2007

 

Cost of sales

 

$

40

 

Selling, general and administrative expenses

 

5

 

Research, development and related expenses

 

(7

)

Total restructuring expense

 

$

38

 

 

The amount of net expenses (credits) incurred in 2007 associated with the restructuring actions are reflected in the Company’s business segments as follows:

 

(Millions)

 

2007

 

Industrial and Transportation

 

$

2

 

Health Care

 

(11

)

Safety, Security and Protection Services

 

28

 

Display and Graphics

 

3

 

Electro and Communications

 

18

 

Corporate and Unallocated

 

(2

)

Total

 

$

38

 

 

Components of these restructuring actions, beginning with accrued liability balances as of December 31, 2006, include:

 

(Millions)

 

Employee-
Related
Items and
Benefits

 

Contract Terminations
and Other

 

Asset
Impairments

 

Total

 

Accrued liability balances as of Dec. 31, 2006:

 

 

 

 

 

 

 

 

 

Pharmaceuticals business actions

 

$

78

 

$

6

 

$

 

$

84

 

Overhead reduction actions

 

100

 

 

 

100

 

Business-specific actions

 

30

 

8

 

 

38

 

Total accrued liability balance

 

$

208

 

$

14

 

$

 

$

222

 

 

 

 

 

 

 

 

 

 

 

Expenses (credits) incurred in 2007:

 

 

 

 

 

 

 

 

 

Pharmaceuticals business actions

 

$

(12

)

$

(4

)

$

 

$

(16

)

Overhead reduction actions

 

2

 

 

 

2

 

Business-specific actions

 

13

 

4

 

35

 

52

 

2007 expense

 

$

3

 

$

 

$

35

 

$

38

 

 

 

 

 

 

 

 

 

 

 

Non-cash changes in 2007:

 

 

 

 

 

 

 

 

 

Pharmaceuticals business actions

 

$

(21

)

$

4

 

$

 

$

(17

)

Overhead reduction actions

 

(5

)

 

 

(5

)

Business-specific actions

 

(12

)

(4

)

(35

)

(51

)

2007 non-cash

 

$

(38

)

$

 

$

(35

)

$

(73

)

 

 

 

 

 

 

 

 

 

 

Cash payments in 2007:

 

 

 

 

 

 

 

 

 

Pharmaceuticals business actions

 

$

(40

)

$

(6

)

$

 

$

(46

)

Overhead reduction actions

 

(87

)

 

 

(87

)

Business-specific actions

 

(26

)

(8

)

 

(34

)

2007 cash payments

 

$

(153

)

$

(14

)

$

 

$

(167

)

 

 

 

 

 

 

 

 

 

 

Accrued liability balances as of Dec. 31, 2007:

 

 

 

 

 

 

 

 

 

Pharmaceuticals business actions

 

$

5

 

$

 

$

 

$

5

 

Overhead reduction actions

 

10

 

 

 

10

 

Business-specific actions

 

5

 

 

 

5

 

Total accrued liability balance

 

$

20

 

$

 

$

 

$

20

 

 

 

 

 

 

 

 

 

 

 

Cash payments in 2008:

 

 

 

 

 

 

 

 

 

Pharmaceuticals business actions

 

$

(5

)

$

 

$

 

$

(5

)

Overhead reduction actions

 

(10

)

 

 

(10

)

Business-specific actions

 

(4

)

 

 

(4

)

2008 cash payments

 

$

(19

)

$

 

$

 

$

(19

)

 

 

 

 

 

 

 

 

 

 

Accrued liability balances as of Dec. 31, 2008:

 

 

 

 

 

 

 

 

 

Pharmaceuticals business actions

 

$

 

$

 

$

 

$

 

Overhead reduction actions

 

 

 

 

 

Business-specific actions

 

1

 

 

 

1

 

Total accrued liability balance

 

$

1

 

$

 

$

 

$

1

 

 

 

 

 

 

 

 

 

 

 

Cash payments in 2009

 

$

(1

)

$

 

$

 

(1

)

Accrued liability balances as of Dec. 31, 2009

 

$

 

$

 

$

 

$

 

 

Non-cash employee-related changes in 2007 primarily relate to special termination pension and medical benefits granted to certain U.S. eligible employees. These pension and medical benefits were reflected as a component of the benefit obligation of the Company’s pension and medical plans as of December 31, 2007. In addition, these changes also reflect non-cash stock option expense due to the reclassification of certain employees age 50 and older to retiree status, resulting in a modification of their original stock option awards for accounting purposes.

 

Business-specific asset impairment charges for 2007 totaled $35 million. This included charges of $24 million related to property, plant and equipment associated with the Company’s decision to phaseout operations at a New Jersey roofing granule facility (Safety, Security and Protection Services segment) and charges of $11 million ($10 million related to property, plant and equipment and $1 million related to intangible assets) related to the Company’s decision to close an Electro and Communications facility in Wisconsin.

 

Exit Activities:

 

During the second and third quarters of 2008, management approved and committed to undertake certain exit activities, which resulted in a pre-tax charge of $68 million. These charges primarily related to employee-related liabilities and fixed asset impairments. During the fourth quarter 2008, a pre-tax benefit of $10 million was recorded, which primarily related to adjustments to employee-related liabilities for second and third-quarter 2008 exit activities. In total for 2008, these actions resulted in pre-tax charges for Industrial and Transportation ($26 million); Display and Graphics ($18 million); Health Care ($9 million); Safety, Security and Protection Services ($3 million); and Corporate and Unallocated ($2 million). These charges were recorded in cost of sales ($38 million), selling, general and administrative expenses ($17 million), and research, development and related expenses ($3 million).

 

During the second half of 2007, the Company recorded net pre-tax charges of $45 million related to exit activities. These charges related to employee reductions and fixed asset impairments, including the consolidation of certain flexible circuit manufacturing operations ($23 million recorded in the Electro and Communications segment) and other actions, primarily in the Display and Graphics segment and Industrial and Transportation segment. These charges were recorded in cost of sales and selling, general and administrative expenses and research, development and related expenses.

 

Supplemental Balance Sheet Information
Supplemental Balance Sheet Information

NOTE 5.  Supplemental Balance Sheet Information

 

(Millions)

 

2009

 

2008

 

Other current assets

 

 

 

 

 

Prepaid expenses and other

 

$

657

 

$

552

 

Deferred income taxes

 

330

 

271

 

Derivative assets-current

 

25

 

215

 

Product and other insurance receivables

 

110

 

130

 

Total other current assets

 

$

1,122

 

$

1,168

 

 

 

 

 

 

 

Investments

 

 

 

 

 

Equity-method

 

$

73

 

$

73

 

Available-for-sale

 

11

 

5

 

Real estate and other

 

19

 

33

 

Total investments

 

$

103

 

$

111

 

 

 

 

 

 

 

Property, plant and equipment — at cost

 

 

 

 

 

Land

 

$

291

 

$

281

 

Buildings and leasehold improvements

 

6,069

 

5,787

 

Machinery and equipment

 

12,296

 

11,742

 

Construction in progress

 

627

 

903

 

Capital leases

 

157

 

99

 

Gross property, plant and equipment

 

19,440

 

18,812

 

Accumulated depreciation*

 

(12,440

)

(11,926

)

Property, plant and equipment — net

 

$

7,000

 

$

6,886

 

 

*                 Includes accumulated depreciation for capital leases of $50 million for 2009 and $40 million for 2008.

 

Other assets

 

 

 

 

 

Deferred income taxes

 

$

625

 

$

1,053

 

Product and other insurance receivables

 

171

 

206

 

Cash surrender value of life insurance policies

 

202

 

175

 

Other

 

277

 

225

 

Total other assets

 

$

1,275

 

$

1,659

 

 

 

 

 

 

 

Other current liabilities

 

 

 

 

 

Accrued trade payables

 

$

464

 

$

428

 

Deferred income

 

316

 

322

 

Derivative liabilities-current

 

94

 

203

 

Restructuring actions

 

76

 

187

 

Employee benefits and withholdings

 

150

 

157

 

Product and other claims

 

123

 

148

 

Property and other taxes

 

198

 

141

 

Pension and postretirement benefits

 

41

 

38

 

Deferred income taxes

 

27

 

19

 

Other

 

410

 

349

 

Total other current liabilities

 

$

1,899

 

$

1,992

 

 

Accounts payable (included as a separate line item in the Consolidated Balance Sheet) includes drafts payable on demand of $83 million and $98 million as of December 31, 2009, and 2008, respectively.

 

Other liabilities

 

 

 

 

 

Long term taxes payable

 

$

611

 

$

541

 

Employee benefits

 

491

 

537

 

Product and other claims

 

330

 

296

 

Capital lease obligations

 

107

 

58

 

Deferred income

 

23

 

22

 

Deferred income taxes

 

91

 

21

 

Other

 

74

 

162

 

Total other liabilities

 

$

1,727

 

$

1,637

 

 

Supplemental Equity and Comprehensive Income Information
Supplemental Equity and Comprehensive Income Information

NOTE 6.  Supplemental Equity and Comprehensive Income Information

 

Common stock ($.01 par value per share) of 3.0 billion shares is authorized, with 944,033,056 shares issued. Treasury stock is reported at cost, with 233,433,937 shares at December 31, 2009, 250,489,769 shares at December 31, 2008, and 234,877,025 shares at December 31, 2007. Preferred stock, without par value, of 10 million shares is authorized but unissued.

 

The components of other comprehensive income (loss) and accumulated other comprehensive income (loss) attributable to 3M follow.

 

Accumulated Other Comprehensive Income (Loss) Attributable to 3M

 

(Millions)

 

Dec. 31,
2009

 

Dec. 31,
2008

 

Cumulative translation adjustment

 

$

122

 

$

(146

)

Defined benefit pension and postretirement plans adjustment

 

(3,831

)

(3,525

)

Debt and equity securities, unrealized gain (loss)

 

(9

)

(19

)

Cash flow hedging instruments, unrealized gain (loss)

 

(36

)

44

 

Total accumulated other comprehensive income (loss)

 

$

(3,754

)

$

(3,646

)

 

Components of Comprehensive Income (Loss) Attributable to 3M

 

(Millions)

 

2009

 

2008

 

2007

 

Net income attributable to 3M

 

$

3,193

 

$

3,460

 

$

4,096

 

 

 

 

 

 

 

 

 

Cumulative translation

 

288

 

(920

)

456

 

Tax effect

 

(2

)

32

 

76

 

Cumulative translation - net of tax

 

286

 

(888

)

532

 

 

 

 

 

 

 

 

 

Defined benefit pension and postretirement plans adjustment

 

(462

)

(3,096

)

941

 

Tax effect

 

153

 

1,024

 

(327

)

Defined benefit pension and postretirement plans adjustment - net of tax

 

(309

)

(2,072

)

614

 

 

 

 

 

 

 

 

 

Debt and equity securities, unrealized gain (loss)

 

17

 

(18

)

(16

)

Tax effect

 

(7

)

7

 

6

 

Debt and equity securities, unrealized gain (loss) - net of tax

 

10

 

(11

)

(10

)

 

 

 

 

 

 

 

 

Cash flow hedging instruments, unrealized gain (loss)

 

(130

)

124

 

(24

)

Tax effect

 

50

 

(52

)

14

 

Cash flow hedging instruments, unrealized gain (loss) - net of tax

 

(80

)

72

 

(10

)

 

 

 

 

 

 

 

 

Total comprehensive income (loss) attributable to 3M

 

$

3,100

 

$

561

 

$

5,222

 

 

Reclassification adjustments are made to avoid double counting in comprehensive income items that are also recorded as part of net income. Reclassifications to earnings from accumulated other comprehensive income attributable to 3M that related to pension and postretirement expense in the income statement were $141 million pre-tax ($92 million after-tax) in 2009, $79 million pre-tax ($52 million after-tax) in 2008, and $198 million pre-tax ($123 million after-tax) in 2007. These pension and postretirement expense amounts are shown in the table in Note 11 as amortization of transition (asset) obligation, amortization of prior service cost (benefit) and amortization of net actuarial (gain) loss. Cash flow hedging instruments reclassifications are provided in Note 12. Reclassifications to earnings from accumulated other comprehensive income attributable to 3M for debt and equity securities primarily relate to a loss of approximately $2 million pre-tax for 2009, as shown in the auction rate securities table in Note 13, a loss of approximately $6 million pre-tax ($4 million after tax) for 2008, and was not material for 2007. Other reclassification adjustments were not material. Income taxes are not provided for foreign translation relating to permanent investments in international subsidiaries, but tax effects within cumulative translation does include impacts from items such as net investment hedge transactions.

 

Transfer of Ownership Interest Involving Non-Wholly Owned Subsidiaries

 

During 2009, a wholly owned subsidiary that, in turn, owned a portion of the Company’s majority owned Sumitomo 3M Limited entity, was transferred to another subsidiary that is majority, rather than wholly, owned. As a result of the transaction, 3M’s effective ownership in Sumitomo 3M Limited was reduced from 75 percent to 71.5 percent. The transfer was effected to further align activities in the associated region and to simplify the Company’s ownership structure. Because the Company retained its controlling interest in the subsidiaries involved, the transfer resulted in a decrease in 3M Company shareholders’ equity and an increase in noncontrolling interest of $81 million. The following table summarizes the effects of this transfer on equity attributable to 3M Company shareholders.

 

(Millions)

 

Twelve months
ended

Dec. 31, 2009

 

Net income attributable to 3M

 

$

3,193

 

Transfer to noncontrolling interest

 

(81

)

Change in 3M Company shareholders’ equity from net income attributable to 3M and transfers to noncontrolling interest

 

$

3,112

 

 

Supplemental Cash Flow Information
Supplemental Cash Flow Information

NOTE 7.  Supplemental Cash Flow Information

 

(Millions)

 

2009

 

2008

 

2007

 

Cash income tax payments

 

$

834

 

$

1,778

 

$

1,999

 

Cash interest payments

 

236

 

196

 

162

 

Capitalized interest

 

27

 

28

 

25

 

 

Individual amounts in the Consolidated Statement of Cash Flows exclude the impacts of acquisitions, divestitures and exchange rate impacts, which are presented separately. “Other — net” in the Consolidated Statement of Cash Flows within operating activities in 2009, 2008 and 2007 includes changes in liabilities related to 3M’s restructuring actions (Note 4).

 

Transactions related to investing and financing activities with significant non-cash components are as follows: During 2009, 3M recorded a capital lease asset and obligation of approximately $50 million related to an IT investment with an amortization period of seven years and contributed $600 million to its U.S. defined benefit pension plan in shares of the Company’s common stock. In 2007, 3M purchased certain assets of Diamond Productions, Inc. for approximately 150 thousand shares of 3M common stock, which has a market value of approximately $13 million at the acquisition’s measurement date. Liabilities assumed from acquisitions are provided in the tables in Note 2.

 

Income Taxes
Income Taxes

NOTE 8.  Income Taxes

 

Income Before Income Taxes

 

(Millions)

 

2009

 

2008

 

2007

 

United States

 

$

2,338

 

$

2,251

 

$

2,820

 

International

 

2,294

 

2,857

 

3,295

 

Total

 

$

4,632

 

$

5,108

 

$

6,115

 

 

Provision for Income Taxes

 

(Millions)

 

2009

 

2008

 

2007

 

Currently payable

 

 

 

 

 

 

 

Federal

 

$

88

 

$

882

 

$

1,344

 

State

 

13

 

14

 

58

 

International

 

586

 

820

 

779

 

Deferred

 

 

 

 

 

 

 

Federal

 

489

 

(168

)

(333

)

State

 

56

 

34

 

1

 

International

 

156

 

6

 

115

 

Total

 

$

1,388

 

$

1,588

 

$

1,964

 

 

Components of Deferred Tax Assets and Liabilities

 

(Millions)

 

2009

 

2008

 

Accruals not currently deductible

 

 

 

 

 

Employee benefit costs

 

$

134

 

$

230

 

Product and other claims

 

174

 

198

 

Pension costs

 

692

 

914

 

Stock-based compensation

 

473

 

425

 

Product and other insurance receivables

 

(85

)

(100

)

Accelerated depreciation

 

(586

)

(463

)

Other

 

35

 

80

 

Net deferred tax asset

 

$

837

 

$

1,284

 

 

Reconciliation of Effective Income Tax Rate

 

 

 

2009

 

2008

 

2007

 

Statutory U.S. tax rate

 

35.0

%

35.0

%

35.0

%

State income taxes — net of federal benefit

 

1.1

 

0.9

 

0.9

 

International income taxes — net

 

(4.9

)

(3.9

)

(2.8

)

U.S. business credits

 

(0.4

)

(0.4

)

(0.3

)

Reserves for tax contingencies/return to provision

 

0.4

 

0.3

 

0.4

 

Restructuring actions

 

 

0.4

 

0.1

 

Medicare Modernization Act

 

(0.2

)

(0.2

)

(0.4

)

Domestic Manufacturer’s deduction

 

(0.7

)

(0.8

)

(0.8

)

All other — net

 

(0.3

)

(0.2

)

 

Effective worldwide tax rate

 

30.0

%

31.1

%

32.1

%

 

The Company files income tax returns in the U.S. federal jurisdiction, and various states and foreign jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2002.

 

The Internal Revenue Service (IRS) completed its examination of the Company’s U.S. federal income tax returns for the years 2002 through 2004 in the first quarter of 2008. The outcome of the 2002 through 2004 audit cycle impacted the 2001 tax year, which was settled in the second quarter of 2008. The IRS completed its field examination of the Company’s U.S. federal income tax returns for the years 2005 through 2007 in the fourth quarter of 2009. The Company has protested certain IRS positions within these tax years and is expected to enter the administrative appeals process with the IRS during 2010. Currently, the Company is under examination by the IRS for its U.S. federal income tax returns for the years 2008 and 2009. It is anticipated that the IRS will complete its examination of the Company for 2008 by the end of the first quarter of 2010 and for 2009 by the end of the first quarter of 2011. As of December 31, 2009, the IRS has not proposed any significant adjustments to the Company’s tax positions for which the Company is not adequately reserved. Payments relating to any proposed assessments arising from the 2005 through 2009 audits may not be made until a final agreement is reached between the Company and the IRS on such assessments or upon a final resolution resulting from the administrative appeals process or judicial action. In addition to the U.S. federal examination, there is also limited audit activity in several U.S. state and foreign jurisdictions.

 

3M anticipates changes to the Company’s uncertain tax positions due to the closing of the various audit years mentioned above. Currently, the Company is not able to reasonably estimate the amount by which the liability for unrecognized tax benefits will increase or decrease during the next 12 months as a result of the ongoing income tax authority examinations.

 

The Company adopted the new guidance relating to accounting for uncertainty in income taxes, in accordance with ASC 740, Income Taxes, on January 1, 2007. Upon adoption, the Company recognized an immaterial increase in the liability for unrecognized tax benefits, which was accounted for as a reduction to the January 1, 2007, balance of retained earnings. A reconciliation of the beginning and ending amount of gross unrecognized tax benefits (UTB) is as follows:

 

Federal, State and Foreign Tax

 

(Millions)

 

2009

 

2008

 

2007

 

Gross UTB Balance at January 1

 

$

557

 

$

680

 

$

691

 

 

 

 

 

 

 

 

 

Additions based on tax positions related to the current year

 

121

 

126

 

79

 

Additions for tax positions of prior years

 

164

 

98

 

143

 

Reductions for tax positions of prior years

 

(177

)

(180

)

(189

)

Settlements

 

 

(101

)

(24

)

Reductions due to lapse of applicable statute of limitations

 

(47

)

(66

)

(20

)

 

 

 

 

 

 

 

 

Gross UTB Balance at December 31

 

$

618

 

$

557

 

$

680

 

 

 

 

 

 

 

 

 

Net UTB impacting the effective tax rate at December 31

 

$

425

 

$

334

 

$

334

 

 

The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate by $425 million as of December 31, 2009, and $334 million as of both December 31, 2008 and December 31, 2007. The ending net UTB results from adjusting the gross balance for items such as Federal, State, and non-U.S. deferred items, interest and penalties, and deductible taxes. The net UTB is included as components of Other Current Assets, Other Assets, and Other Liabilities within the Consolidated Balance Sheet.

 

The Company recognizes interest and penalties accrued related to unrecognized tax benefits in tax expense. The Company recognized in the consolidated statement of income on a gross basis approximately $6 million, $8 million, and $9 million of expense in 2009, 2008, and 2007, respectively. At December 31, 2009 and December 31, 2008, accrued interest and penalties in the consolidated balance sheet on a gross basis were $53 million and $47 million, respectively. Included in these interest and penalty amounts are interest and penalties related to tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. Because of the impact of deferred tax accounting, other than interest and penalties, the disallowance of the shorter deductibility period would not affect the annual effective tax rate but would accelerate the payment of cash to the taxing authority to an earlier period.

 

The Company made discretionary contributions to its U.S. qualified pension plan of $710 million in 2009, $200 million in 2008, and $200 million in 2007. In addition, the Company made contributions to its international pension plans of $504 million in 2009, $186 million in 2008, and $151 million in 2007. The current income tax provision includes a benefit for the pension contributions; the deferred tax provision includes a cost for the related temporary difference.

 

As a result of certain employment commitments and capital investments made by 3M, income from manufacturing activities in Taiwan, China, Brazil, Korea, and Singapore is subject to reduced tax rates or, in some cases, is exempt from tax for years through 2011, 2012, 2013, 2014, and 2023, respectively. The income tax benefits attributable to the tax status of these subsidiaries are estimated to be $50 million (7 cents per diluted share) in 2009, $44 million (6 cents per diluted share) in 2008, and $47 million (6 cents per diluted share) in 2007.

 

The Company has not provided deferred taxes on unremitted earnings attributable to international companies that have been considered to be reinvested indefinitely. These earnings relate to ongoing operations and were approximately $5.6 billion as of December 31, 2009. Because of the availability of U.S. foreign tax credits, it is not practicable to determine the income tax liability that would be payable if such earnings were not indefinitely reinvested.

 

Marketable Securities
Marketable Securities

NOTE 9.  Marketable Securities

 

The Company invests in asset-backed securities, agency securities, corporate medium-term note securities and other securities. The following is a summary of amounts recorded on the Consolidated Balance Sheet for marketable securities (current and non-current).

 

(Millions)

 

Dec. 31, 2009

 

Dec. 31, 2008

 

 

 

 

 

 

 

Agency securities

 

$

326

 

$

180

 

Corporate securities

 

154

 

145

 

Asset-backed securities:

 

 

 

 

 

Automobile loans related

 

198

 

24

 

Credit cards related

 

9

 

 

Other

 

49

 

11

 

Asset-backed securities total

 

256

 

35

 

Other securities

 

8

 

13

 

 

 

 

 

 

 

Current marketable securities

 

$

744

 

$

373

 

 

 

 

 

 

 

Agency securities

 

$

165

 

$

200

 

Corporate securities

 

112

 

62

 

Treasury securities

 

94

 

12

 

Asset-backed securities:

 

 

 

 

 

Automobile loans related

 

317

 

25

 

Credit cards related

 

98

 

40

 

Other

 

34

 

11

 

Asset-backed securities total

 

449

 

76

 

Auction rate and other securities

 

5

 

2

 

 

 

 

 

 

 

Non-current marketable securities

 

$

825

 

$

352

 

 

 

 

 

 

 

Total marketable securities

 

$

1,569

 

$

725

 

 

Classification of marketable securities as current or non-current is dependent upon management’s intended holding period, the security’s maturity date and liquidity considerations based on market conditions. If management intends to hold the securities for longer than one year as of the balance sheet date, they are classified as non-current. At December 31, 2009, gross unrealized losses totaled approximately $12 million (pre-tax), while gross unrealized gains totaled approximately $3 million (pre-tax). At December 31, 2008, gross unrealized losses totaled approximately $30 million (pre-tax), while gross unrealized gains were not material. Gross realized gains on sales or maturities of marketable securities were not material in 2009, $5 million in 2008 and $7 million in 2007. Gross realized losses on sales or maturities of marketable securities were $3 million for 2009 and were not material for 2008 and 2007. Cost of securities sold use the first in, first out (FIFO) method. Since these marketable securities are classified as available-for-sale securities, changes in fair value will flow through other comprehensive income, with amounts reclassified out of other comprehensive income into earnings upon sale or “other-than-temporary” impairment.

 

3M reviews impairments associated with the above in accordance with the measurement guidance provided by ASC 320, Investments-Debt and Equity Securities, when determining the classification of the impairment as “temporary” or “other-than-temporary”. In addition, as discussed in Note 1, beginning in April 2009, the Company considers the new accounting standard with respect to the determination of “other-than-temporary” impairments associated with investments in debt securities. A temporary impairment charge results in an unrealized loss being recorded in the other comprehensive income component of shareholders’ equity. Such an unrealized loss does not reduce net income attributable to 3M for the applicable accounting period because the loss is not viewed as other-than-temporary. The factors evaluated to differentiate between temporary and other-than-temporary include the projected future cash flows, credit ratings actions, and assessment of the credit quality of the underlying collateral, as well as the factors included in the impairment model for debt securities included in the new standard relating to “other-than temporary” impairments, as described in Note 1.

 

The balance at December 31, 2009 for marketable securities and short-term investments by contractual maturity are shown below. Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.

 

(Millions)

 

Dec. 31, 2009

 

 

 

 

 

Due in one year or less

 

$

487

 

Due after one year through three years

 

960

 

Due after three years through five years

 

88

 

Due after five years

 

34

 

 

 

 

 

Total marketable securities

 

$

1,569

 

 

3M has a diversified marketable securities portfolio of $1.569 billion as of December 31, 2009. Within this portfolio, current and long-term asset-backed securities (estimated fair value of $705 million) are primarily comprised of interests in automobile loans and credit cards. At December 31, 2009, the asset-backed securities credit ratings were AAA or A-1+, with the exception of three securities rated AA with a fair market value of less than $12 million, and one security rated A with a fair market value of less than $1 million.

 

Historically, 3M’s marketable securities portfolio included auction rate securities that represented interests in investment grade credit default swaps; however, the estimated fair value of auction rate securities are $5 million and $1 million as of December 31, 2009 and December 31, 2008, respectively. Gross unrealized losses within accumulated other comprehensive income related to auction rate securities totaled $8 million and $16 million (pre-tax) as of December 31, 2009 and December 31, 2008, respectively. As of December 31, 2009, auction rate securities associated with these balances have been in a loss position for more than 12 months. Since the second half of 2007, these auction rate securities failed to auction due to sell orders exceeding buy orders. Liquidity for these auction-rate securities is typically provided by an auction process that resets the applicable interest rate at pre-determined intervals, usually every 7, 28, 35, or 90 days. The funds associated with failed auctions will not be accessible until a successful auction occurs or a buyer is found outside of the auction process. 3M recorded “other-than-temporary” impairment charges associated with these auction rate securities that reduced pre-tax income by approximately $9 million in 2008 and $8 million 2007. In addition, 3M recognized a loss in 2009 when it reclassified an unrealized loss of $2 million from other comprehensive income in connection with the sale of its position in one of these auction rate securities. Refer to Note 13 for a table that reconciles the beginning and ending balances of auction rate securities.

 

Long-Term Debt and Short-Term Borrowings
Long-Term Debt and Short-Term Borrowings

NOTE 10.  Long-Term Debt and Short-Term Borrowings

 

Long-term debt and short-term borrowings as of December 31 consisted of the following (with interest rates as of December 31, 2009):

 

Long-Term Debt

 

(Millions)
Description / Principal Amount

 

Currency/
Fixed vs.
Floating*

 

Effective
Interest
Rate*

 

Final
Maturity
Date

 

2009

 

2008

 

Eurobond (625 million Euros)

 

Euro Fixed

 

4.98

%

2014

 

$

898

 

$

882

 

Medium-term note ($850 million)

 

USD Fixed

 

4.42

%

2013

 

849

 

849

 

Medium-term note ($800 million)

 

USD Floating

 

3.22

%

2011

 

801

 

799

 

30-year bond ($750 million)

 

USD Fixed

 

5.73

%

2037

 

747

 

747

 

Eurobond (400 million Euros)

 

Euro Floating

 

1.33

%

2014

 

623

 

603

 

Medium-term note ($500 million)

 

USD Fixed

 

4.67

%

2012

 

500

 

500

 

Medium-term note ($400 million)

 

USD Floating

 

 

2009

 

 

411

 

30-year debenture ($330 million)

 

USD Fixed

 

6.01

%

2028

 

350

 

351

 

Dealer Remarketable Securities ($350 million)

 

USD Fixed

 

5.61

%

2010

 

350

 

350

 

Convertible notes ($252 million)

 

USD Fixed

 

0.50

%

2032

 

225

 

224

 

Floating rate note ($100 million)

 

USD Floating

 

0.00

%

2041

 

100

 

100

 

Floating rate note ($60 million)

 

USD Floating

 

0.00

%

2044

 

60

 

62

 

ESOP debt guarantee ($44 million)

 

USD Fixed

 

 

2009

 

 

44

 

Other borrowings

 

Various

 

1.37

%

2010-2040

 

116

 

136

 

Total long-term debt

 

 

 

 

 

 

 

$

5,619

 

$

6,058

 

Less: current portion of long-term debt

 

 

 

 

 

 

 

522

 

892

 

Long-term debt (excluding current portion)

 

 

 

 

 

 

 

$

5,097

 

$

5,166

 

 

Short-Term Borrowings and Current Portion of Long-Term Debt

 

(Millions)

 

Effective
Interest Rate*

 

2009

 

2008

 

Current portion of long-term debt

 

4.00

%

$

522

 

$

892

 

U.S. dollar commercial paper

 

 

 

575

 

Other borrowings

 

7.46

%

91

 

85

 

Total short-term borrowings and current portion of long-term debt

 

 

 

$

613

 

$

1,552

 

 

Weighted-Average Effective Interest Rate*

 

 

 

Total

 

Excluding ESOP Debt

 

At December 31

 

2009

 

2008

 

2009

 

2008

 

Short-term

 

4.51

%

3.59

%

N/A

 

3.53

%

Long-term

 

4.04

%

4.72

%

N/A

 

4.72

%

 

*                 Debt tables reflect the effects of interest rate swaps at December 31; weighted-average effective interest rate table reflects the combined effects of interest rate and currency swaps at December 31. The ESOP debt matured in 2009.

 

Maturities of long-term debt for the five years subsequent to December 31, 2009 are as follows (in millions):

 

2010

 

2011

 

2012

 

2013

 

2014

 

After 2014

 

Total

$

522

 

$

923

 

$

724

 

$

849

 

$

1,521

 

$

1,080

 

$

5,619

 

The Company’s $350 million of Dealer Remarketable Securities (classified as current portion of long-term debt) were remarketed for one year in December 2009. Long-term debt payments due in 2010 include these $350 million of Dealer Remarketable Securities, which mature in December 2010, and $146 million of floating rate notes. The floating rate notes are classified as current portion of long-term debt as the result of put provisions associated with these debt instruments. Long-term debt payments due in 2011 include floating rate notes totaling $100 million as a result of put provisions. Additionally, payments due in 2012 include the $225 million carrying amount of Convertible Notes, as a result of put provisions.

 

The ESOP debt, which matured in 2009, was serviced by dividends on stock held by the ESOP and by Company contributions. These contributions were not reported as interest expense, but were reported as an employee benefit expense in the Consolidated Statement of Income. Refer to Note 15 for more detail on the ESOP. Other borrowings included debt held by 3M’s international companies and floating rate notes in the United States, with the long-term portion of this debt primarily composed of U.S. dollar floating rate debt.

 

The Company has an AA- credit rating, with a stable outlook, from Standard & Poor’s and an Aa2 credit rating, with a stable outlook, from Moody’s Investors Service. At December 31, 2009, the $350 million of Dealer Remarketable Securities had ratings triggers (BBB-/Baa3 or lower) that would require repayment of debt. In addition, under the Company’s $1.5-billion five-year credit facility agreement that was effective April 30, 2007, 3M is required to maintain its EBITDA to Interest Ratio as of the end of each fiscal quarter at not less than 3.0 to 1. This is calculated (as defined in the agreement) as the ratio of consolidated total EBITDA for the four consecutive quarters then ended to total interest expense on all funded debt for the same period. At December 31, 2009, this ratio was approximately 27 to 1. At December 31, 2009, available short-term committed lines of credit, including the preceding $1.5 billion five-year credit facility, totaled approximately $1.593 billion, of which approximately $145 million was utilized in connection with normal business activities. Debt covenants do not restrict the payment of dividends.

 

The floating rate notes due in 2044 have an annual put feature. According to the terms, holders can require 3M to repurchase the securities at a price of 98 percent of par value each December from 2005 through 2008, at 99 percent of par value from 2009 through 2013, and at 100 percent of par value from 2014 and every anniversary thereafter until final maturity in December 2044. In December 2009 and 2008, the Company was required to repurchase an immaterial amount of principal on this bond.

 

The Company has a “well-known seasoned issuer” shelf registration statement, effective February 17, 2009, which registers an indeterminate amount of debt or equity securities for future sales. No securities have been issued under this shelf. The Company intends to use the proceeds from future securities sales off this shelf for general corporate purposes. In connection with a prior “well-known seasoned issuer” shelf registration, in June 2007 the Company established a $3 billion medium-term notes program. Three debt securities have been issued under this medium-term notes program. First, in December 2007, 3M issued a five-year, $500 million, fixed rate note with a coupon rate of 4.65%. Second, in August 2008, 3M issued a five-year, $850 million, fixed rate note with a coupon rate of 4.375%. Third, in October 2008, the Company issued a three-year $800 million, fixed rate note with a coupon rate of 4.50%. The Company entered into an interest rate swap to convert this $800 million note to a floating rate.

 

The Company also issued notes under an earlier $1.5 billion medium-term note program. In March 2007, the Company issued a 30-year, $750 million, fixed rate note with a coupon rate of 5.70%. In November 2006, 3M issued a three-year, $400 million, fixed rate note. The Company entered into an interest rate swap to convert this to a rate based on a floating LIBOR index. Both the note and related swap matured in November 2009. In December 2004, 3M issued a 40-year, $62 million floating rate note ($60 million outstanding at December 31, 2009), with the rate based on a floating LIBOR index. This earlier $1.5 billion medium term note program was replaced by the $3 billion program established in June 2007.

 

In July 2007, 3M issued a seven year 5.0% fixed rate Eurobond for an amount of 750 million Euros (book value of approximately $1.123 billion in U.S. Dollars at December 31, 2009). Upon debt issuance in July 2007, 3M completed a fixed-to-floating interest rate swap on a notional amount of 400 million Euros as a fair value hedge of a portion of the fixed interest rate Eurobond obligation. In December 2007, 3M reopened the existing seven year 5.0% fixed rate Eurobond for an additional amount of 275 million Euros (book value of approximately $398 million in U.S. Dollars at December 31, 2009). This security was issued at a premium and was subsequently consolidated with the original security on January 15, 2008.

 

3M may redeem its 30-year zero-coupon senior notes (the “Convertible Notes”) at any time in whole or in part at the accreted conversion price; however, bondholders may convert upon notification of redemption each of the notes into 9.4602 shares of 3M common stock (which 3M would intend to payout in cash). Holders of the 30-year zero-coupon senior notes have the option to require 3M to purchase their notes at accreted value on November 21 in the years 2005, 2007, 2012, 2017, 2022 and 2027. In November 2005, 22,506 of the 639,000 in outstanding bonds were redeemed, resulting in a payout from 3M of approximately $20 million. In November 2007, an additional 364,598 outstanding bonds were redeemed resulting in a payout from 3M of approximately $322 million. These payouts reduced the Convertible Notes’ face value at maturity to $252 million, which equates to a book value of approximately $225 million at December 31, 2009. As disclosed in a Form 8-K in November 2005, 3M amended the terms of these securities to pay cash at a rate of 2.40% per annum of the principal amount at maturity of the Company’s Convertible Notes, which equated to 2.75% per annum of the notes’ accreted value on November 21, 2005. The cash interest payments were made semiannually in arrears on May 22, 2006, November 22, 2006, May 22, 2007 and November 22, 2007 to holders of record on the 15th calendar day preceding each such interest payment date. Effective November 22, 2007, the effective interest rate reverted back to the original yield of 0.50%.

 

3M originally sold $639 million in aggregate face amount of these “Convertible Notes” on November 15, 2002, which are convertible into shares of 3M common stock. The gross proceeds from the offering, to be used for general corporate purposes, were $550 million ($540 million net of issuance costs). As discussed in Note 1, 3M adopted changes to accounting for convertible debt instruments that may be settled in cash upon conversion (including partial cash settlement), effective January 1, 2009, with retrospective application to all periods presented. As such, additional interest expense essentially equivalent to the portion of issuance proceeds retroactively allocated to the instrument’s equity component was recognized over the period from the Convertible Notes’ issuance on November 15, 2002 through November 15, 2005 (the first date holders of these Notes had the ability to put them back to 3M). Debt issuance costs were amortized on a straight-line basis over a three-year period beginning in November 2002. Debt issue costs allocated to the Notes’ equity component were not material. On February 14, 2003, 3M registered these Convertible Notes in a registration statement filed with the Securities and Exchange Commission. The terms of the Convertible Notes include a yield to maturity of 0.50% and an initial conversion premium of 40 percent over the $65.00 (split-adjusted) closing price of 3M common stock on November 14, 2002. If certain conditions for conversion (relating to the closing common stock prices of 3M exceeding the conversion trigger price for specified periods) are met, holders may convert each of the 30-year zero-coupon senior notes into 9.4602 shares of 3M common stock in any calendar quarter commencing after March 31, 2003. The conversion trigger price for the fourth quarter of 2009 was $122.42 per share. If the conditions for conversion are met, and 3M elects not to settle in cash, the 30-year zero-coupon senior notes will be convertible in the aggregate into approximately 2.4 million shares of 3M common stock. The conditions for conversion related to the Company’s Convertible Notes have never been met. If the conditions for conversion are met, 3M may choose to pay in cash and/or common stock; however, if this occurs, the Company has the intent and ability to settle this debt security in cash. Accordingly, there was no impact on 3M’s diluted earnings per share.

 

In December 2009, the Company’s $350 million of Dealer Remarketable Securities were remarketed. They were reissued with a fixed coupon rate of 5.61%. These securities, which are classified as current portion of long-term debt, were originally issued in December 2000 and have a final maturity date of December 2010.

 

Pension and Postretirement Benefit Plans
Pension and Postretirement Benefit Plans

NOTE 11.  Pension and Postretirement Benefit Plans

 

3M has company-sponsored retirement plans covering substantially all U.S. employees and many employees outside the United States. In total, 3M has over 60 plans in 24 countries. Pension benefits associated with these plans generally are based on each participant’s years of service, compensation, and age at retirement or termination. In addition to providing pension benefits, the Company provides certain postretirement health care and life insurance benefits for substantially all of its U.S. employees who reach retirement age while employed by the Company. Most international employees and retirees are covered by government health care programs. The cost of company-provided postretirement health care plans for international employees is not material and is combined with U.S. amounts in the tables that follow.

 

The Company’s pension funding policy is to deposit with independent trustees amounts allowable by law. Trust funds and deposits with insurance companies are maintained to provide pension benefits to plan participants and their beneficiaries. There are no plan assets in the non-qualified plan due to its nature. For its U.S. postretirement health care and life insurance benefit plans, the Company has set aside amounts at least equal to annual benefit payments with an independent trustee.

 

In August 2006, the Pension Protection Act (PPA) was signed into law in the U.S. The PPA increases the funding target for defined benefit pension plans to 100% of the target liability. The PPA transition rules require a funding liability target of 92% in 2008, reaching 100% by 2011. 3M’s U.S. qualified defined benefit plans are funded at the applicable transition funding liability target for 2009.

 

During the first quarter of 2008, the Company made modifications to its U.S. postretirement benefits plan. The changes were effective beginning January 1, 2009, and allow current retired employees and employees who retire before January 1, 2013 the option to continue on the existing postretirement plans or elect the new plans. Current employees who retire after December 31, 2012, will receive a savings account benefits-based plan. As a result of the modification to the U.S. postretirement benefits plan, the Company remeasured its U.S. plans’ assets and accumulated postretirement benefit obligation (APBO) as of March 31, 2008. The impact of the plan modifications reduced the APBO by $148 million, which was partially offset by asset values being $97 million lower than on December 31, 2007. Therefore, the accrued benefit cost liability recorded on the balance sheet as of March 31, 2008, was reduced by $51 million. The remeasurement reduced the 2008 expense by $15 million.

 

In 2009, the Company made further modifications to its U.S. postretirement benefit plan. The changes are effective beginning January 1, 2010, and limit the amount of medical inflation absorbed by the Company to three percent a year. As a result, as of the December 31, 2009 measurement date, the APBO was reduced by $168 million.

 

During the second quarter of 2009, the Company offered a voluntary early retirement incentive program to certain eligible participants of its U.S. pension plans who met age and years of pension service requirements. The eligible participants who accepted the offer and retired by June 1, 2009, received an enhanced pension benefit. Pension benefits were enhanced by adding one additional year of pension service and one additional year of age for certain benefit calculations. Approximately 700 participants accepted the offer and retired by June 1, 2009. As a result, the Company incurred a $21 million charge related to these special termination benefits.

 

During 2009, 3M Sumitomo (Japan) experienced a higher number of retirements than normal, largely due to early retirement incentive programs, which required eligible employees who elected to leave the Company to retire by September 2009. Participants in the Japan pension plan had the option of receiving cash lump sum payments when exiting the plan, which a number of participants exiting the pension plan elected to receive. In accordance with ASC 715, Compensation — Retirement Benefits, settlement accounting is required when the lump sum distributions in a year are greater than the sum of the annual service and interest costs. Due to the large number of lump sum payment elections in 2009 the Company incurred $17 million of settlement charges.

 

3M was informed during the first quarter of 2009 that the general partners of WG Trading Company, in which 3M’s benefit plans hold limited partnership interests, are the subject of a criminal investigation as well as civil proceedings by the SEC and CFTC (Commodity Futures Trading Commission). As of December 31, 2009 these holdings represented less than 2 percent of 3M’s fair value of total plan assets. The court appointed receiver has taken control of WG Trading Company and other entities controlled by its general partners, and further redemptions of limited partnership interests are restricted pending court proceedings. 3M currently believes that the resolution of these events will not have a material adverse effect on the consolidated financial position of the Company. The Company has insurance that it believes, based on what is currently known, is applicable to this potential loss.

 

Following is a reconciliation of the beginning and ending balances of the benefit obligation and the fair value of plan assets as of December 31:

 

 

 

Qualified and Non-qualified
Pension Benefits

 

Postretirement

 

 

 

United States

 

International

 

Benefits

 

(Millions)

 

2009

 

2008

 

2009

 

2008

 

2009

 

2008

 

Change in benefit obligation

 

 

 

 

 

 

 

 

 

 

 

 

 

Benefit obligation at beginning of year

 

$

10,395

 

$

10,215

 

$

4,037

 

$

4,856

 

$

1,611

 

$

1,809

 

Acquisitions

 

 

22

 

 

 

 

 

Service cost

 

183

 

192

 

98

 

120

 

51

 

53

 

Interest cost

 

619

 

597

 

235

 

252

 

97

 

100

 

Participant contributions

 

 

 

4

 

5

 

52

 

56

 

Foreign exchange rate changes

 

 

 

284

 

(620

)

14

 

(20

)

Plan amendments

 

 

9

 

14

 

(9

)

(168

)

(148

)

Actuarial (gain) loss

 

822

 

(40

)

255

 

(369

)

80

 

(93

)

Medicare Part D Reimbursement

 

 

 

 

 

10

 

12

 

Benefit payments

 

(649

)

(606

)

(245

)

(194

)

(168

)

(158

)

Settlements, curtailments, special termination benefits and other

 

21

 

6

 

3

 

(4

)

 

 

Benefit obligation at end of year

 

$

11,391

 

$

10,395

 

$

4,685

 

$

4,037

 

$

1,579

 

$

1,611

 

Change in plan assets

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of plan assets at beginning of year

 

$

9,243

 

$

11,096

 

$

3,022

 

$

4,424

 

$

929

 

$

1,355

 

Acquisitions

 

 

13

 

 

 

 

 

Actual return on plan assets

 

1,148

 

(1,495

)

361

 

(872

)

129

 

(377

)

Company contributions

 

755

 

235

 

504

 

186

 

133

 

53

 

Participant contributions

 

 

 

4

 

5

 

52

 

56

 

Foreign exchange rate changes

 

 

 

251

 

(527

)

 

 

Benefit payments

 

(649

)

(606

)

(245

)

(194

)

(168

)

(158

)

Settlements, curtailments, special termination benefits and other

 

(4

)

 

 

 

 

 

Fair value of plan assets at end of year

 

$

10,493

 

$

9,243

 

$

3,897

 

$

3,022

 

$

1,075

 

$

929

 

Funded status at end of year

 

$

(898

)

$

(1,152

)

$

(788

)

$

(1,015

)

$

(504

)

$

(682

)

 

 

 

Qualified and Non-qualified
Pension Benefits

 

Postretirement

 

 

 

United States

 

International

 

Benefits

 

(Millions)

 

2009

 

2008

 

2009

 

2008

 

2009

 

2008

 

Amounts recognized in the Consolidated Balance Sheet as of Dec. 31,

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current assets

 

$

 

$

 

$

78

 

$

36

 

$

 

$

 

Accrued benefit cost

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

(30

)

(31

)

(7

)

(5

)

(4

)

(2

)

Non-current liabilities

 

(868

)

(1,121

)

(859

)

(1,046

)

(500

)

(680

)

Ending balance

 

$

(898

)

$

(1,152

)

$

(788

)

$

(1,015

)

$

(504

)

$

(682

)

Amounts recognized in accumulated other comprehensive income as of Dec. 31,

 

 

 

 

 

 

 

 

 

 

 

 

 

Net transition obligation (asset)

 

$

 

$

 

$

(5

)

$

(3

)

$

 

$

 

Net actuarial loss (gain)

 

3,975

 

3,489

 

1,650

 

1,468

 

1,059

 

1,089

 

Prior service cost (credit)

 

46

 

62

 

(57

)

(80

)

(504

)

(416

)

Ending balance

 

$

4,021

 

$

3,551

 

$

1,588

 

$

1,385

 

$

555

 

$

673

 

 

The balance of amounts recognized for international plans in accumulated other comprehensive income as of December 31 in the preceding table are presented based on the foreign currency exchange rate on that date.

 

The accumulated benefit obligation of the U.S. pension plans was $10.769 billion and $9.844 billion at December 31, 2009 and 2008, respectively. The accumulated benefit obligation of the international pension plans was $4.279 billion and $3.681 billion at December 2009 and 2008, respectively.

 

The following amounts relate to pension plans with accumulated benefit obligations in excess of plan assets as of December 31:

 

 

 

Qualified and Non-qualified Pension Plans

 

 

 

United States

 

International

 

(Millions)

 

2009

 

2008

 

2009

 

2008

 

Projected benefit obligation

 

$

454

 

$

10,395

 

$

3,322

 

$

3,562

 

Accumulated benefit obligation

 

448

 

9,844

 

3,126

 

3,293

 

Fair value of plan assets

 

23

 

9,243

 

2,526

 

2,529

 

 

Components of net periodic benefit cost and other supplemental information for the years ended December 31 follow:

 

Components of net periodic benefit cost and other amounts recognized in other comprehensive income

 

 

 

Qualified and Non-qualified
Pension Benefits

 

Postretirement

 

 

 

United States

 

International

 

Benefits

 

(Millions)

 

2009

 

2008

 

2007

 

2009

 

2008

 

2007

 

2009

 

2008

 

2007

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net periodic benefit cost

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service cost

 

$

183

 

$

192

 

$

192

 

$

98

 

$

120

 

$

125

 

$

51

 

$

53

 

$

57

 

Interest cost

 

619

 

597

 

568

 

235

 

252

 

228

 

97

 

100

 

104

 

Expected return on plan assets

 

(906

)

(889

)

(840

)

(260

)

(305

)

(290

)

(86

)

(104

)

(107

)

Amortization of transition (asset) obligation

 

 

 

 

3

 

3

 

3

 

 

 

 

Amortization of prior service cost (benefit)

 

16

 

15

 

14

 

(4

)

(2

)

(2

)

(81

)

(97

)

(72

)

Amortization of net actuarial (gain) loss

 

99

 

58

 

126

 

42

 

38

 

55

 

66

 

64

 

74

 

Net periodic benefit cost

 

$

11

 

$

(27

)

$

60

 

$

114

 

$

106

 

$

119

 

$

47

 

$

16

 

$

56

 

Settlements, curtailments, special termination benefits and other

 

26

 

7

 

7

 

25

 

3

 

4

 

 

 

9

 

Net periodic benefit cost after settlements, curtailments, special termination benefits and other

 

$

37

 

$

(20

)

$

67

 

$

139

 

$

109

 

$

123

 

$

47

 

$

16

 

$

65

 

 

The estimated amortization from accumulated other comprehensive income into net periodic benefit cost in 2010 follows:

 

Amounts expected to be amortized from accumulated other comprehensive income into net periodic benefit costs over next fiscal year

 

 

 

Qualified and Non-qualified
Pension Benefits

 

 

 

(Millions)

 

United
States

 

International

 

Postretirement
Benefits

 

Amortization of transition (asset) obligation

 

$

 

$

1

 

$

 

Amortization of prior service cost (benefit)

 

13

 

(3

)

(94

)

Amortization of net actuarial (gain) loss

 

221

 

85

 

86

 

Total amortization expected over the next fiscal year

 

$

234

 

$

83

 

$

(8

)

 

Other supplemental information for the years ended December 31 follows:

 

Weighted-average assumptions used to determine benefit obligations

 

 

 

Qualified and Non-qualified Pension Benefits

 

Postretirement

 

 

 

United States

 

International

 

Benefits

 

 

 

2009

 

2008

 

2007

 

2009

 

2008

 

2007

 

2009

 

2008

 

2007

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Discount rate

 

5.77

%

6.14

%

6.00

%

5.30

%

5.53

%

5.39

%

5.62

%

6.14

%

6.00

%

Compensation rate increase

 

4.30

%

4.30

%

4.30

%

3.72

%

3.50

%

3.82

%

N/A

 

N/A

 

N/A

 

 

Weighted-average assumptions used to determine net cost for years ended

 

 

 

2009

 

2008

 

2007

 

2009

 

2008

 

2007

 

2009

 

2008

 

2007

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Discount rate

 

6.14

%

6.00

%

5.75

%

5.53

%

5.39

%

4.88

%

6.14

%

6.00

%

5.75

%

Expected return on assets

 

8.50

%

8.50

%

8.75

%

6.86

%

7.19

%

7.19

%

7.24

%

8.60

%

8.60

%

Compensation rate increase

 

4.30

%

4.30

%

4.30

%

3.50

%

3.82

%

3.67

%

N/A

 

N/A

 

N/A

 

 

The Company determines the discount rate used to measure plan liabilities as of the December 31 measurement date for the U.S. pension and postretirement benefit plans, which is also the date used for the related annual measurement assumptions. The discount rate reflects the current rate at which the associated liabilities could be effectively settled at the end of the year. The Company sets its rate to reflect the yield of a portfolio of high quality, fixed-income debt instruments that would produce cash flows sufficient in timing and amount to settle projected future benefits. Using this methodology, the Company determined a discount rate of 5.77% for pension and 5.62% for postretirement benefits to be appropriate as of December 31, 2009, which is a decrease of 0.37 of a percentage point and 0.52 of a percentage point, respectively, from the rate used as of December 31, 2008. For the international pension and postretirement plans the discount rates also reflect the current rate at which the associated liabilities could be effectively settled at the end of the year. If the country has a deep market in corporate bonds the Company matches the expected cash flows from the plan either to a portfolio of bonds that generate sufficient cash flow or a notional yield curve generated from available bond information. In countries that do not have a deep market in corporate bonds, government bonds are considered with a risk premium to approximate corporate bond yields.

 

For the U.S. qualified pension plans, the Company’s assumption for the expected return on plan assets was 8.50% in 2009. Projected returns are based primarily on broad, publicly traded equity and fixed-income indices and forward-looking estimates of active portfolio and investment management. As of December 31, 2009, the Company’s 2010 expected long-term rate of return on U.S. plan assets is based on an asset allocation assumption of 40% global equities, with an expected long-term rate of return of 8.7%, 13% private equities with an expected long-term rate of return of 12.7%; 26% fixed-income securities with an expected long-term rate of return of 4.6%; 16% absolute return investments independent of traditional performance benchmarks, with an expected long term return of 6.5%; and 5% commodities with an expected long-term rate of return of 6.4%. The Company expects additional positive return from active investment management. These assumptions result in an 8.50% expected rate of return on an annualized basis in 2010. The actual rate of return on plan assets in 2009 was 12.6%. In 2008 the plan experienced a loss of 13.6% and in 2007 earned a rate of return in excess of 14%. The average annual actual return on the plan assets over the past 10 and 25 years has been 5.6% and 11.2%, respectively. Return on assets assumptions for international pension and other post-retirement benefit plans are calculated on a plan-by-plan basis using plan asset allocations and expected long-term rate of return assumptions.

 

During 2009, the Company made discretionary contributions totaling $710 million to its principal U.S. qualified pension plan. Of the $710 million, $600 million was contributed in shares of the Company’s common stock, which is considered a non-cash financing activity. In 2010, the Company expects to contribute an amount in the range of $500 million to $700 million to its U.S. and international retirement plans. The Company does not have a required minimum pension contribution obligation for its U.S. plans in 2010. Therefore, the amount of the anticipated discretionary contribution could vary significantly depending on the U.S. plans’ funded status and the anticipated tax deductibility of the contribution.

 

Assumed Health Care Trend Rates

 

The Company reviews external data and its own historical trends for health care costs to determine the health care trend rates for the postretirement medical plans. As of December 31, 2006, the Company modified its health care trend rates assumption by raising the rate and separating the trend rates used for plan participants less than 65 years of age and plan participants 65 years of age or older. The separation of the trend rates reflects the higher costs associated with prescription drugs in the 65 or older age group. The assumed health care trend rates as of December 31 are as follows:

 

 

 

2009

 

2008

 

 

 

Pre-65

 

Post-65

 

Pre-65

 

Post-65

 

Health care cost trend rate used to determine benefit obligations

 

7.75

%

8.50

%

8.00

%

9.25

%

Rate that the cost trend rate is assumed to decline to (ultimate trend rate)

 

5.00

%

5.00

%

5.00

%

5.00

%

Years to Ultimate Trend Rate

 

6

 

6

 

7

 

7

 

 

The assumed health care trend rates shown above reflect 3M’s expected medical and drug claims experience. As noted above, the Company made modifications to its postretirement health plan to limit the amount of inflation it will cover to three percent; the remaining inflation will be passed on to plan participants. Since the Company has limited its inflationary costs a change in medical trend rate only impacts the amount of Medicare Subsidy it will receive. A one percentage point change in assumed health cost trend rates would have the following effects:

 

Health Care Cost

 

(Millions)

 

One Percentage
Point Increase

 

One Percentage
Point Decrease

 

Effect on total of service and interest cost

 

$

14

 

$

(11

)

Effect on postretirement benefit obligation

 

(13

)

11

 

 

Future Pension and Postretirement Benefit Payments

 

The following table provides the estimated pension and postretirement benefit payments that are payable from the plans to participants, and also provides the Medicare subsidy receipts expected to be received.

 

 

 

Qualified and Non-qualified
Pension Benefits

 

Postretirement

 

Medicare Subsidy

 

(Millions)

 

United States

 

International

 

Benefits

 

Receipts

 

 

 

 

 

 

 

 

 

 

 

2010 Benefit Payments

 

$

652

 

$

194

 

$

127

 

$

12

 

2011 Benefit Payments

 

670

 

196

 

130

 

14

 

2012 Benefit Payments

 

691

 

213

 

132

 

15

 

2013 Benefit Payments

 

712

 

220

 

138

 

17

 

2014 Benefit Payments

 

735

 

235

 

146

 

18

 

Following five years

 

4,032

 

1,385

 

794

 

101

 

 

Plan Asset Management

 

3M’s investment strategy for its pension and postretirement plans is to manage the funds on a going-concern basis. The primary goal of the funds is to meet the obligations as required. The secondary goal is to earn the highest rate of return possible, without jeopardizing its primary goal, and without subjecting the Company to an undue amount of contribution rate volatility. Fund returns are used to help finance present and future obligations to the extent possible within actuarially determined funding limits and tax-determined asset limits, thus reducing the level of contributions 3M must make. The investment strategy has used long duration cash and derivative instruments to offset approximately 50 percent of the interest rate sensitivity of U.S. pension liabilities. In addition, credit risk is managed through mandates for public securities and maximum issuer limits that are established and monitored on a regular basis.

 

During 2009, $600 million of 3M common stock was contributed to the principal U.S. qualified pension plan. All of the 3M shares contributed to the U.S. pension plan were sold before year end by an independent fiduciary to the plan. Normally, 3M does not buy or sell any of its own stock as a direct investment for its pension and other postretirement benefit funds. However, due to external investment management of the funds, the plans may indirectly buy, sell or hold 3M stock. The aggregate amount of the shares would not be considered to be material relative to the aggregate fund percentages.

 

The discussion that follows references the fair value measurements of certain assets in terms of levels 1, 2 and 3. See Note 13 for descriptions of these levels.

 

U.S. Pension Plans Assets

 

In order to achieve the investment objectives in the U.S. pension plans, the investment policy includes a target strategic asset allocation. The investment policy allows some tolerance around the target in recognition that market fluctuations and illiquidity of some investments may cause the allocation to a specific asset class to stray from the target allocation, potentially for long periods of time. Acceptable ranges have been designed to allow for deviation from long-term targets and to allow for the opportunity for tactical over- and under-weights. The portfolio will normally be rebalanced when the quarter-end asset allocation deviates from acceptable ranges. The allocation is reviewed regularly by the named fiduciary of the plans.

 

The fair values of the assets held by the U.S. pension plans by asset category are as follows:

 

(Millions)

 

Fair Value
At Dec. 31,

 

Fair Value Measurements
Using Inputs Considered as

 

Asset Category

 

2009

 

Level 1

 

Level 2

 

Level 3

 

Global equity

 

$

3,109

 

$

2,391

 

$

714

 

$

4

 

Fixed income

 

2,878

 

795

 

1,898

 

185

 

Private equity

 

1,997

 

36

 

 

1,961

 

Absolute return

 

1,766

 

 

1,038

 

728

 

Commodities

 

396

 

 

159

 

237

 

Cash

 

489

 

489

 

 

 

Total

 

$

10,635

 

$

3,711

 

$

3,809

 

$

3,115

 

 

 

 

 

 

 

 

 

 

 

Other items to reconcile to fair value of plan assets

 

$

(142

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of plan assets

 

$

10,493

 

 

 

 

 

 

 

 

Global equity consists primarily of publicly traded U.S. and non-U.S. equities, Europe, Australasia, Far East (EAFE) index funds, equity private placement funds and some cash and cash equivalents. Publicly traded equities are valued at the closing price reported in the active market in which the individual securities are traded. Index funds are valued at the net asset value (NAV) as determined by the custodian of the fund. The NAV is based on the fair value of the underlying assets owned by the fund, minus its liabilities then divided by the number of units outstanding. Private placement funds are valued using the most recent general partner statement of fair value, updated for any subsequent partnership interests’ cash flows.

 

Fixed income consists of U.S. treasuries, preferred securities, convertible securities, U.S. and non-U.S. corporate bonds, asset backed securities, collateralized mortgage obligations, agencies, private placements and cash and cash equivalents. Included in fixed income are derivative investments such as credit default swaps, interest rate swaps and futures contracts that are used to help manage risks. U.S. government and government agency bonds and notes are valued at the closing price reported in the active market in which the individual security is traded. Corporate and other bonds and notes are valued at either the yields currently available on comparable securities of issuers with similar credit ratings or valued under a discounted cash flows approach that maximizes observable inputs, such as current yields of similar instruments, but includes adjustments for certain risks that may not be observable such as credit and liquidity risks. Swaps and derivative instruments are valued by the custodian using closing market swap curves and market derived inputs.

 

Private equity consists of interests in partnerships that invest in U.S. and non-U.S. debt and equity securities. The portfolio is a diversified mix of partnership interests including buyouts, distressed debt, growth equity, mezzanine, real estate and venture capital investments. Partnership interests are valued using the most recent general partner statement of fair value, updated for any subsequent partnership interests’ cash flows.

 

Absolute return consists primarily of private partnership interests in hedge funds, hedge fund of funds and bank loan funds. Partnership interests are valued using the NAV as determined by the administrator or custodian of the fund. Hedge fund partnership interests, which have a redemption right and are past any lock-up redemption period, are classified as level 2.

 

Commodities consist of commodity-linked notes and commodity-linked derivative contracts designed to deliver investment returns similar to the Goldman Sachs Commodities Index (GSCI) or Dow Jones UBS Commodity index returns. Commodities are valued at closing prices determined by calculation agents for outstanding transactions.

 

Other items to reconcile to fair value of plan assets is the net of interest receivable, amounts due for securities sold, amounts payable for securities purchased and interest payable.

 

The following table sets forth a summary of changes in the fair values of the U.S. pension plans’ level 3 assets for the year ended December 31, 2009:

 

 

 

Fair Value Measurement Using Significant Unobservable Inputs (Level 3)

 

(Millions)

 

Global
equity

 

Fixed
income

 

Private
equity

 

Absolute
return

 

Comm-
odities

 

Total

 

Beginning balance at January 1, 2009

 

$

1

 

$

122

 

$

2,054

 

$

1,548

 

$

 

$

3,725

 

Net transfers into / (out of) level 3

 

(106

)

 

 

(1,043

)

 

(1,149

)

Purchases, sales, issuances and settlements, net

 

1

 

11

 

(241

)

(162

)

237

 

(154

)

Realized gain/(loss)

 

 

1

 

(9

)

(4

)

 

(12

)

Unrealized gains/(losses) relating to instruments still held at the reporting date

 

108

 

51

 

157

 

389

 

 

705

 

Ending balance at December 31, 2009

 

$

4

 

$

185

 

$

1,961

 

$

728

 

$

237

 

$

3,115

 

 

International Pension Plans Assets

 

Outside the U.S., pension plan assets are typically managed by decentralized fiduciary committees. The disclosure below of asset categories is presented in aggregate for the 55 plans in 23 countries, however there is significant variation in policy asset allocation from country to country. Local regulations, local funding rules, and local financial and tax considerations are part of the funding and investment allocation process in each country. 3M’s Treasury group provides standard funding and investment guidance to all international plans with more focused guidance to the larger plans.

 

Each plan has its own strategic asset allocation. The asset allocations are reviewed periodically and rebalanced when necessary.

 

The fair values of the assets held by the international pension plans by asset category are as follows:

 

(Millions)

 

Fair Value
At Dec. 31,

 

Fair Value Measurements
Using Inputs Considered as

 

Asset Category

 

2009

 

Level 1

 

Level 2

 

Level 3

 

Global equity

 

$

1,619

 

$

1,330

 

$

275

 

$

14

 

Domestic fixed income

 

936

 

283

 

623

 

30

 

Foreign fixed income

 

622

 

222

 

400

 

 

Real estate

 

54

 

 

3

 

51

 

Insurance

 

375

 

 

 

375

 

Other

 

104

 

 

104

 

 

Cash

 

208

 

208

 

 

 

Total

 

$

3,918

 

$

2,043

 

$

1,405

 

$

470

 

 

 

 

 

 

 

 

 

 

 

Other items to reconcile to fair value of plan assets

 

$

(21

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of plan assets

 

$

3,897

 

 

 

 

 

 

 

 

Global equity consists primarily of mandates in public equity securities managed to the Morgan Stanley Capital All Country World Index. Publicly traded equities are valued at the closing price reported in the active market in which the individual securities are traded.

 

Domestic and foreign fixed income consists of both active and passive mandates including governments, corporate, mortgage backed and other fixed income instruments. Included in fixed income are derivative investments such as interest rate swaps that are used to help manage risks. Governments, corporate bonds and notes and mortgage backed securities are valued at either the closing price reported if traded on an active market or at yields currently available on comparable securities of issuers with similar credit ratings or valued under a discounted cash flows approach that maximizes observable inputs, such as current yields of similar instruments, but includes adjustments for certain risks that may not be observable such as credit and liquidity risks.

 

Real estate consists of property funds and REITS (Real Estate Investment Trusts). Property funds are valued using the most recent partnership statement of fair value, updated for any subsequent partnership interests’ cash flows. REITS are valued at the closing price reported in the active market in which it is traded.

 

Insurance consists of insurance contracts, which are valued using cash surrender values which is the amount the plan would receive if the contract was cashed out at year end.

 

Other consists primarily of interests in hedge funds. Hedge funds are valued at the NAV as determined by the independent administrator or custodian of the fund.

 

Other items to reconcile to fair value of plan assets is the net of interest receivable, amounts due for securities sold, amounts payable for securities purchased and interest payable.

 

The following table sets forth a summary of changes in the fair values of the international pension plans level 3 assets for the year ended December 31, 2009:

 

 

 

Fair Value Measurement Using Significant Unobservable Inputs (Level 3)

 

(Millions)

 

Global
equity

 

Domestic
fixed
income

 

Real
estate

 

Insur-
ance

 

Total

 

Beginning balance at January 1, 2009

 

$

23

 

$

29

 

$

45

 

$

337

 

$

434

 

Net transfers into / (out of) level 3

 

 

 

 

11

 

11

 

Foreign currency exchange

 

2

 

4

 

3

 

7

 

16

 

Purchases, sales, issuances and settlements, net

 

(7

)

(2

)

 

(10

)

(19

)

Realized gain/(loss)

 

 

 

 

 

 

Unrealized gains/(losses) relating to instruments still held at the reporting date

 

(4

)

(1

)

3

 

30

 

28

 

Ending balance at December 31, 2009

 

$

14

 

$

30

 

$

51

 

$

375

 

$

470

 

 

Postretirement Benefit Plans Assets

 

In order to achieve the investment objectives in the U.S. postretirement plan, the investment policy includes a target strategic asset allocation. The investment policy allows some tolerance around the target in recognition that market fluctuations and illiquidity of some investments may cause the allocation to a specific asset class to stray from the target allocation, potentially for long periods of time. Acceptable ranges have been designed to allow for deviation from long-term targets and to allow for the opportunity for tactical over- and under-weights. The portfolio will normally be rebalanced when the quarter-end asset allocation deviates from acceptable ranges. The allocation is reviewed regularly by the named fiduciary of the plan.

 

The fair values of the assets held by the postretirement benefits plans by asset category are as follows:

 

(Millions)

 

Fair Value
At Dec. 31,

 

Fair Value Measurements
Using Inputs Considered as

 

Asset Category

 

2009

 

Level 1

 

Level 2

 

Level 3

 

Global equity

 

$

470

 

$

417

 

$

53

 

$

 

Fixed income

 

268

 

50

 

212

 

6

 

Private equity

 

246

 

1

 

 

245

 

Absolute return

 

53

 

 

31

 

22

 

Commodities

 

12

 

 

5

 

7

 

Cash

 

42

 

42

 

 

 

Total

 

$

1,091

 

$

510

 

$

301

 

$

280

 

 

 

 

 

 

 

 

 

 

 

Other items to reconcile to fair value of plan assets

 

$

(16

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of plan assets

 

$

1,075

 

 

 

 

 

 

 

 

Global equity consists primarily of publicly traded U.S. and non-U.S. equities, EAFE index funds, equity private placement funds and some cash and cash equivalents. Publicly traded equities are valued at the closing price reported in the active market in which the individual securities are traded. Index funds are valued at the NAV as determined by the custodian of the fund. The NAV is based on the fair value of the underlying assets owned by the fund, minus its liabilities then divided by the number of units outstanding. Private placement funds are valued using the most recent general partner statement of fair value, updated for any subsequent partnership interests’ cash flows.

 

Fixed income consists of U.S. treasuries, municipal bonds, preferred securities, convertible securities, U.S. and non-U.S. corporate bonds, asset backed securities, collateralized mortgage obligations, agencies, private placements and cash and cash equivalents. Included in fixed income are derivative investments such as credit default swaps, interest rate swaps and futures contracts that are used to help manage risks. U.S. government and government agency bonds and notes are valued at the closing price reported in the active market in which the individual security is traded. Corporate and other bonds and notes are valued at either the yields currently available on comparable securities of issuers with similar credit ratings or valued under a discounted cash flows approach that maximizes observable inputs, such as current yields of similar instruments, but includes adjustments for certain risks that may not be observable such as credit and liquidity risks. Swaps and derivative instruments are valued by the custodian using market swap curves and market derived inputs.

 

Private equity consists of interests in partnerships that invest in U.S. and non-U.S. debt and equity securities. The portfolio is a diversified mix of partnership interests including buyouts, distressed debt, growth equity, mezzanine, real estate and venture capital investments. Partnership interests are valued using the most recent general partner statement of fair value, updated for any subsequent partnership interests’ cash flows.

 

Absolute return primarily consists of private partnership interests in hedge funds, hedge fund of funds and bank loan funds. Partnership interests are valued using the NAV as determined by the independent administrator or custodian of the fund.

 

Commodities consist of commodity-linked notes and commodity-linked derivative contracts designed to deliver investment returns similar to the GSCI or Dow Jones UBS Commodity index returns. Commodities are valued at closing prices determined by calculation agents for outstanding transactions.

 

Other items to reconcile to fair value of plan assets is the net of interest receivable, amounts due for securities sold, foreign currency fluctuations, amounts payable for securities purchased and interest payable.

 

The following table sets forth a summary of changes in the fair values of the postretirement plans’ level 3 assets for the year ended December 31, 2009:

 

 

 

Fair Value Measurement Using Significant Unobservable Inputs (Level 3)

 

(Millions)

 

Fixed
income

 

Private
equity

 

Absolute
return

 

Commo-
dities

 

Total

 

Beginning balance at January 1, 2009

 

$

4

 

$

265

 

$

47

 

$

 

$

316

 

Net transfers into / (out of) level 3

 

 

 

(31

)

 

(31

)

Purchases, sales, issuances and settlements, net

 

 

(38

)

(5

)

7

 

(36

)

Realized gain/(loss)

 

 

(14

)

 

 

(14

)

Unrealized gains/(losses) relating to instruments still held at the reporting date

 

2

 

32

 

11

 

 

45

 

Ending balance at December 31, 2009

 

$

6

 

$

245

 

$

22

 

$

7

 

$

280

 

 

Derivatives
Derivatives

NOTE 12.  Derivatives

 

The Company uses interest rate swaps, currency swaps, commodity price swaps, and forward and option contracts to manage risks generally associated with foreign exchange rate, interest rate and commodity price fluctuations. The information that follows explains the various types of derivatives and financial instruments used by 3M, how and why 3M uses such instruments, how such instruments are accounted for, and how such instruments impact 3M’s financial position and performance.

 

Additional information with respect to the impacts on other comprehensive income of nonderivative hedging and derivative instruments is included in Note 6. Additional information with respect to the fair value of derivative instruments is included in Note 13. References to information regarding derivatives and/or hedging instruments associated with the Company’s long-term debt are also made in Note 10.

 

Types of Derivatives/Hedging Instruments and Inclusion in Income/Other Comprehensive Income

 

Cash Flow Hedges:

 

For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income and reclassified into earnings in the same period during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings.

 

Cash Flow Hedging - Foreign Currency Forward and Option Contracts: The Company enters into foreign exchange forward and option contracts to hedge against the effect of exchange rate fluctuations on cash flows denominated in foreign currencies and certain intercompany financing transactions. These transactions are designated as cash flow hedges. The settlement or extension of these derivatives will result in reclassifications (from accumulated other comprehensive income) to earnings in the period during which the hedged transactions affect earnings. Generally, 3M dedesignates these cash flow hedge relationships in advance of the occurrence of the forecasted transaction. The portion of gains or losses on the derivative instrument previously accumulated in other comprehensive income for dedesignated hedges remains in accumulated other comprehensive income until the forecasted transaction occurs. Changes in the value of derivative instruments after dedesignation are recorded in earnings and are included in the Derivatives Not Designated as Hedging Instruments section below. Hedge ineffectiveness and the amount excluded from effectiveness testing recognized in income on cash flow hedges were not material for 2009 and 2008. The maximum length of time over which 3M hedges its exposure to the variability in future cash flows for a majority of the forecasted transactions is 12 months and, accordingly, at December 31, 2009, the majority of the Company’s open foreign exchange forward and option contracts had maturities of one year or less. The dollar equivalent gross notional amount of the Company’s foreign exchange forward and option contracts designated as cash flow hedges at December 31, 2009 was approximately $2.9 billion.

 

Cash Flow Hedging - Commodity Price Management: The Company manages commodity price risks through negotiated supply contracts, price protection agreements and forward physical contracts. The Company uses commodity price swaps relative to natural gas as cash flow hedges of forecasted transactions to manage price volatility. The related mark-to-market gain or loss on qualifying hedges is included in other comprehensive income to the extent effective, and reclassified into cost of sales in the period during which the hedged transaction affects earnings. Generally, the length of time over which 3M hedges its exposure to the variability in future cash flows for its forecasted natural gas transactions is 12 months. No significant commodity cash flow hedges were discontinued and hedge ineffectiveness was not material for 2009 and 2008. The dollar equivalent gross notional amount of the Company’s natural gas commodity price swaps designated as cash flow hedges at December 31, 2009 was $30 million.

 

The location in the consolidated statements of income and comprehensive income and amounts of gains and losses related to derivative instruments designated as cash flow hedges are as follows. Reclassifications of amounts from accumulated other comprehensive income into income include accumulated gains (losses) on dedesignated hedges at the time earnings are impacted by the forecasted transaction.

 

Year ended December 31, 2009
(Millions)

 

Pretax Gain (Loss)
Recognized in Other
Comprehensive
Income on
Effective Portion of
Derivative

 

Pretax Gain (Loss) Recognized
in Income on Effective Portion
of Derivative as a Result of
Reclassification from
Accumulated Other
Comprehensive Income

 

Ineffective Portion of Gain
(Loss) on Derivative and
Amount Excluded from
Effectiveness Testing
Recognized in Income

 

Derivatives in Cash Flow Hedging Relationships

 

Amount

 

Location

 

Amount

 

Location

 

Amount

 

Foreign currency forward/option contracts

 

$

(58

)

Cost of sales

 

$

96

 

Cost of sales

 

$

 

Foreign currency forward contracts

 

55

 

Interest expense

 

(82

)

Interest expense

 

 

Commodity price swap contracts

 

(18

)

Cost of sales

 

(34

)

Cost of sales

 

 

Total

 

$

(21

)

 

 

$

(20

)

 

 

$

 

 

As of December 31, 2009, the Company had a balance of $36 million associated with the after tax net unrealized loss associated with cash flow hedging instruments recorded in accumulated other comprehensive income. 3M expects to reclassify to earnings over the next 12 months a majority of this balance (with the impact offset by cash flows from underlying hedged items).

 

Fair Value Hedges:

 

For derivative instruments that are designated and qualify as fair value hedges, the gain or loss on the derivatives as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings.

 

Fair Value Hedging - Interest Rate Swaps: The Company manages interest expense using a mix of fixed and floating rate debt. To help manage borrowing costs, the Company may enter into interest rate swaps. Under these arrangements, the Company agrees to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. The dollar equivalent (based on inception date foreign currency exchange rates) gross notional amount of the Company’s interest rate swaps at December 31, 2009 was $1.352 billion.

 

At December 31, 2009, the Company had interest rate swaps designated as fair value hedges of underlying fixed rate obligations. In November 2006, the Company entered into a $400 million fixed-to-floating interest rate swap concurrent with the issuance of the three-year medium-term note due in 2009. The swap and the underlying note matured in November 2009. In July 2007, in connection with the issuance of a seven-year Eurobond for an amount of 750 million Euros, the Company completed a fixed-to-floating interest rate swap on a notional amount of 400 million Euros as a fair value hedge of a portion of the fixed interest rate Eurobond obligation. In May 2009, the Company entered into two fixed-to-floating interest rate swaps with an aggregate notional amount of $800 million designated as fair value hedges of the fixed interest rate obligation under the existing $800 million, three-year, 4.50% notes issued in October 2008. The mark-to-market of these fair value hedges is recorded as gains or losses in interest expense and is offset by the gain or loss on the underlying debt instrument, which also is recorded in interest expense. These fair value hedges are highly effective and, thus, there is no impact on earnings due to hedge ineffectiveness.

 

Fair Value Hedging — Foreign Currency: In November 2008, the Company entered into foreign currency forward contracts to purchase Japanese Yen, Pound Sterling, and Euros with a notional amount of $255 million at the contract rates. These contracts were designated as fair value hedges of a U.S. dollar tax obligation. These fair value hedges matured in early January 2009. The mark-to-market of these forward contracts was recorded as gains or losses in tax expense and was offset by the gain or loss on the underlying tax obligation, which also was recorded in tax expense. The fair value of these contracts as of December 31, 2008 was $25 million. Changes in the value of these contracts in 2009 through their maturity were not material.

 

The location in the consolidated statements of income and amounts of gains and losses related to derivative instruments designated as fair value hedges and similar information relative to the hedged items are as follows:

 

Year ended December 31, 2009
(Millions)

 

Gain (Loss) on Derivative
Recognized in Income

 

Gain (Loss) on Hedged Item
Recognized in Income

 

Derivatives in Fair Value Hedging Relationships

 

Location

 

Amount

 

Location

 

Amount

 

Interest rate swap contracts

 

Interest expense

 

$

16

 

Interest expense

 

$

(16

)

Total

 

 

 

$

16

 

 

 

$

(16

)

 

Net Investment Hedges:

 

As circumstances warrant, the Company uses cross currency swaps, forwards and foreign currency denominated debt to hedge portions of the Company’s net investments in foreign operations. For hedges that meet the effectiveness requirements, the net gains or losses attributable to changes in spot exchange rates are recorded in cumulative translation within other comprehensive income. The remainder of the change in value of such instruments is recorded in earnings. Recognition in earnings of amounts previously recorded in cumulative translation is limited to circumstances such as complete or substantially complete liquidation of the net investment in the hedged foreign operation. At December 31, 2009, there were no cross currency swaps or foreign currency forward contracts designated as net investment hedges.

 

In November 2006, the Company entered into a three-year floating-to-floating cross currency swap with a notional amount of $200 million. This transaction was a partial hedge of the Company’s net investment in its European subsidiaries. This swap converted U.S. dollar-based variable interest payments to Euro-based variable interest payments associated with the notional amount. This swap matured in November 2009.

 

In September 2006, the Company entered into a three-year floating-to-floating cross currency swap with a notional amount of $300 million. This transaction was a partial hedge of the Company’s net investment in its Japanese subsidiaries. This swap converted U.S. dollar-based variable interest payments to yen-based variable interest payments associated with the notional amount. This swap matured in September 2009.

 

In addition to the derivative instruments used as hedging instruments in net investment hedges, 3M also uses foreign currency denominated debt as nonderivative hedging instruments in certain net investment hedges. In July and December 2007, the Company issued seven-year fixed rate Eurobond securities for amounts of 750 million Euros and 275 million Euros, respectively. 3M designated each of these Eurobond issuances as hedging instruments of the Company’s net investment in its European subsidiaries.

 

The location in the consolidated statements of income and comprehensive income and amounts of gains and losses related to derivative and nonderivative instruments designated as net investment hedges are as follows. There were no reclassifications of the effective portion of net investment hedges out of accumulated other comprehensive income into income for the period presented in the table below.

 

Year ended December 31, 2009
(Millions)
Derivative and Nonderivative Instruments in

 

Pretax Gain (Loss) Recognized as
Cumulative Translation within Other
Comprehensive Income on Effective
Portion of Instrument

 

Ineffective Portion of Gain (Loss) on
Instrument and Amount Excluded from
Effectiveness Testing Recognized in
Income

 

Net Investment Hedging Relationships

 

Amount

 

Location

 

Amount

 

Cross currency swap contracts

 

$

(12

)

Interest expense

 

$

 

Foreign currency denominated debt

 

(27

)

N/A

 

 

Total

 

$

(39

)

 

 

$

 

 

Derivatives Not Designated as Hedging Instruments:

 

Derivatives not designated as hedging instruments include dedesignated foreign currency forward and option contracts that formerly were designated in cash flow hedging relationships (as referenced in the preceding Cash Flow Hedges section). In addition, 3M enters into foreign currency forward contracts and commodity price swaps to offset, in part, the impacts of certain intercompany activities (primarily associated with intercompany licensing arrangements and certain intercompany loans) and fluctuations in costs associated with the use of certain precious metals, respectively. These derivative instruments are not designated in hedging relationships; therefore, fair value gains and losses on these contracts are recorded in earnings. The dollar equivalent gross notional amount of these forward, option and swap contracts not designated as hedging instruments totaled $860 million as of December 31, 2009. The Company does not hold or issue derivative financial instruments for trading purposes.

 

The location in the consolidated statements of income and amounts of gains and losses related to derivative instruments not designated as hedging instruments are as follows:

 

Year ended Dec. 31, 2009
(Millions)

 

Gain (Loss) on Derivative
Recognized in Income

 

Derivatives Not Designated as Hedging Instruments

 

Location

 

Amount

 

Foreign currency forward/option contracts

 

Cost of sales

 

$

(41

)

Foreign currency forward contract

 

Interest expense

 

20

 

Commodity price swap contracts

 

Cost of sales

 

1

 

Total

 

 

 

$

(20

)

 

Location and Fair Value Amount of Derivative Instruments

 

The following table summarizes the fair value of 3M’s derivative instruments, excluding nonderivative instruments used as hedging instruments, and their location in the consolidated balance sheet.

 

December 31, 2009
(Millions)

 

Assets

 

Liabilities

 

Fair Value of Derivative Instruments

 

Location

 

Amount

 

Location

 

Amount

 

 

 

 

 

 

 

 

 

 

 

Derivatives designated as hedging instruments

 

 

 

 

 

 

 

 

 

Foreign currency forward/option contracts

 

Other current assets

 

$

17

 

Other current liabilities

 

$

41

 

Commodity price swap contracts

 

Other current assets

 

1

 

Other current liabilities

 

1

 

Interest rate swap contracts

 

Other assets

 

54

 

Other liabilities

 

 

Total derivatives designated as hedging instruments

 

 

 

$

72

 

 

 

$

42

 

 

 

 

 

 

 

 

 

 

 

Derivatives not designated as hedging instruments

 

 

 

 

 

 

 

 

 

Foreign currency forward/option contracts

 

Other current assets

 

$

6

 

Other current liabilities

 

$

52

 

Commodity price swap contracts

 

Other current assets

 

1

 

Other current liabilities

 

 

Total derivatives not designated as hedging instruments

 

 

 

$

7

 

 

 

$

52

 

 

 

 

 

 

 

 

 

 

 

Total derivative instruments

 

 

 

$

79

 

 

 

$

94

 

 

Additional information with respect to the fair value of derivative instruments is included in Note 13.

 

Currency Effects and Credit Risk

 

Currency Effects: 3M estimates that year-on-year currency effects, including hedging impacts, decreased net income attributable to 3M by approximately $220 million in 2009 and increased net income attributable to 3M by approximately $160 million in 2008 and $150 million in 2007. This estimate includes the effect of translating profits from local currencies into U.S. dollars; the impact of currency fluctuations on the transfer of goods between 3M operations in the United States and abroad; and transaction gains and losses, including derivative instruments designed to reduce foreign currency exchange rate risks and the negative impact of swapping Venezuelan bolivars into U.S. dollars. 3M estimates that year-on-year derivative and other transaction gains and losses had an immaterial impact in 2009, and increased net income attributable to 3M by approximately $40 million in 2008 and by approximately $10 million in 2007.

 

Credit risk: The Company is exposed to credit loss in the event of nonperformance by counterparties in interest rate swaps, currency swaps, commodity price swaps, and forward and option contracts. However, the Company’s risk is limited to the fair value of the instruments. The Company actively monitors its exposure to credit risk through the use of credit approvals and credit limits, and by selecting major international banks and financial institutions as counterparties. The Company does not anticipate nonperformance by any of these counterparties. 3M has credit support agreements in place with two of its primary derivatives counterparties. Under these agreements, either party is required to post eligible collateral when the market value of transactions covered by these agreements exceeds specified thresholds, thus limiting credit exposure for both parties.

 

Fair Value Measurements
Fair Value Measurements

NOTE 13.  Fair Value Measurements

 

As discussed in Note 1, 3M adopted the new fair value measurements standard, codified in ASC 820, prospectively effective January 1, 2008, with respect to fair value measurements of (a) nonfinancial assets and liabilities that are recognized or disclosed at fair value in the Company’s financial statements on a recurring basis (at least annually) and (b) all financial assets and liabilities. 3M adopted the remaining aspects of the fair value measurement standard relative to nonfinancial assets and liabilities that are measured at fair value, but are recognized and disclosed at fair value on a nonrecurring basis, prospectively effective January 1, 2009.

 

Under the new standard, fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. The standard also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability developed based upon the best information available in the circumstances. The hierarchy is broken down into three levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and inputs (other than quoted prices) that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability. Categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

 

Assets and Liabilities that are Measured at Fair Value on a Recurring Basis:

 

As described in Note 1, at 3M, effective January 1, 2008, fair value measurement under ASC 820 principally applied to financial asset and liabilities such as available-for-sale marketable securities, available-for-sale investments (included as part of investments in the Consolidated Balance Sheet) and certain derivative instruments. Derivatives include cash flow hedges, interest rate swaps and most net investment hedges. These items were previously and will continue to be marked-to-market at each reporting period; however, the definition of fair value used for these mark-to-markets is now applied using ASC 820. The information in the following paragraphs and tables primarily addresses matters relative to these financial assets and liabilities. The information incorporates guidance relating to determining the fair value of a financial asset when the market for that asset is not active, which was effective for 3M beginning with the quarter ended September 30, 2008. The information also incorporates the new guidance described in Note 1 related to determining fair values when the volume and level of activity for the asset or liability have significantly decreased and identifying transactions that are not orderly, which was effective for 3M beginning April 1, 2009. Separately, there were no material fair value measurements with respect to nonfinancial assets or liabilities that are recognized or disclosed at fair value in the Company’s financial statements on a recurring basis subsequent to the effective date of the new standard (as impacted by associated updates codified in ASC 820).

 

3M uses various valuation techniques, which are primarily based upon the market and income approaches, with respect to financial assets and liabilities. Following is a description of the valuation methodologies used for the respective financial assets and liabilities measured at fair value.

 

Available-for-sale marketable securities — except auction rate securities:

 

Marketable securities, except auction rate securities, are valued utilizing multiple sources. A weighted average price is used for these securities. Market prices are obtained for these securities from a variety of industry standard data providers, security master files from large financial institutions, and other third-party sources. These multiple prices are used as inputs into a distribution-curve-based algorithm to determine the daily fair value to be used. 3M classifies treasury securities as level 1, while all other marketable securities (excluding auction rate securities) are classified as level 2. Marketable securities are discussed further in Note 9.

 

Available-for-sale marketable securities — auction rate securities only:

 

As discussed in Note 9, auction rate securities held by 3M failed to auction since the second half of 2007. As a result, investments in auction rate securities are valued utilizing broker-dealer valuation models and third-party indicative bid levels in markets that are not active. 3M classifies these securities as level 3.

 

Available-for-sale investments:

 

Investments include equity securities that are traded in an active market. Closing stock prices are readily available from active markets and are used as being representative of fair value. 3M classifies these securities as level 1.

 

Derivative instruments:

 

The Company’s derivative assets and liabilities within the scope of ASC 815 are required to be recorded at fair value. The Company’s derivatives that are recorded at fair value include foreign currency forward and option contracts, commodity price swaps, interest rate swaps, and net investment hedges where the hedging instrument is recorded at fair value. Net investment hedges that use foreign currency denominated debt to hedge 3M’s net investment are not impacted by the fair value measurement standard under ASC 820, as the debt used as the hedging instrument is marked to a value with respect to changes in spot foreign currency exchange rates and not with respect to other factors that may impact fair value.

 

3M has determined that foreign currency forwards and commodity price swaps will be considered level 1 measurements as these are traded in active markets which have identical asset or liabilities, while currency swaps, foreign currency options, interest rate swaps and cross-currency swaps will be considered level 2. For level 2 derivatives, 3M uses inputs other than quoted prices that are observable for the asset. These inputs include foreign currency exchange rates, volatilities, and interest rates. The level 2 derivative positions are primarily valued using standard calculations/models that use as their basis readily observable market parameters. Industry standard data providers are 3M’s primary source for forward and spot rate information for both interest rates and currency rates, with resulting valuations periodically validated through third-party or counterparty quotes and a net present value stream of cash flows model.

 

The following table provides information by level for assets and liabilities that are measured at fair value, as defined by ASC 820, on a recurring basis.

 

(Millions)

 

Fair Value
at Dec, 31

 

Fair Value Measurements
Using Inputs Considered as

 

Description

 

2009

 

Level 1

 

Level 2

 

Level 3

 

Assets:

 

 

 

 

 

 

 

 

 

Available-for-sale:

 

 

 

 

 

 

 

 

 

Marketable securities:

 

 

 

 

 

 

 

 

 

Agency securities

 

$

491

 

$

 

$

491

 

$

 

Corporate securities

 

266

 

 

266

 

 

Asset-backed securities:

 

 

 

 

 

 

 

 

 

Automobile loans related

 

515

 

 

515

 

 

Credit cards related

 

107

 

 

107

 

 

Other

 

83

 

 

83

 

 

Treasury securities

 

94

 

94

 

 

 

Auction rate securities

 

5

 

 

 

5

 

Other securities

 

8

 

 

8

 

 

Investments

 

11

 

11

 

 

 

Derivative instruments — assets

 

79

 

25

 

54

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

Derivative instruments — liabilities

 

94

 

94

 

 

 

 

(Millions)

 

Fair Value
at Dec, 31

 

Fair Value Measurements
Using Inputs Considered as

 

Description

 

2008

 

Level 1

 

Level 2

 

Level 3

 

Assets:

 

 

 

 

 

 

 

 

 

Available-for-sale:

 

 

 

 

 

 

 

 

 

Marketable securities:

 

 

 

 

 

 

 

 

 

Agency securities

 

$

380

 

$

 

$

380

 

$

 

Corporate securities

 

207

 

 

207

 

 

Asset-backed securities:

 

 

 

 

 

 

 

 

 

Automobile loans related

 

49

 

 

49

 

 

Credit cards related

 

40

 

 

40

 

 

Other

 

22

 

 

22

 

 

Treasury securities

 

12

 

12

 

 

 

Auction rate securities

 

1

 

 

 

1

 

Other securities

 

14

 

 

14

 

 

Investments

 

5

 

5

 

 

 

Derivative instruments — assets

 

279

 

221

 

58

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

Derivative instruments — liabilities

 

212

 

99

 

113

 

 

 

The following table provides a reconciliation of the beginning and ending balances of items measured at fair value on a recurring basis in the table above that used significant unobservable inputs (Level 3).

 

(Millions)

 

Year ended Dec. 31,

 

Marketable securities — auction rate securities only

 

2009

 

2008

 

Beginning balance

 

$

1

 

$

16

 

Total gains or (losses):

 

 

 

 

 

Included in earnings

 

 

(3

)

Included in other comprehensive income

 

6

 

(12

)

Application of proceeds from sale

 

(2

)

 

Transfers in and/or out of Level 3

 

 

 

Ending balance (December 31)

 

5

 

1

 

 

 

 

 

 

 

Additional losses included in earnings due to reclassifications from other comprehensive income for:

 

 

 

 

 

Securities sold during the period ended December 31

 

(2

)

 

Securities still held at December 31

 

 

(6

)

 

In addition, the plan assets of 3M’s pension and postretirement benefit plans are measured at fair value on a recurring basis (at least annually). Refer to Note 11.

 

Assets and Liabilities that are Measured at Fair Value on a Nonrecurring Basis:

 

Disclosures for nonfinancial assets and liabilities that are measured at fair value, but are recognized and disclosed at fair value on a nonrecurring basis, are required prospectively beginning January 1, 2009. During 2009, such measurements of fair value related primarily to the nonfinancial assets and liabilities with respect to the business combinations that closed in 2009 and long-lived asset impairments in 2009.

 

The net identifiable tangible and intangible assets and liabilities (excluding goodwill) for business combinations that closed in 2009 (discussed in Note 2) was $50 million. For business combinations, 3M uses inputs other than quoted prices that are observable, such as interest rates, cost of capital, and market comparable royalty rates, which are applied to income and market valuation approaches. 3M considers these level 2 inputs.

 

Long-lived asset impairments totaled approximately $32 million pre-tax for 2009, which included the portion of 2009 restructuring actions related to long-lived asset impairments as discussed in Note 4, with the complete carrying amount of such assets written off and included in operating income results. In addition to the restructuring activities, in June 2009 the Company recorded a $13 million impairment of certain long-lived assets associated with the UK passport production activity of 3M’s Security Systems Division (within the Safety, Security and Protection Services business segment). In June 2009, 3M was notified that the UK government decided to award the production of its passports to a competitor upon the expiration of 3M’s existing UK passport contracts in October 2010. Accordingly, 3M tested the long lived assets associated with the UK passport activity for recoverability which indicated that the asset grouping’s carrying amount exceeded the remaining expected cash flows. As a result, associated assets were written down to a fair value of $41 million in June 2009. 3M primarily uses a discounted cash flow model that uses inputs other than quoted prices that are observable, such as interest rates and cost of capital, to determine the fair value of such assets. 3M considers these level 2 inputs. Refer to Note 1 (“Property, plant and equipment” and “Intangible Assets”) for further discussion of accounting policies related to long-lived asset impairments.

 

The following table provides information by level for nonfinancial assets and liabilities that were measured at fair value during 2009, as defined by ASC 820, on a nonrecurring basis.

 

Twelve months ended December 31, 2009

 

 

 

 

 

Fair Value Measurements Using

 

 

 

 

 

 

 

Quoted Prices

 

 

 

 

 

 

 

 

 

Fair value

 

in Active

 

Significant

 

 

 

 

 

 

 

Twelve

 

Markets

 

Other

 

Significant

 

 

 

 

 

months

 

for

 

Observable

 

Unobservable

 

 

 

(Millions)

 

ended

 

Identical Assets

 

Inputs

 

Inputs

 

Total Gains

 

Description

 

Dec. 31, 2009

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

(Losses)

 

Long-lived assets held and used

 

$

41

 

$

 

$

41

 

$

 

$

(32

)

Business combinations

 

50

 

 

50

 

 

 

Total

 

 

 

 

 

 

 

 

 

$

(32

)

 

Fair value of financial instruments: At December 31, 2009 and 2008, the Company’s financial instruments included cash and cash equivalents, marketable securities, accounts receivable, investments, accounts payable, borrowings, and derivative contracts. The fair values of cash and cash equivalents, accounts receivable, accounts payable, and short-term borrowings and current portion of long-term debt (except the $350 million Dealer Remarketable Securities prior to 2009) approximated carrying values because of the short-term nature of these instruments. Available-for-sale marketable securities and investments, in addition to certain derivative instruments, are recorded at fair values as indicated in the preceding disclosures. Fair values for investments held at cost are not readily available, but are estimated to approximate fair value. The Company utilized third-party quotes to estimate fair values for its Dealer Remarketable Securities and long-term debt. Information with respect to the carrying amounts and estimated fair values of these financial instruments follow:

 

 

 

2009

 

2008

 

(Millions)

 

Carrying
Amount

 

Fair
Value

 

Carrying
Amount

 

Fair
Value

 

Dealer Remarketable Securities

 

$

350

 

$

350

 

$

350

 

$

364

 

Long-term debt

 

5,097

 

5,355

 

5,166

 

5,375

 

 

The fair values reflected above consider the terms of the related debt absent the impacts of derivative/hedging activity. The carrying amount of long-term debt referenced above is impacted by certain fixed-to-floating interest rate swaps that are designated as fair value hedges and by the designation of 1,025 million Euros of fixed rate Eurobond securities issued by the Company as hedging instruments of the Company’s net investment in its European subsidiaries. 3M’s fixed-rate bonds are trading at a premium at December 31, 2009 due to the low market interest rates and tightening of 3M’s credit spreads during 2009.

 

Commitments and Contingencies
Commitments and Contingencies

NOTE 14.  Commitments and Contingencies

 

Capital and Operating Leases:

 

Rental expense under operating leases was $244 million in 2009, $247 million in 2008 and $226 million in 2007. It is 3M’s practice to secure renewal rights for leases, thereby giving 3M the right, but not the obligation, to maintain a presence in a leased facility. 3M has two primary capital leases. First, 3M has a capital lease, which became effective in April 2003, that involves a building in the United Kingdom (with a lease term of 22 years). During the second quarter of 2003, 3M recorded a capital lease asset and obligation of approximately 33.5 million United Kingdom pounds (approximately $53 million at December 31, 2009 exchange rates). Second, during the fourth quarter of 2009, 3M recorded a capital lease asset and obligation of approximately $50 million related to an IT investment with an amortization period of seven years.

 

Minimum lease payments under capital and operating leases with non-cancelable terms in excess of one year as of December 31, 2009, were as follows:

 

(Millions)

 

Capital
Leases

 

Operating
Leases

 

2010

 

$

16

 

$

125

 

2011

 

18

 

95

 

2012

 

18

 

76

 

2013

 

18

 

38

 

2014

 

18

 

23

 

After 2014

 

40

 

91

 

Total

 

$

128

 

$

448

 

Less: Amounts representing interest

 

8

 

 

 

Present value of future minimum lease payments

 

120

 

 

 

Less: Current obligations under capital leases

 

13

 

 

 

Long-term obligations under capital leases

 

$

107

 

 

 

 

Warranties/Guarantees:

 

3M’s accrued product warranty liabilities, recorded on the Consolidated Balance Sheet as part of current and long-term liabilities, are estimated at approximately $25 million as of December 31, 2009 and 2008. 3M does not consider this amount to be material. The fair value of 3M guarantees of loans with third parties and other guarantee arrangements, except for the guarantee discussed below, are not material.

 

3M Security Printing and Systems Limited, a subsidiary of 3M, has provided a guarantee through 3M United Kingdom Holdings PLC (another subsidiary of 3M) to The Identity and Passport Service (IPS). 3M has guaranteed default on performance and payment of liabilities under a contract with IPS. The amount guaranteed is 45 million Great British Pounds (approximately $71 million U.S. dollars at December 31, 2009). The contract expires on October 4, 2010. 3M does not expect to pay out any funds under this guarantee.

 

Related Party Activity:

 

3M does not have any related party activity that is not in the ordinary course of business.

 

Legal Proceedings:

 

The Company and some of its subsidiaries are involved in numerous claims and lawsuits, principally in the United States, and regulatory proceedings worldwide. These include various products liability (involving products that the Company now or formerly manufactured and sold), intellectual property, and commercial claims and lawsuits, including those brought under the antitrust laws, and environmental proceedings. The following sections first describe the significant legal proceedings in which the Company is involved, and then describe the liabilities and associated insurance receivables the Company has accrued relating to its significant legal proceedings. Unless otherwise stated, the Company is vigorously defending all such litigation.

 

Shareholder Derivative Litigation

 

As previously reported, in July 2007, a shareholder derivative lawsuit was filed in the U.S. District Court for the District of Delaware against the Company as nominal defendant and against each then current member of the Board of Directors and the officers named in the Summary Compensation Table of the 2007 Proxy Statement. The suit alleged that the Company’s 2007 Proxy Statement contained false and misleading statements concerning the tax deductibility of compensation payable under the Executive Annual Incentive Plan (“Plan”) and the standards for determining the amounts payable under the Plan. The lawsuit sought a declaration voiding shareholder approval of the Plan, termination of the Plan, voiding the elections of directors, equitable accounting, and awarding costs, including attorneys’ fees.

 

In May 2008, the Company and the individual defendants agreed to settle the litigation without admitting any liability or wrongdoing of any kind. The settlement agreement, which was subject to court approval, called for the Compensation Committee of the Company’s Board of Directors to adopt a resolution formally stating its interpretation of certain aspects of the Plan, and the Company to file a Current Report on Form 8-K to the same effect, and to pay up to $600,000 in attorney’s fees to the plaintiff’s counsel. On December 30, 2008, the Court issued an order preliminarily approving the settlement agreement. As a result, the Company notified all stockholders of the proposed settlement and its terms and their right to object to the terms of the settlement. On June 5, 2009, the Court issued an order approving the settlement.

 

French Competition Council Investigation

 

On December 4, 2008, the Company’s subsidiary in France received a Statement of Objections from the French Competition Council alleging an abuse of a dominant position regarding the supply of retro-reflective films for vertical signing applications in France and of participation in a concerted practice with the major French manufacturers of vertical signs. The Statement of Objections is an intermediate stage in the proceedings and no final determination regarding an infringement of French competition rules has been made. 3M has filed its response denying that the Statement of Objections states a valid claim against 3M. It is difficult to predict the final outcome of the investigation at this time.

 

Compliance Matters

 

On November 12, 2009, the Company contacted the Department of Justice (DOJ) and Securities and Exchange Commission (SEC) to voluntarily disclose that the Company was conducting an internal investigation as a result of reports it received about its subsidiary in Turkey, alleging bid rigging and bribery and other inappropriate conduct in connection with the supply of certain reflective and other materials and related services to Turkish government entities. The Company also contacted certain affected government agencies in Turkey. The Company continues to cooperate with the DOJ and SEC in the Company’s ongoing investigation of this matter. The Company retained outside counsel to conduct an assessment of its policies, practices, and controls and to evaluate its overall compliance with the Foreign Corrupt Practices Act. The Company cannot predict at this time the outcome of its investigation or what regulatory actions may be taken or what other consequences may result.

 

Respirator Mask/Asbestos Litigation

 

As of December 31, 2009, the Company is a named defendant, with multiple co-defendants, in numerous lawsuits in various courts that purport to represent approximately 2,510 individual claimants, down from the approximately 2,700 individual claimants with actions pending at December 31, 2008.

 

The vast majority of the lawsuits and claims resolved by and currently pending against the Company allege use of some of the Company’s mask and respirator products and seek damages from the Company and other defendants for alleged personal injury from workplace exposures to asbestos, silica, coal mine dust or other occupational dusts found in products manufactured by other defendants or generally in the workplace. A minority of claimants generally allege personal injury from occupational exposure to asbestos from products previously manufactured by the Company, which are often unspecified, as well as products manufactured by other defendants, or occasionally at Company premises.

 

Since approximately 2006, the Company has experienced a significant decline in the number of new claims filed annually by apparently unimpaired claimants. The Company attributes this decline to several factors, including certain changes enacted in several states in recent years of the law governing asbestos-related claims, and the highly-publicized decision in mid-2005 of the United States District Court for the Southern District of Texas that identified and criticized abuses by certain attorneys, doctors and x-ray screening companies on behalf of primarily unimpaired claimants, many of whom were recruited by plaintiffs’ lawyers through mass chest x-ray screenings. The Company expects the filing of claims by unimpaired claimants in the future to continue at much lower levels than in the past. The Company believes that due to this change in the type and volume of incoming claims, it is likely that the number of claims alleging more serious injuries, including mesothelioma and other malignancies, while remaining relatively constant, will represent a greater percentage of total claims than in the past. The Company has demonstrated in past trial proceedings that its respiratory protection products are effective as claimed when used in the intended manner and in the intended circumstances. Consequently the Company believes that claimants are unable to establish that their medical conditions, even if significant, are attributable to the Company’s respiratory protection products. Nonetheless the Company’s litigation experience indicates that claims of persons with malignant conditions are costlier to resolve than the claims of unimpaired persons, and it therefore believes the average cost of resolving pending and future claims on a per-claim basis will continue to be higher than it experienced in prior periods when the vast majority of claims were asserted by the unimpaired.

 

The Company tried its ninth respirator case in the Superior Court of Alameda County, California. The plaintiff, who is suffering from mesothelioma as a result of his exposure to asbestos, claimed that the Company’s respirators were defective and failed to provide him with adequate protection and came with inadequate warnings. On July 6, 2009, after nearly four months of trial, the judge granted the Company’s motion to dismiss all claims against the Company at the end of the plaintiff’s case. The trial judge dismissed the claims against the Company because the plaintiff failed to prove that a defect in the Company’s respirator or its warnings was a substantial factor in causing the plaintiff’s mesothelioma. The plaintiff has filed an appeal of the trial judge’s decision. With this dismissal, the Company has prevailed in all nine cases taken to trial, including seven of the eight cases tried to verdict (such trials occurred in 1999, 2000, 2001, 2003, 2004, and 2007), and an appellate reversal in 2005 of the one jury verdict adverse to the Company.

 

Plaintiffs have asserted specific dollar claims for damages in approximately 32% of the 913 lawsuits that were pending against the Company at the end of 2009 in all jurisdictions. A majority of states restrict or prohibit specifying damages in tort cases such as these, and most of the remaining jurisdictions do not require such specification. In those cases in which plaintiffs choose to assert specific dollar amounts in their complaints, brought in states that permit such pleading, the amounts claimed are typically not meaningful as an indicator of the Company’s potential liability. This is because (a) the amounts claimed typically bear no relation to the extent of the plaintiff’s injury, if any; (b) the complaints nearly always assert claims against multiple defendants with the typical complaint asserting claims against as few as a dozen different defendants to upwards of 275 different defendants, the damages alleged are not attributed to individual defendants, and a defendant’s share of liability may turn on the law of joint and several liability, which can vary by state, and by the amount of fault a jury allocates to each defendant if a case is ultimately tried before a jury; (c) many cases are filed against the Company even though the plaintiffs did not use any of the Company’s products and, ultimately, are withdrawn or dismissed without any payment; and (d) many cases are brought on behalf of plaintiffs who have not suffered any medical injury, and, ultimately, are resolved without any payment or a payment that is a small fraction of the damages initially claimed. Of the 288 pending cases in which purported damage amounts are specified in the complaints, 144 cases involve claims of $100,000 or less, (five (5) of which also allege punitive damages of $20 million); 104 cases involve claims between $100,000 and $3 million (six (6) of which also allege punitive damages of $1 million, thirty-six (36) of which also allege punitive damages of $1.5 million, and one (1) of which also allege punitive damages of $2 million); four (4) cases involve claims of $3 million to $7.5 million (one (1) of which also allege punitive damages of $5 million and one (1) of which also allege punitive damages of $25 million); six (6) cases involve claims of $7.5 million to $10 million (two (2) of which also allege punitive damages of $5 million and four (4) of which also allege punitive damages of $21 million); fourteen (14) cases involve claims of $10 million (one (1) of which also allege punitive damages of $5 million and seven (7) of which also allege punitive damages of $10 million); eleven (11) cases involve claims of $10 million to $50 million (one (1) of which also allege punitive damages of $5 million, one (1) of which also allege punitive damages of $15 million, five (5) of which also allege punitive damages of $15.5 million, and one (1) of which also allege punitive damages of $20 million); and five (5) cases involve claims of $50 million (three (3) of which also allege punitive damages of $50 million). Some complaints allege that the compensatory and punitive damages are at least the amounts specified. As previously stated, the Company’s experience and the other reasons cited indicate that the damage amounts specified in complaints are not a meaningful factor in any assessment of the Company’s potential liability.

 

As previously reported, the State of West Virginia, through its Attorney General, filed a complaint in 2003 against the Company and two other manufacturers of respiratory protection products in the Circuit Court of Lincoln County, West Virginia and amended it in 2005. The amended complaint seeks substantial, but unspecified, compensatory damages primarily for reimbursement of the costs allegedly incurred by the State for worker’s compensation and healthcare benefits provided to all workers with occupational pneumoconiosis and unspecified punitive damages. This case has been inactive since the fourth quarter of 2007.

 

Respirator Mask/Asbestos Litigation — Aearo Technologies

 

On April 1, 2008, a subsidiary of the Company purchased the stock of Aearo Holding Corp., the parent of Aearo Technologies (“Aearo”). Aearo manufactures and sells various products, including personal protection equipment, such as eye, ear, head, face, fall and certain respiratory protection products.

 

As of December 31, 2009, Aearo and/or other companies that previously owned and operated Aearo’s respirator business (American Optical Corporation, Warner-Lambert LLC, AO Corp. and Cabot Corporation (“Cabot”)) are named defendants, with multiple co-defendants, including the Company, in numerous lawsuits in various courts in which plaintiffs allege use of mask and respirator products and seek damages from Aearo and other defendants for alleged personal injury from workplace exposures to asbestos, silica-related, or other occupational dusts found in products manufactured by other defendants or generally in the workplace.

 

As of December 31, 2009, the Company, through its Aearo subsidiary, has recorded $34 million as an estimate of the probable liabilities for product liabilities and defense costs related to current and future Aearo-related asbestos and silica-related claims. Responsibility for legal costs, as well as for settlements and judgments, is currently shared in an informal arrangement among Aearo, Cabot, American Optical Corporation and a subsidiary of Warner Lambert and their insurers (the “Payor Group”). Liability is allocated among the parties based on the number of years each company sold respiratory products under the “AO Safety” brand and/or owned the AO Safety Division of American Optical Corporation and the alleged years of exposure of the individual plaintiff. Aearo’s share of the contingent liability is further limited by an agreement entered into between Aearo and Cabot on July 11, 1995. This agreement provides that, so long as Aearo pays to Cabot an annual fee of $400,000, Cabot will retain responsibility and liability for, and indemnify Aearo against, asbestos and silica-related product liability claims for respirators manufactured prior to July 11, 1995. Because the date of manufacture for a particular respirator allegedly used in the past is often difficult to determine, Aearo and Cabot have applied the agreement to claims arising out of the alleged use of respirators while exposed to asbestos or silica or products containing asbestos or silica prior to January 1, 1997. With these arrangements in place, Aearo’s potential liability is limited to exposures alleged to have arisen from the use of respirators while exposed to asbestos, silica or other occupational dusts on or after January 1, 1997.

 

To date, Aearo has elected to pay the annual fee. Aearo could potentially be exposed to additional claims for some part of the pre-July 11, 1995 period covered by its agreement with Cabot if Aearo elects to discontinue its participation in this arrangement, or if Cabot is no longer able to meet its obligations in these matters.

 

Developments may occur that could affect the estimate of Aearo’s liabilities. These developments include, but are not limited to: (i) significant changes in the number of future claims, (ii) significant changes in the average cost of resolving claims, (iii) significant changes in the legal costs of defending these claims, (iv) significant changes in the mix and nature of claims received, (v) trial and appellate outcomes, (vi) significant changes in the law and procedure applicable to these claims, (vii) significant changes in the liability allocation among the co-defendants, (viii) the financial viability of members of the Payor Group including exhaustion of available coverage limits, (ix) the outcome of pending insurance coverage litigation among certain other members of the Payor Group and their respective insurers, and/or (x) a determination that the interpretation of the contractual obligations on which Aearo has estimated its share of liability is inaccurate. The Company cannot determine the impact of these potential developments on its current estimate of Aearo’s share of liability for these existing and future claims. If any of the developments described above were to occur, the actual amount of these liabilities for existing and future claims could be significantly larger than the reserved amount.

 

Employment Litigation

 

Whitaker lawsuit: As previously reported, in December, 2004, one current and one former employee of the Company filed a purported class action in the District Court of Ramsey County, Minnesota, seeking to represent a class of all current and certain former salaried employees employed by the Company in Minnesota below a certain salary grade who were age 46 or older at any time during the applicable period to be determined by the Court (the “Whitaker” lawsuit). The complaint alleges the plaintiffs suffered various forms of employment discrimination on the basis of age in violation of the Minnesota Human Rights Act and seeks injunctive relief, unspecified compensatory damages (which they seek to treble under the statute), including back and front pay, punitive damages (limited by statute to $8,500 per claimant) and attorneys’ fees. In January 2006, the plaintiffs filed a motion to join four additional named plaintiffs. This motion was unopposed by the Company and the four plaintiffs were joined in the case, although one claim has been dismissed following an individual settlement. The class certification hearing was held in December 2007. On April 11, 2008, the Court granted the plaintiffs’ motion to certify the case as a class action and defined the class as all persons who were 46 or older when employed by 3M in Minnesota in a salaried exempt position below a certain salary grade at any time on or after May 10, 2003, and who did not sign a document on their last day of employment purporting to release claims arising out of their employment with 3M. On June 25, 2008, the Minnesota Court of Appeals granted the Company’s petition for interlocutory review of the District Court’s decision granting class certification in the case. On April 28, 2009, the Court of Appeals issued its decision, reversing the District Court’s class certification decision. The Court of Appeals found that the District Court had not required plaintiffs to meet the proper legal standards for certification of a class under Minnesota law and had deferred resolving certain factual disputes that were relevant to the class certification requirements. The Court of Appeals remanded the case to the District Court for further proceedings in line with the evidentiary standards defined in its opinion. The Company believes that the Court of Appeals correctly determined the proper legal standards to apply to motions to certify a class action, but the Company also believes that plaintiffs’ motion for class certification in this case should be denied as a matter of law. Accordingly, on May 28, 2009, the Company filed in the Minnesota Supreme Court a Petition for Partial Review of the Decision of the Court of Appeals. On July 22, 2009, the Minnesota Supreme Court denied the Petition. The trial court has scheduled a hearing on May 5 and 6, 2010 to take testimony on the class certification issue.

 

Garcia lawsuit: The Company was served on May 7, 2009 with a purported class action/collective action age discrimination lawsuit, which was filed in United States District Court for the Northern District of California, San Jose Division (the “Garcia lawsuit”). Five former and one current employee of the Company are seeking to represent all current and former salaried employees employed by the Company in the United States during the liability period, which plaintiffs define as 2001 to the present. In addition to the six named plaintiffs, 91 other current or former employees have signed “opt-in” forms, seeking to join the action. The Garcia lawsuit expressly excludes those persons encompassed within the proposed class in the Whitaker lawsuit. The same counsel, joined by additional California counsel for the Garcia lawsuit, represents the plaintiffs in both cases.

 

The allegations of the complaint in the Garcia lawsuit are similar to those in the Whitaker lawsuit. Plaintiffs claim that they and other similarly situated employees suffered various forms of employment discrimination on the basis of age in violation of the federal Age Discrimination in Employment Act. In regard to these claims, plaintiffs seek to represent “all persons who were 46 or older when employed by 3M in the United States in a salaried position below the level of director, or salary grade 18, during the liability period.”  Because federal law protects persons age 40 and older from age discrimination, with respect to their claim of disparate impact only, plaintiffs also propose an alternative definition of similarly situated persons that would begin at age 40. On behalf of this group, plaintiffs seek injunctive relief, unspecified compensatory damages including back and front pay, benefits, liquidated damages and attorneys’ fees.

 

Certain of the plaintiffs’ and putative class members’ employment terminated under circumstances in which they were eligible for group severance plan benefits and in connection with those plans they signed waivers of claims, including age discrimination claims. Plaintiffs claim the waivers of age discrimination claims were invalid in various respects. This subset of release-signing plaintiffs seeks a declaration that the waivers of age discrimination claims are invalid, other injunctive, but non-monetary, remedies, and attorneys’ fees. On July 2, 2009, the Company filed its Answer to the Garcia lawsuit complaint and filed a motion, which was granted, to transfer the venue of the lawsuit to the United States District Court for the District of Minnesota.

 

EEOC age-discrimination charges: Six former employees and one current employee, all but one of whom are plaintiffs in the Garcia lawsuit, have also filed age discrimination charges against the Company with the U.S. Equal Employment Opportunity Commission and various pertinent state agencies. Of these, three former employees filed charges in 2005 in Minnesota, Texas, and California. These filings include allegations that the release of claims signed by certain former employees in the purported class defined in the charges is invalid for various reasons and assert age discrimination claims on behalf of certain current and former salaried employees in states other than Minnesota and New Jersey. In 2006, a current employee filed an age discrimination charge against the Company with the U.S. Equal Employment Opportunity Commission and the pertinent state agency in Missouri, asserting claims on behalf of a class of all current and certain former salaried employees who worked in Missouri and other states other than Minnesota and New Jersey. In 2007, a former employee filed an age discrimination charge against the Company with the U.S. Equal Employment Opportunity Commission and the pertinent state agency in California, asserting claims on behalf of a class of all current and certain former salaried employees who worked in California. In January 2009, two former employees filed age discrimination charges against the Company with the U.S. Equal Employment Opportunity Commission and the pertinent state agency in Minnesota. The filings include allegations that the release of claims signed by certain former employees in the purported class defined in the charges is invalid for various reasons and assert age discrimination claims on behalf of certain current and former salaried employees in states other than Minnesota. The same law firm represents the plaintiffs in the Whitaker lawsuit as well as the claimants in each of these EEOC proceedings.

 

Environmental Matters and Litigation

 

The Company’s operations are subject to environmental laws and regulations including those pertaining to air emissions, wastewater discharges, toxic substances, and the handling and disposal of solid and hazardous wastes enforceable by national, state, and local authorities around the world, and private parties in the United States and abroad. These laws and regulations provide, under certain circumstances, a basis for the remediation of contamination and for personal injury and property damage claims. The Company has incurred, and will continue to incur, costs and capital expenditures in complying with these laws and regulations, defending personal injury and property damage claims, and modifying its business operations in light of its environmental responsibilities. In its effort to satisfy its environmental responsibilities and comply with environmental laws and regulations, the Company has established, and periodically updates, policies relating to environmental standards of performance for its operations worldwide.

 

Remediation: Under certain environmental laws, including the United States Comprehensive Environmental Response, Compensation and Liability Act of 1980 and similar state laws, the Company may be jointly and severally liable, typically with other companies, for the costs of environmental contamination at current or former facilities and at off-site locations. The Company has identified numerous locations, most of which are in the United States, at which it may have some liability. Please refer to the “Environmental remediation liabilities” in the table in the following section, “Accrued Liabilities and Insurance Receivables Related to Legal Proceedings,” for information on the amount of the reserve.

 

Regulatory Activities: As previously reported, the Company has been voluntarily cooperating with ongoing reviews by local, state, national (primarily the U.S. Environmental Protection Agency (EPA)), and international agencies of possible environmental and health effects of various perfluorinated compounds (“PFCs”), including perfluorooctanyl compounds (perflurooctanoic acid or “PFOA” and perfluorooctane sulfonate or “PFOS”). As a result of its phase-out decision in May 2000, the Company no longer manufactures perfluorooctanyl compounds, and has agreed to a product stewardship initiative with the EPA to end its use of PFOA by 2015.

 

Regulatory activities concerning PFOA and/or PFOS continue in Europe and elsewhere, and before certain international bodies. These activities include gathering of exposure and use information, risk assessment, and consideration of regulatory approaches.

 

In late 2008 and early 2009, the EPA implemented testing of private wells and soils at certain agricultural sites in Alabama where wastewater treatment sludge was applied from a local wastewater treatment plant that received wastewater from numerous industrial sources. The EPA also tested public drinking water in Lawrence and Morgan Counties and concluded that the levels of PFOA and PFOS are lower than 0.04 part per billion (ppb). The EPA currently believes that these levels are not of concern and is working with local industry, including 3M, to continue testing municipal and private wells in the area. 3M and other companies are jointly conducting a survey of properties near the sites where wastewater treatment sludge was applied to determine if any further private drinking water wells are present. Where such wells are determined to be present, PFOA and PFOS levels will be assessed. The EPA also issued provisional health advisory values (above which action should be taken to reduce exposure to these compounds in drinking water) for PFOA of 0.4 ppb and PFOS of 0.2 ppb.

 

As previously reported, the Minnesota Department of Health (“MDH”) detected low levels of another perfluorinated compound called perfluorobutanoic acid (PFBA) in municipal wells (and in private wells as announced by the MDH in June 2007) in six nearby communities (Woodbury, Cottage Grove, Newport, St. Paul Park, South St. Paul, and Hastings, all communities located southeast of St. Paul), some of which slightly exceeded the MDH’s interim advisory level for PFBA of 1 ppb. In February 2008, the MDH established a health-based value (HBV) for PFBA of 7 ppb based on a clearer understanding of PFBA through the results of three major studies. An HBV is the amount of a chemical in drinking water considered by the MDH staff to be safe for people to drink for a lifetime. As a result of this new HBV for PFBA, well advisories will no longer be required for certain wells in the Minnesota communities of Lake Elmo, Oakdale and Cottage Grove. Residents in the affected communities where the levels of PFBA in private wells exceed the HBV either have been provided water treatment systems or connected to a city water system. As part of legislation passed during the 2007 Minnesota legislative session directing the MDH to develop and implement a statewide Environmental Health Tracking and Biomonitoring program, the MDH announced in July 2008 that it will measure the amount of PFCs in the blood of 200 adults who live in the Minnesota communities of Oakdale, Lake Elmo and Cottage Grove. In July 2009, the MDH reported that the levels of three PFCs in the blood of residents in these communities who participated in the study were slightly higher than the national average. A large body of research, including laboratory studies and epidemiology studies of exposed employees, shows that no human health effects are caused by PFCs at current levels of exposure. This research has been published in peer-reviewed scientific journals and shared with the EPA and global scientific-community.

 

The Company continues to work with the Minnesota Pollution Control Agency (MPCA) pursuant to the terms of the previously disclosed May 2007 Settlement Agreement and Consent Order to address the presence of perfluorinated compounds in the soil and groundwater at former disposal sites in Washington County Minnesota and at the Company’s manufacturing facility at Cottage Grove Minnesota. Under this agreement, the Company’s principal obligations include (i) evaluation of releases of perfluoronated compounds from these sites and propose response actions; (ii) providing alternative drinking water if and when an HBV or Health Risk Limit (“HRL”) (i.e., the amount of a chemical in drinking water determined by the MDH to be safe for people to drink for a lifetime) is exceeded for any perfluoronated compounds as a result of contamination from these sites; (iii) remediation of any source of other PFCs at these sites that is not controlled by actions to remediate PFOA and PFOS; and (iv) sharing information with the MPCA about perfluoronated compounds. During 2008, the MPCA issued formal decisions adopting remedial options for the former disposal sites in Washington County Minnesota (Oakdale and Woodbury). In August 2009, the MPCA issued a formal decision adopting remedial options for the Company’s Cottage Grove manufacturing facility. At each location the remedial options were among those recommended by the Company.

 

As previously reported, the Company entered into a voluntary remedial action agreement with the Alabama Department of Environmental Management (ADEM) to address the presence of PFCs in the soil on the Company’s manufacturing facility in Decatur, Alabama. For approximately twenty years, the Company incorporated wastewater treatment plant sludge containing PFCs in fields surrounding its Decatur facility pursuant to a permit issued by ADEM. After a review of the available options to address the presence of PFCs in the soil, ADEM agreed that the preferred remediation option is to use a multilayer cap over the former sludge incorporation areas on the manufacturing site with groundwater migration controls and treatment.

 

Please refer to the “Other environmental liabilities” in the table in the following section, “Accrued Liabilities and Insurance Receivables Related to Legal Proceedings” for information on the balance of the reserve established to implement the Settlement Agreement and Consent Order with the MPCA, the remedial action agreement with ADEM, and to address trace amounts of perfluorinated compounds in drinking water sources in the City of Oakdale and Lake Elmo, Minnesota, as well as presence in the soil and groundwater at the Company’s manufacturing facilities in Decatur, Alabama, and Cottage Grove, Minnesota, and at two former disposal sites in Minnesota.

 

The Company cannot predict what regulatory actions arising from the foregoing proceedings and activities, if any, may be taken regarding such compounds or the consequences of any such actions.

 

Litigation: As previously reported, a former employee filed a purported class action lawsuit in 2002 in the Circuit Court of Morgan County, Alabama, involving perfluorooctanyl chemistry, alleging that the plaintiffs suffered fear, increased risk, subclinical injuries, and property damage from exposure to perfluorooctanyl chemistry at or near the Company’s Decatur, Alabama, manufacturing facility. The Circuit Court in 2005 granted the Company’s motion to dismiss the named plaintiff’s personal injury-related claims on the basis that such claims are barred by the exclusivity provisions of the state’s Workers Compensation Act. The plaintiffs’ counsel filed an amended complaint in November 2006, limiting the case to property damage claims on behalf of a purported class of residents and property owners in the vicinity of the Decatur plant. Also in 2005, the judge in a second purported class action lawsuit (filed by three residents of Morgan County, Alabama, seeking unstated compensatory and punitive damages involving alleged damage to their property from emissions of perfluorooctanyl compounds from the Company’s Decatur, Alabama, manufacturing facility that formerly manufactured those compounds) granted the Company’s motion to abate the case, effectively putting the case on hold pending the resolution of class certification issues in the action described above filed in the same court in 2002. Despite the stay, plaintiffs filed an amended complaint seeking damages for alleged personal injuries and property damage on behalf of the named plaintiffs and the members of a purported class. No further action in the case is expected unless and until the stay is lifted.

 

In February 2009, a resident of Franklin County, Alabama, filed a purported class action lawsuit in the Circuit Court of Franklin County seeking compensatory damages and injunctive relief based on the application by the Decatur wastewater treatment plant of wastewater treatment sludge to farmland and grasslands in the state that allegedly contain PFOA, PFOS and other perfluorochemicals. The named defendants in the case include 3M, Dyneon LLC, Daikin America, Inc., Synagro-WWT, Inc., Synagro South, LLC and Biological Processors of America. The named plaintiff seeks to represent a class of all persons within the State of Alabama, Inc. who, within the past six years, have had PFOA, PFOS and other perfluorochemicals released or deposited on their property.

 

As previously reported, two residents of Washington County, Minnesota, filed in October 2004 a purported class action in the District Court of Washington County on behalf of Washington County residents who have allegedly suffered personal injuries and property damage from alleged emissions from the former perfluorooctanyl production facility at Cottage Grove, Minnesota, and from historic waste disposal sites in the vicinity of that facility. After the District Court granted the Company’s motion to dismiss the claims for medical monitoring and public nuisance in April 2005, the plaintiffs filed an amended complaint adding additional allegations involving other perfluorinated compounds manufactured by the Company, alleging additional legal theories in support of their claims, adding four plaintiffs, and seeking relief based on alleged contamination of the City of Oakdale municipal water supply and certain private wells in the vicinity of Lake Elmo, Minnesota. In April 2006, the plaintiffs filed a second amended complaint adding two additional plaintiffs. The two original plaintiffs thereafter dismissed their claims against the Company. On June 19, 2007 the Court denied the plaintiffs’ motion to certify the litigation as a class action. Thereafter, two of the remaining named plaintiffs voluntarily dismissed their claims. In December 2008 and January 2009 the Court granted the Company’s summary judgment motions dismissing all of the plaintiffs’ claims under the Minnesota Environmental Response and Liability Act and all claims for personal injury and emotional distress, but allowed the plaintiffs to add a claim for punitive damages with respect to their property damage claims. In March 2009, the Court granted the Company’s summary judgment motions seeking dismissal of the plaintiffs’ private nuisance and trespass to blood claims, but denied the Company’s summary judgment motion with respect to the plaintiffs’ negligence and trespass to soil and water claims, and denied the Company’s motion to dismiss the plaintiffs’ claim for punitive damages. Subsequent rulings by the Court in April 2009 limited the plaintiffs to property damage claims based on negligence and trespass, and punitive damages if plaintiffs proved their trespass claim. On June 17, 2009, after six weeks of trial, a Washington County jury returned a unanimous verdict in favor of the Company on all remaining issues in the lawsuit. The jury decided that the Company was not negligent and had not committed a trespass, and that plaintiffs had not suffered damage to their properties. The Court entered judgment on August 13, 2009 dismissing all of the plaintiffs’ claims based on the unanimous jury verdict in favor of the Company.

 

In July 2009, the Emerald Coast Utilities Authority in Florida filed a lawsuit against the Company, E.I. DuPont de Nemours and Company, Solutia, Inc., and Fire Ram International, Inc. in the Escambia County Circuit Court alleging contamination of public drinking water wells from PFOA and PFOS and seeking to recover costs related to investigation, treatment, remediation and monitoring of alleged PFOA and PFOS contamination of its wells. The Company, joined by the other defendants, removed the lawsuit to the U. S. District Court for the Northern District of Florida. On November 19, 2009 the District Court denied the plaintiff’s motion to remand the case to state court, finding that plaintiff’s joinder of the only Florida defendant, Fire Ram International, Inc., was fraudulent. The District Court subsequently denied the plaintiff’s motion for leave to file an amended complaint on grounds of timeliness.

 

In June 2009, the Company, along with more than 250 other companies, was served with a third-party complaint seeking contribution towards the cost of cleaning up a 17-mile stretch of the Passaic River in New Jersey. After commencing an enforcement action in 1990, the State of New Jersey filed suit against Maxus Energy, Tierra Solutions, Occidental Chemical and two other companies seeking cleanup and removal costs and other damages associated with the presence of dioxin and other hazardous substances in the sediment of the Passaic. The third-party complaint seeks to spread those costs among the third-party defendants, including the Company. Based on the cleanup remedy currently proposed by the EPA, the total costs at issue could easily exceed $1 billion. The Company’s recent involvement in the case appears to relate to its past disposal of industrial waste at two commercial waste disposal facilities in New Jersey. Whether, and to what extent, the Company may be required to contribute to the costs at issue in the case remains to be determined. The Company does not yet have a basis for estimating its potential exposure in this case, although the Company currently believes its allocable share, if any, of the total costs is likely to be a fraction of one percent.

 

Accrued Liabilities and Insurance Receivables Related to Legal Proceedings

 

The Company complies with the requirements of ASC 450, Contingencies, and related guidance, and records liabilities for legal proceedings in those instances where it can reasonably estimate the amount of the loss and where liability is probable. Where the reasonable estimate of the probable loss is a range, the Company records the most likely estimate of the loss, or the low end of the range if there is no one best estimate. The Company either discloses the amount of a possible loss or range of loss in excess of established reserves if estimable, or states that such an estimate cannot be made. For those insured matters where the Company has taken a reserve, the Company also records receivables for the amount of insurance that it expects to recover under the Company’s insurance program. For those insured matters where the Company has not taken a reserve because the liability is not probable or the amount of the liability is not estimable, or both, but where the Company has incurred an expense in defending itself, the Company records receivables for the amount of insurance that it expects to recover for the expense incurred. The Company discloses significant legal proceedings even where liability is not probable or the amount of the liability is not estimable, or both, if the Company believes there is at least a reasonable possibility that a loss may be incurred.

 

Because litigation is subject to inherent uncertainties, and unfavorable rulings or developments could occur, there can be no certainty that the Company may not ultimately incur charges in excess of presently recorded liabilities. A future adverse ruling, settlement, or unfavorable development could result in future charges that could have a material adverse effect on the Company’s results of operations or cash flows in the period in which they are recorded. The Company currently believes that such future charges, if any, would not have a material adverse effect on the consolidated financial position of the Company, taking into account its significant available insurance coverage. Based on experience and developments, the Company periodically reexamines its estimates of probable liabilities and associated expenses and receivables, and whether it is able to estimate a liability previously determined to be not estimable and/or not probable. Where appropriate, the Company makes additions to or adjustments of its estimated liabilities. As a result, the current estimates of the potential impact on the Company’s consolidated financial position, results of operations and cash flows for the legal proceedings and claims pending against the Company could change in the future.

 

The Company estimates insurance receivables based on an analysis of its numerous policies, including their exclusions, pertinent case law interpreting comparable policies, its experience with similar claims, and assessment of the nature of the claim, and records an amount it has concluded is likely to be recovered.

 

The following table shows the major categories of on-going litigation, environmental remediation and other environmental liabilities for which the Company has been able to estimate its probable liability and for which the Company has taken reserves and the related insurance receivables:

 

At December 31 (Millions)

 

2009

 

2008

 

2007

 

Respirator mask/asbestos liabilities (includes Aearo in December 31, 2009 and 2008 balances)

 

138

 

140

 

121

 

Respirator mask/asbestos insurance receivables

 

143

 

193

 

332

 

 

 

 

 

 

 

 

 

Environmental remediation liabilities

 

31

 

31

 

37

 

Environmental remediation insurance receivables

 

15

 

15

 

15

 

 

 

 

 

 

 

 

 

Other environmental liabilities

 

117

 

137

 

147

 

 

For those significant pending legal proceedings that do not appear in the table and that are not the subject of pending settlement agreements, the Company has determined that liability is not probable or the amount of the liability is not estimable, or both, and the Company is unable to estimate the possible loss or range of loss at this time. The Company does not believe that there is any single best estimate of the respirator/mask/asbestos liability, the environmental remediation or the other environmental liabilities shown above, nor that it can reliably estimate the amount or range of amounts by which those liabilities may exceed the reserves the Company has established.

 

Respirator Mask/Asbestos Liabilities and Insurance Receivables: The Company estimates its respirator mask/asbestos liabilities, including the cost to resolve the claim and defense costs, by examining: (i) the Company’s experience in resolving claims, (ii) apparent trends, (iii) the apparent quality of claims (e.g., whether the claim has been asserted on behalf of asymptomatic claimants), (iv) changes in the nature and mix of claims (e.g., the proportion of claims asserting usage of the Company’s mask or respirator products and alleging exposure to each of asbestos, silica, coal or other occupational dusts, and claims pleading use of asbestos-containing products allegedly manufactured by the Company), (v) the number of current claims and a projection of the number of future asbestos and other claims that may be filed against the Company, (vi) the cost to resolve recently settled claims, and (vii) an estimate of the cost to resolve and defend against current and future claims. Because of the inherent difficulty in projecting the number of claims that have not yet been asserted, particularly with respect to the Company’s respiratory products that themselves did not contain any harmful materials (which makes the various published studies that purport to project future asbestos claims substantially removed from the Company’s principal experience and which themselves vary widely), the Company does not believe that there is any single best estimate of this liability, nor that it can reliably estimate the amount or range of amounts by which the liability may exceed the reserve the Company has established. No liability has been recorded regarding the pending action brought by the West Virginia Attorney General previously described.

 

Developments may occur that could affect the Company’s estimate of its liabilities. These developments include, but are not limited to, significant changes in (i) the number of future claims, (ii) the average cost of resolving claims, (iii) the legal costs of defending these claims and in maintaining trial readiness, (iv) changes in the mix and nature of claims received, (v) trial and appellate outcomes, (vi) changes in the law and procedure applicable to these claims, and (vii) the financial viability of other co-defendants and insurers.

 

As a result of the costs of aggressively defending itself and the greater cost of resolving claims of persons with malignant conditions, the Company increased its reserves in 2009 for respirator mask/asbestos liabilities by $33 million. As of December 31, 2009, the Company had reserves for respirator mask/asbestos liabilities of $104 million (excluding Aearo reserves).

 

As of December 31, 2009, the Company’s receivable for insurance recoveries related to the respirator mask/asbestos litigation was $143 million. The Company increased its receivables for insurance recoveries by $7 million in 2009 related to this litigation. As a result of settlements reached with its insurers, the Company was paid approximately $57 million in 2009 and has an agreement in principle to receive an additional $28 million in connection with the respirator mask/asbestos litigation.

 

Various factors could affect the timing and amount of recovery of this receivable, including (i) delays in or avoidance of payment by insurers; (ii) the extent to which insurers may become insolvent in the future, and (iii) the outcome of negotiations with insurers and legal proceedings with respect to respirator mask/asbestos liability insurance coverage. The difference between the accrued liability and insurance receivable represents in part the time delay between payment of claims on the one hand and receipt of insurance reimbursements on the other hand. Because of the lag time between settlement and payment of a claim, no meaningful conclusions may be drawn from quarterly or annual changes in the amount of receivables for expected insurance recoveries or changes in the number of claimants.

 

On January 5, 2007 the Company was served with a declaratory judgment action filed on behalf of two of its insurers (Continental Casualty and Continental Insurance Co. — both part of the Continental Casualty Group) disclaiming coverage for respirator mask/asbestos claims. These insurers represent approximately $14 million of the $143 million insurance recovery receivable referenced in the above table. The action seeks declaratory judgment regarding the allocation of covered costs among the policies issued by the various insurers. It was filed in Hennepin County, Minnesota and named, in addition to the Company, over 60 of the Company’s insurers. This action is similar in nature to an action filed in 1994 with respect to breast implant coverage, which ultimately resulted in the Minnesota Supreme Court’s ruling of 2003 that was largely in the Company’s favor. At the Company’s request, the case was transferred to Ramsey County, over the objections of the insurers. The Minnesota Supreme Court heard oral argument of the insurers’ appeal of that decision in March 2008 and ruled in May 2008 that the proper venue of that case is Ramsey County. The case has been assigned to a judge in Ramsey County District Court. The plaintiff insurers have served an amended complaint that names some additional insurers and deletes others. Several of the insurer defendants named in the amended complaint have been dismissed because of settlements they have reached with 3M regarding the matters at issue in the lawsuit. The case remains in its early stages with a trial scheduled to begin in June, 2012.

 

Environmental and Other Liabilities and Insurance Receivables: As of December 31, 2009, the Company had recorded liabilities of $31 million for estimated environmental remediation costs based upon an evaluation of currently available facts with respect to each individual site and also recorded related insurance receivables of $15 million. The Company records liabilities for remediation costs on an undiscounted basis when they are probable and reasonably estimable, generally no later than the completion of feasibility studies or the Company’s commitment to a plan of action. Liabilities for estimated costs of environmental remediation, depending on the site, are based primarily upon internal or third-party environmental studies, and estimates as to the number, participation level and financial viability of any other potentially responsible parties, the extent of the contamination and the nature of required remedial actions. The Company adjusts recorded liabilities as further information develops or circumstances change. The Company expects that it will pay the amounts recorded over the periods of remediation for the applicable sites, currently ranging up to 30 years.

 

As of December 31, 2009, the Company had recorded liabilities of $117 million for estimated other environmental liabilities based upon an evaluation of currently available facts for addressing trace amounts of perfluorinated compounds in drinking water sources in the City of Oakdale and Lake Elmo, Minnesota, as well as presence in the soil and groundwater at the Company’s manufacturing facilities in Decatur, Alabama, and Cottage Grove, Minnesota, and at two former disposal sites in Minnesota. The Company expects that most of the spending will occur over the next seven years.

 

It is difficult to estimate the cost of environmental compliance and remediation given the uncertainties regarding the interpretation and enforcement of applicable environmental laws and regulations, the extent of environmental contamination and the existence of alternate cleanup methods. Developments may occur that could affect the Company’s current assessment, including, but not limited to: (i) changes in the information available regarding the environmental impact of the Company’s operations and products; (ii) changes in environmental regulations, changes in permissible levels of specific compounds in drinking water sources, or changes in enforcement theories and policies, including efforts to recover natural resource damages; (iii) new and evolving analytical and remediation techniques; (iv) success in allocating liability to other potentially responsible parties; and (v) the financial viability of other potentially responsible parties and third-party indemnitors.

 

Employee Savings and Stock Ownership Plans
Employee Savings and Stock Ownership Plans

NOTE 15.  Employee Savings and Stock Ownership Plans

 

The Company sponsors employee savings plans under Section 401(k) of the Internal Revenue Code. These plans are offered to substantially all regular U.S. employees. During 2008 the Board of Directors approved various changes to the employee savings plans. For employees hired prior to January 1, 2009, employee 401(k) contributions of up to 6% of eligible compensation are matched in Company stock at rates of 60% or 75%, depending on the plan the employee participated in. Employees hired on or after January 1, 2009 receive a cash match of 100% for employee 401(k) contributions of up to 6% of eligible compensation and also receive an employer retirement income account cash contribution of 3% of the participant’s total eligible compensation. All employee contributions are invested in a number of investment funds pursuant to their elections. Vested employees may diversify their 3M shares into other investment options. Effective January 1, 2010, the matching contributions for all participants will be made in cash.

 

The Company maintained an Employee Stock Ownership Plan (ESOP) that was established in 1989 as a cost-effective way of funding the majority of the Company’s contributions under 401(k) employee savings plans. Total ESOP shares were considered to be shares outstanding for earnings per share calculations. The ESOP debt obligation matured in 2009 (Note 10).

 

Dividends on shares held by the ESOP were paid to the ESOP trust and, together with Company contributions, were used by the ESOP to repay principal and interest on the outstanding ESOP debt. The tax benefit related to dividends paid on unallocated shares was charged directly to equity and totaled approximately $1 million in 2009, $2 million in 2008, and $3 million in 2007. Over the life of the ESOP debt, shares were released for allocation to participants based on the ratio of the current year’s debt service to the remaining debt service prior to the current payment.

 

Until 2009, the ESOP was the primary funding source for the Company’s employee savings plans. As permitted by accounting standards relating to employers’ accounting for employee stock ownership plans, the debt of the ESOP was recorded as debt, and shares pledged as collateral were reported as unearned compensation in the Consolidated Balance Sheet and Consolidated Statement of Changes in Equity. Unearned compensation was reduced symmetrically as the ESOP made principal payments on the debt. Expenses related to the ESOP included total debt service on the notes, less dividends. The Company contributed treasury shares (accounted for at fair value) and cash (in 2009) to employee savings plans to cover obligations not funded by the ESOP (reported as an employee benefit expense).

 

Employee Savings and Stock Ownership Plans

 

(Millions)

 

2009

 

2008

 

2007

 

Dividends on shares held by the ESOP

 

$

31

 

$

33

 

$

37

 

Company contributions to the ESOP

 

16

 

14

 

10

 

Interest incurred on ESOP notes

 

1

 

3

 

5

 

Amounts reported as an employee benefit expense:

 

 

 

 

 

 

 

Expenses related to ESOP debt service

 

10

 

9

 

5

 

Expenses related to treasury shares

 

25

 

3

 

34

 

Expenses for Company contributions made in cash

 

6

 

 

 

 

ESOP Debt Shares

 

 

 

2009

 

2008

 

2007

 

Allocated

 

14,473,474

 

14,240,026

 

14,039,070

 

Committed to be released

 

 

27,201

 

278,125

 

Unreleased

 

 

1,333,692

 

2,457,641

 

 

Various international countries participate in defined contribution plans. Expenses related to employer contributions to these plans were $22 million, $23 million and $18 million for 2009, 2008 and 2007, respectively.

 

Stock-Based Compensation
Stock-Based Compensation

NOTE 16.  Stock-Based Compensation

 

In May 2008, shareholders approved 35 million shares for issuance under the “3M 2008 Long-Term Incentive Plan”, which replaced and succeeded the 2005 Management Stock Ownership Program (MSOP), the 3M Performance Unit Plan, and the 1992 Directors Stock Ownership Program. Shares under this plan may be issued in the form of Incentive Stock Options, Nonqualified Stock Options, Progressive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Other Stock Awards, and Performance Units and Performance Shares. Awards denominated in shares of common stock other than options and Stock Appreciation Rights, per the 2008 Plan, will be counted against the 35 million share limit as 3.38 shares for every one share covered by such award. The remaining total shares available for grant under the 3M 2008 Long Term Incentive Plan are 15,507,162 as of December 31, 2009.

 

In 2009, the Company changed the timing of its annual stock option and restricted stock unit grant dates from May to February, in order to provide a stronger and more immediate link between the performance of individuals during the preceding year and the size of their annual stock option grants. In 2008 and prior, the Company issued options to eligible employees annually in May using the closing stock price on the grant date, which was the date of the Annual Stockholders’ Meeting. Accounting rules require recognition of expense under a non-substantive vesting period approach, requiring compensation expense recognition when an employee is eligible to retire. 3M employees in the United States are eligible to retire at age 55 and after having completed five years of service. Approximately 25 percent of the stock-based compensation award expense dollars are for this retiree-eligible population. Therefore, in 2009 the retiree-eligible impact shifted stock-based compensation expense to the first quarter, whereas in 2008 and prior this impact was recognized in the second quarter (because of the May grant date).

 

In addition to these annual grants, the Company makes other minor grants of stock options, restricted stock units and other stock-based grants. The Company issues cash settled Restricted Stock Units and Stock Appreciation Rights in certain countries. These grants do not result in the issuance of Common Stock and are considered immaterial by the Company. There were approximately 14,008 participants with outstanding options, restricted stock, or restricted stock units at December 31, 2009.

 

Effective with the May 2005 MSOP annual grant, the Company changed its vesting period from one to three years with the expiration date remaining at 10 years from date of grant. Beginning in 2007, the Company reduced the number of traditional stock options granted under the MSOP plan by reducing the number of employees eligible to receive annual grants and by shifting a portion of the annual grant away from traditional stock options primarily to restricted stock units. However, associated with the reduction in the number of eligible employees, the Company provided a one-time “buyout” grant of restricted stock units to the impacted employees, which resulted in increased stock-based compensation expense in 2007. The income tax benefits shown in the following table can fluctuate by period due to the amount of Incentive Stock Options (ISOs) exercised since the Company receives the ISOs tax benefit upon exercise. The Company last granted ISOs in 2002. Amounts recognized in the financial statements with respect to stock-based compensation programs, which include stock options, restricted stock, restricted stock units and the General Employees’ Stock Purchase Plan (GESPP), are as follows:

 

Stock-Based Compensation Expense

 

 

 

Years ended December 31

 

(Millions)

 

2009

 

2008

 

2007

 

Cost of sales

 

$

38

 

$

43

 

$

47

 

Selling, general and administrative expenses

 

144

 

122

 

137

 

Research, development and related expenses

 

35

 

37

 

44

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

$

(217

)

$

(202

)

$

(228

)

 

 

 

 

 

 

 

 

Income tax benefits

 

$

62

 

$

71

 

$

93

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to 3M

 

$

(155

)

$

(131

)

$

(135

)

 

The following table summarizes stock option activity during the twelve months ended December 31:

 

Stock Option Program

 

 

 

2009

 

2008

 

2007

 

 

 

Number of

 

Exercise

 

Number of

 

Exercise

 

Number of

 

Exercise

 

 

 

Options

 

Price*

 

Options

 

Price*

 

Options

 

Price*

 

Under option —

 

 

 

 

 

 

 

 

 

 

 

 

 

January 1

 

75,452,722

 

$

71.96

 

74,613,051

 

$

70.50

 

82,867,903

 

$

67.41

 

Granted:

 

 

 

 

 

 

 

 

 

 

 

 

 

Annual

 

6,649,672

 

53.93

 

5,239,660

 

77.22

 

4,434,583

 

84.81

 

Progressive (Reload)

 

68,189

 

77.37

 

78,371

 

79.53

 

461,815

 

87.12

 

Other

 

4,654

 

50.85

 

20,389

 

79.25

 

51,730

 

82.93

 

Exercised

 

(6,930,544

)

49.83

 

(3,797,663

)

49.38

 

(12,498,051

)

55.34

 

Canceled

 

(976,528

)

73.50

 

(701,086

)

79.12

 

(704,929

)

77.36

 

December 31

 

74,268,165

 

$

72.39

 

75,452,722

 

$

71.96

 

74,613,051

 

$

70.50

 

Options exercisable December 31

 

62,414,398

 

$

73.73

 

63,282,408

 

$

70.01

 

58,816,963

 

$

66.83

 

 

*                 Weighted average

 

Outstanding shares under option include grants from previous plans. For options outstanding at December 31, 2009, the weighted-average remaining contractual life was 58 months and the aggregate intrinsic value was $844 million. For options exercisable at December 31, 2009, the weighted-average remaining contractual life was 50 months and the aggregate intrinsic value was $636 million. As of December 31, 2009, there was $68 million of compensation expense that has yet to be recognized related to non-vested stock option-based awards. This expense is expected to be recognized over the remaining vesting period with a weighted-average life of 1.7 years.

 

The total intrinsic values of stock options exercised during 2009, 2008 and 2007, respectively, was $108 million, $107 million and $373 million. Cash received from options exercised during 2009, 2008 and 2007, respectively, was $345 million, $188 million and $692 million. The Company’s actual tax benefits realized for the tax deductions related to the exercise of employee stock options for 2009, 2008 and 2007, respectively, was $38 million, $34 million and $122 million. Capitalized stock-based compensation amounts were not material for the twelve months ended 2009, 2008, and 2007.

 

The Company does not have a specific policy to repurchase common shares to mitigate the dilutive impact of options; however, the Company has historically made adequate discretionary purchases, based on cash availability, market trends and other factors, to satisfy stock option exercise activity.

 

For annual and progressive (reload) options, the weighted average fair value at the date of grant was calculated using the Black-Scholes option-pricing model and the assumptions that follow.

 

Stock Option Assumptions

 

 

 

Annual

 

Progressive (Reload)

 

 

 

2009

 

2008

 

2007

 

2009

 

2008

 

2007

 

Exercise price

 

$

54.11

 

$

77.22

 

$

84.79

 

$

77.83

 

$

79.76

 

$

87.12

 

Risk-free interest rate

 

2.2

%

3.1

%

4.6

%

1.4

%

4.3

%

4.6

%

Dividend yield

 

2.3

%

2.0

%

2.1

%

2.0

%

2.0

%

2.1

%

Volatility

 

30.3

%

21.7

%

20.0

%

30.7

%

18.7

%

18.4

%

Expected life (months)

 

71

 

70

 

69

 

32

 

25

 

25

 

Black-Scholes fair value

 

$

13.00

 

$

15.28

 

$

18.12

 

$

14.47

 

$

12.00

 

$

13.26

 

 

Expected volatility is a statistical measure of the amount by which a stock price is expected to fluctuate during a period. For the 2009, 2008 and 2007 annual grant date, the Company estimated the expected volatility based upon the average of the most recent one year volatility, the median of the term of the expected life rolling volatility, the median of the most recent term of the expected life volatility of 3M stock, and the implied volatility on the grant date. The expected term assumption is based on the weighted average of historical grants.

 

As previously mentioned, beginning in 2007, the Company expanded its utilization of restricted stock units. Restricted stock unit grants generally vest at the end of three years. The one-time “buyout” restricted stock unit grant in 2007 vests at the end of five years. Restricted stock unit grants issued in 2008 and prior did not accrue dividends during the vesting period. Substantially all restricted stock unit grants made after 2008 accrue dividends during the vesting period, which will be paid out in cash at the vest date on all vested restricted stock units. The following table summarizes restricted stock and restricted stock unit activity during the twelve months ended December 31:

 

Restricted Stock and Restricted Stock Units

 

 

 

2009

 

2008

 

 

 

Number of
Awards

 

Grant Date
Fair Value*

 

Number of
Awards

 

Grant Date
Fair Value*

 

Nonvested balance —

 

 

 

 

 

 

 

 

 

As of January 1

 

2,957,538

 

$

77.41

 

2,001,581

 

$

77.63

 

Granted:

 

 

 

 

 

 

 

 

 

Annual

 

1,150,819

 

53.89

 

924,120

 

77.23

 

Other

 

522,581

 

54.82

 

188,473

 

73.16

 

Vested

 

(157,104

)

73.26

 

(64,806

)

68.72

 

Forfeited

 

(94,354

)

69.57

 

(91,830

)

77.76

 

As of December 31

 

4,379,480

 

$

68.85

 

2,957,538

 

$

77.41

 

 

*                 Weighted average

 

As of December 31, 2009, there was $91 million of compensation expense that has yet to be recognized related to non-vested restricted stock and restricted stock units. This expense is expected to be recognized over the remaining vesting period with a weighted-average life of 1.9 years. The total fair value of restricted stock and restricted stock units that vested during the twelve-month periods ended December 31, 2009, 2008 and 2007, respectively, was $10 million, $4 million and $6 million.

 

General Employees’ Stock Purchase Plan (GESPP):

 

In May 1997, shareholders approved 30 million shares for issuance under the Company’s GESPP. Substantially all employees are eligible to participate in the plan. Participants are granted options at 85% of market value at the date of grant. There are no GESPP shares under option at the beginning or end of each year because options are granted on the first business day and exercised on the last business day of the same month.

 

General Employees’ Stock Purchase Plan

 

 

 

2009

 

2008

 

2007

 

 

 

Shares

 

Exercise
Price*

 

Shares

 

Exercise
Price*

 

Shares

 

Exercise
Price*

 

Options granted

 

1,655,936

 

$

50.58

 

1,624,775

 

$

62.68

 

1,507,335

 

$

69.34

 

Options exercised

 

(1,655,936

)

50.58

 

(1,624,775

)

62.68

 

(1,507,335

)

69.34

 

Shares available for grant — December 31

 

5,659,939

 

 

 

7,315,875

 

 

 

8,940,650

 

 

 

 

*                 Weighted average

 

The weighted-average fair value per option granted during 2009, 2008 and 2007 was $8.93, $11.06 and $12.24, respectively. The fair value of GESPP options was based on the 15% purchase price discount. The Company recognized compensation expense for GESSP options of $15 million in 2009 and $18 million in both 2008 and 2007.

 

Business Segments
Business Segments

NOTE 17.  Business Segments

 

Effective in the first quarter of 2010, 3M made certain product moves between its business segments in its continuing effort to drive growth by aligning businesses around markets and customers. There were no changes impacting business segments related to product moves for the Health Care segment, Consumer and Office segment, Display and Graphics segment, or Electro and Communications segment. The product moves between business segments are summarized as follows:

 

·                  Certain acoustic systems products in the Occupational Health and Environmental Safety Division (part of the Safety, Security and Protection Services business segment) were transferred to the Automotive Division within the Industrial and Transportation business segment. In addition, thermal acoustics systems products which were included in the Occupational Health and Environmental Safety Division as a result of 3M’s April 2008 acquisition of Aearo Holding Corp. were transferred to the Aerospace and Aircraft Maintenance Department within the Industrial and Transportation business segment. These product moves establish an acoustic center of excellence within the Industrial and Transportation business segment. The preceding product moves resulted in an increase in net sales for total year 2009 of $116 million for Industrial and Transportation, which was offset by a corresponding decrease in net sales for Safety, Security and Protection Services.

 

3M’s businesses are organized, managed and internally grouped into segments based on differences in products, technologies and services. 3M continues to manage its operations in six operating business segments: Industrial and Transportation; Health Care; Consumer and Office; Safety, Security and Protection Services; Display and Graphics; and Electro and Communications. 3M’s six business segments bring together common or related 3M technologies, enhancing the development of innovative products and services and providing for efficient sharing of business resources. These segments have worldwide responsibility for virtually all 3M product lines. 3M is not dependent on any single product/service or market. Certain small businesses and lab-sponsored products, as well as various corporate assets and expenses, are not attributed to the business segments. Transactions among reportable segments are recorded at cost.

 

The financial information presented herein reflects the impact of all of the preceding segment structure changes for all periods presented.

 

Business Segment Products

 

Business Segment

 

Major Products

Industrial and Transportation

 

Tapes, coated and nonwoven abrasives, adhesives, specialty materials, filtration products, closure systems for personal hygiene products, acoustic systems products, automotive components, abrasion-resistant films, structural adhesives and paint finishing and detailing products, energy control products

Health Care

 

Medical and surgical supplies, skin health and infection prevention products, pharmaceuticals (sold in December 2006 and January 2007), drug delivery systems, dental and orthodontic products, health information systems and food safety products

Consumer and Office

 

Sponges, scouring pads, high-performance cloths, consumer and office tapes, repositionable notes, carpet and fabric protectors, construction and home improvement products, home care products, protective material products and consumer health care products

Safety, Security and Protection Services

 

Personal protection products, safety and security products, commercial cleaning and protection products, floor matting, roofing granules for asphalt shingles, and Track and Trace products, such as library patron self-checkout systems (supply chain execution software solutions sold in June 2008)

Display and Graphics

 

Optical films solutions for electronic displays, reflective sheeting for transportation safety, commercial graphics systems, and projection systems, including mobile display technology and visual systems

Electro and Communications

 

Packaging and interconnection devices, insulating and splicing solutions for the electronics, telecommunications and electrical industries, and touch screens and touch monitors

 

Business Segment Information

 

 

 

Net Sales

 

Operating Income

 

(Millions)

 

2009

 

2008

 

2007

 

2009

 

2008

 

2007

 

Industrial and Transportation

 

$

7,232

 

$

8,294

 

$

7,692

 

$

1,259

 

$

1,568

 

$

1,590

 

Health Care

 

4,294

 

4,303

 

3,980

 

1,350

 

1,175

 

1,884

 

Consumer and Office

 

3,471

 

3,578

 

3,494

 

748

 

683

 

710

 

Safety, Security and Protection Services

 

3,064

 

3,330

 

2,891

 

724

 

689

 

573

 

Display and Graphics

 

3,132

 

3,268

 

3,916

 

590

 

583

 

1,166

 

Electro and Communications

 

2,276

 

2,835

 

2,805

 

322

 

540

 

501

 

Corporate and Unallocated

 

12

 

22

 

79

 

(100

)

59

 

(144

)

Elimination of Dual Credit

 

(358

)

(361

)

(395

)

(79

)

(79

)

(87

)

Total Company

 

$

23,123

 

$

25,269

 

$

24,462

 

$

4,814

 

$

5,218

 

$

6,193

 

 

 

 

Assets

 

Depreciation & Amortization

 

Capital Expenditures

 

(Millions)

 

2009

 

2008

 

2007

 

2009

 

2008

 

2007

 

2009

 

2008

 

2007

 

Industrial and Transportation

 

$

6,441

 

$

6,373

 

$

5,981

 

$

333

 

$

288

 

$

265

 

$

235

 

$

355

 

$

335

 

Health Care

 

3,218

 

3,096

 

2,909

 

143

 

146

 

124

 

125

 

169

 

173

 

Consumer and Office

 

1,819

 

1,815

 

1,720

 

88

 

79

 

73

 

43

 

87

 

82

 

Safety, Security and Protection Services

 

3,206

 

3,127

 

2,235

 

169

 

147

 

142

 

93

 

107

 

152

 

Display and Graphics

 

3,564

 

3,479

 

3,199

 

174

 

220

 

199

 

160

 

305

 

276

 

Electro and Communications

 

2,067

 

2,186

 

2,063

 

102

 

127

 

131

 

60

 

143

 

110

 

Corporate and Unallocated

 

6,935

 

5,717

 

6,592

 

148

 

146

 

138

 

187

 

305

 

294

 

Total Company

 

$

27,250

 

$

25,793

 

$

24,699

 

$

1,157

 

$

1,153

 

$

1,072

 

$

903

 

$

1,471

 

$

1,422

 

 

Corporate and Unallocated operating income includes a variety of miscellaneous items, such as corporate investment gains and losses, certain derivative gains and losses, insurance-related gains and losses, certain litigation and environmental expenses, corporate restructuring charges and certain under- or over-absorbed costs (e.g. pension) that the Company may choose not to allocate directly to its business segments. Because this category includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly and annual basis.

 

3M business segment reporting measures include dual credit to business segments for certain U.S. sales and related operating income. Management evaluates each of its six operating business segments based on net sales and operating income performance, including dual credit U.S. reporting to further incentivize U.S. sales growth. As a result, 3M provides additional (“dual”) credit to those business segments selling products in the U.S. to an external customer when that segment is not the primary seller of the product. For example, certain respirators are primarily sold by the Occupational Health and Environmental Safety Division within the Safety, Security and Protection Services business segment; however, the Industrial and Transportation business segment also sells this product to certain customers in its U.S. markets. In this example, the non-primary selling segment (Industrial and Transportation) would also receive credit for the associated net sales it initiated and the related approximate operating income. The assigned operating income related to dual credit activity may differ from operating income that would result from actual costs associated with such sales. The offset to the dual credit business segment reporting is reflected as a reconciling item entitled “Elimination of Dual Credit,” such that sales and operating income for the U.S. in total are unchanged.

 

3M is an integrated enterprise characterized by substantial intersegment cooperation, cost allocations and inventory transfers. Therefore, management does not represent that its business segments, if operated independently, would report the operating income and other financial information shown. The difference between operating income and pre-tax income relates to interest income and interest expense, which are not allocated to business segments. Segment operating income and assets in the preceding table include allocations resulting from the shared utilization of certain corporate or otherwise unallocated assets. However, the separate amounts stated for segment depreciation, amortization, and capital expenditures are based on secondary performance measures used by management that do not include allocations of certain corporate items.

 

Segment assets for the operating business segments (excluding Corporate and Unallocated) primarily include accounts receivable; inventory; property, plant and equipment — net; goodwill and intangible assets; and other miscellaneous assets. Assets included in Corporate and Unallocated principally are cash, cash equivalents and marketable securities; insurance receivables; deferred income taxes; certain investments and other assets, including prepaid pension assets. Corporate and unallocated assets can change from year to year due to changes in cash, cash equivalents and marketable securities, changes in prepaid pension benefits, and changes in other unallocated asset categories.

 

The most significant items impacting 2009 and 2008 results were restructuring actions and exit activities. The most significant items impacting 2007 results are the net gain on sale of the pharmaceuticals business (within the Health Care segment) and restructuring and other actions. Refer to Note 4 for discussion of restructuring actions and exit activities and Note 2 for discussion of divestitures.

 

Geographic Areas
Geographic Areas

NOTE 18.  Geographic Areas

 

Geographic area information is used by the Company as a secondary performance measure to manage its businesses. Export sales and certain income and expense items are generally reported within the geographic area where the final sales to 3M customers are made.

 

 

 

Net Sales

 

Operating Income

 

Property, Plant and
Equipment - net

 

(Millions)

 

2009

 

2008

 

2007

 

2009

 

2008

 

2007

 

2009

 

2008

 

United States

 

$

8,509

 

$

9,179

 

$

8,987

 

$

1,640

 

$

1,578

 

$

1,894

 

$

3,809

 

$

3,901

 

Asia Pacific

 

6,120

 

6,423

 

6,601

 

1,528

 

1,662

 

2,062

 

1,366

 

1,304

 

Europe, Middle East and Africa

 

5,972

 

6,941

 

6,503

 

1,003

 

1,294

 

1,626

 

1,318

 

1,263

 

Latin America and Canada

 

2,516

 

2,723

 

2,365

 

631

 

693

 

616

 

507

 

418

 

Other Unallocated

 

6

 

3

 

6

 

12

 

(9

)

(5

)

 

 

Total Company

 

$

23,123

 

$

25,269

 

$

24,462

 

$

4,814

 

$

5,218

 

$

6,193

 

$

7,000

 

$

6,886

 

 

Restructuring and exit activities significantly impacted results by geographic area in 2009, 2008 and 2007. In 2007, results were also significantly impacted by the sale of businesses. Refer to Note 2 and Note 4 for discussion of these items.

 

Asia Pacific includes Japan net sales to customers of $1.979 billion in 2009, $2.180 billion in 2008 and $2.063 billion in 2007. Asia Pacific includes Japan net property, plant and equipment of $364 million in 2009 and $420 million in 2008.

 

Quarterly Data (Unaudited)
Quarterly Data (Unaudited)

NOTE 19.  Quarterly Data (Unaudited)

 

(Millions, except per-share amounts)
2009

 

First
Quarter

 

Second
Quarter

 

Third
Quarter

 

Fourth
Quarter

 

Year
2009

 

Net sales

 

$

5,089

 

$

5,719

 

$

6,193

 

$

6,122

 

$

23,123

 

Cost of sales

 

2,772

 

2,977

 

3,171

 

3,189

 

12,109

 

Net income attributable to 3M

 

518

 

783

 

957

 

935

 

3,193

 

Earnings per share attributable to 3M common shareholders — basic

 

0.75

 

1.12

 

1.36

 

1.32

 

4.56

 

Earnings per share attributable to 3M common shareholders — diluted

 

0.74

 

1.12

 

1.35

 

1.30

 

4.52

 

 

(Millions, except per-share amounts)
2008

 

First
Quarter

 

Second
Quarter

 

Third
Quarter

 

Fourth
Quarter

 

Year
2008

 

Net sales

 

$

6,463

 

$

6,739

 

$

6,558

 

$

5,509

 

$

25,269

 

Cost of sales

 

3,336

 

3,510

 

3,432

 

3,101

 

13,379

 

Net income attributable to 3M

 

988

 

945

 

991

 

536

 

3,460

 

Earnings per share attributable to 3M common shareholders — basic

 

1.40

 

1.35

 

1.43

 

0.77

 

4.95

 

Earnings per share attributable to 3M common shareholders — diluted

 

1.38

 

1.33

 

1.41

 

0.77

 

4.89

 

 

Gross profit is calculated as net sales minus cost of sales. In 2009, restructuring charges, partially offset by a gain on sale of real estate, decreased net income attributable to 3M by $119 million, or $0.17 per diluted share, with $45 million ($0.07 per diluted share) in the first quarter, $60 million ($0.08 per diluted share) in the second quarter and $14 million ($0.02 per diluted share) in the third quarter. 2008 included restructuring actions, exit activities and a loss on sale of businesses, which were partially offset by a gain on sale of real estate. In 2008, these restructuring and other items decreased net income attributable to 3M by $194 million, or $0.28 per diluted share, with $140 million, or $0.20 per diluted share in the fourth quarter of 2008.

 

Document and Entity Information (USD $)
In Billions, except Share data
Jan. 31, 2010
Year Ended
Dec. 31, 2009
Jun. 30, 2009
Document and Entity Information
 
 
 
Document Type
 
8-K 
 
Document Period End Date
 
12/31/2009 
 
Amendment Flag
 
FALSE 
 
Entity Registrant Name
 
3M CO 
 
Entity Central Index Key
 
0000066740 
 
Entity Current Reporting Status
 
Yes 
 
Entity Voluntary Filers
 
No 
 
Current Fiscal Year End Date
 
12/31 
 
Entity Filer Category
 
Large Accelerated Filer 
 
Entity Well-known Seasoned Issuer
 
Yes 
 
Entity Common Stock, Shares Outstanding
711,733,377 
 
 
Entity Public Float
 
 
$ 42.0 
Document Fiscal Year Focus
 
2009 
 
Document Fiscal Period Focus
 
FY